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OLD MAN 
 
Old man is walking. 
Has a dream in his pocket 
which he eats when he is hungry. 
 
Old man is thinking 
Thinks to force impossibility 
Which he couldn’t do when he is child. 
 
Old man is looking 
Has a view in his mind 
Which no body can see the same. 
 
Old man is smiling 
Smiles because he has just frozen the time 
Which is not more than his age. 
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GED   GTPase effector domain 
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BSA    bovine serum albumine 
FCS    fetal calf serum 
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PH    pleckstrin homology domain 
EG   Effector genes 
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SDS-PAGE   SDS polyacrylamide gel electrophoresis 
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                                                                                                                                                               Introduction 
 1
I.INTRODUCTION 
 
Life on earth began about 3.5 billion years ago from a single replicating unit (Schopf, 
1993). From the Precambrian period until now life is represented by more than 1.5 million 
described species and the actual number of species is expected to be more than 10 million 
(Wilson, 2000). From Larmarck and Darwin on, nearly all of the leading evolutionary 
biologists believed that main source of this complex diversity of life is evolutionary change. 
As summarized by Dobzhansky: “nothing makes sense in biology except in the light of 
evolution,” Evolution in biology is defined as change in diversity and adaptation in 
populations of organisms (Mayr, 1978) (Dobzhansky, 1973). However, how the evolutionary 
changes have been maintained since the beginning of life is a hard question that may never be 
answered completely (Lewontin, 2002). Natural selection, the primary causal influence of 
phenotypic evolutionary changes, is the basis of adaptation (Dobzhansky, 1982), (Mayr, 
2001), (Lewontin, 1978). Thus, organismal diversity is directly dependent on adaptation of 
organisms to different conditions occurring throughout the course of evolution.  
Adaptive capability of organisms underlies the genetic composition of population as 
well as environmental interactions and varies from species to species (Dobzhansky, 1982), 
(Lewontin, 1978). The degree of adaptation is especially important in the co-evolutionary 
process where two organisms have direct and dynamic interactions with each other, as in host-
pathogen interaction. In host pathogen interaction, two independent organisms with their 
specific adaptation capacity become adaptively interrelated and they start evolving under the 
selective conditions imposed by each on the other. As a result, both organisms pose 
continuous positive or negative selection force on each other. Perhaps this is one of the most 
effective processes at speciation, since fluctuation of two organisms in a population must be 
continuous from the beginning of their interaction (Haldane, 1949; Rausher, 2001b).  
 
I.1.Host-Pathogen Coevolution 
 
Host pathogen coevolution is the parasitic exploitation of one organism by another. 
This kind of coevolution requires direct interaction of two species with each other as in a 
never ending battle. 
It was Haldane (Haldane, 1949) who first stated that host-pathogen interactions 
generate diversity both within and between species which not only keeps the species variable, 
but also leads to speciation. When the pathogen attempts to exploit resources of the host, it 
gets a tremendous selective pressure, and conversely defense against the pathogen drives 
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selective pressure on pathogen (Rausher, 2001b; Summers et al., 2003). This antagonistic, and 
direct relationship brings high fitness costs for both the pathogen and the host (Tian et al., 
2003) (Rigby et al., 2002). To avoid this high cost for survival both organisms (pathogen and 
host) prefer to undergo coadaptation. It is expected that host and pathogen coadapt to each 
other in two different ways. The first way follows from directional selection leading to an 
arms races and the second way from heterozygote advantage or negative frequency dependent 
selection, leading to population diversity and transmission problems for the pathogen 
(Rausher, 2001a; Summers et al., 2003).      
Arms races can be any type of adaptation in order to avoid or eliminate the pathogen, 
grouped under organisms undergoing external coevolution such as increase in fitness, change 
in structure, behavior, a robust immune system and internal coevolution such as recognition, 
destruction of pathogen at the cellular level (Fig 1). The escalating arms races generally lead 
to low level of polymorphism, whereas the negative frequency dependent selection gives 
higher level of polymorphism since it is working in a statistical way at the populational level.  
 
Figure 1. Host-parasite interactions (Rigby et al., 2002),  
Parasites infect a host by penetrating thorough the external defenses five different ways (indicated by the purple 
rugby shirts on the front line players). The internal defenses system represented by cell autonomous immunity; 
recognition system and effector system (see below) must be defeated (represented by the yellow rugby shirts on 
the back line) fight with the parasites before the onset of an infection. On the other hand, adaptive evolution by 
arms race can either be at the level of the above described external or internal defense systems. Cartoon by Neil 
Smith. 
As it is already stated by Haldane “it is much easier for a mouse to get a set of genes 
which enabled it to resist Bacillus typhimurium than a set which enabled it to resist cat” 
(Haldane, 1949). Organismal internal coevolution, also named as molecular coevolution, is 
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the first step in the process of coadaptation. It is very different from the organismal external 
coevolution, which usually entails high fitness costs. During host pathogen interaction the 
host tries to reduce the attacks from the pathogen by building a proper defense system, which 
increases the organism’s fitness. This leads to generation of organismal diversity as seen in 
the large differences in resistance between different breeds of mice to a variety of pathogens 
(Haldane, 1949).  
Molecular coevolution (internal defense system) derived by arms races can be 
explained in two different ways: the first being gene to gene type of molecular coevolution 
mainly established by early studies on plant-pathogen interaction especially crop plants (Flor, 
1971; Summers et al., 2003). In this type of interaction, there are multiple loci in both host 
and pathogen. For each locus in the host, there is a corresponding locus in pathogens. This 
type of interaction is usually related with low level of polymorphism. The second type is 
called as matching allele type molecular coevolution, mainly dependent on higher rate of 
polymorphism (Frank, 1994). Antagonistic host pathogen interactions are maintained by 
corresponding loci on each side. In both host and pathogen, there are multiple resistance 
alleles and virulence alleles respectively. If the pathogen allele matches with resistance allele 
in the host, then resistance to pathogen is induced. When the pathogens interact with the host, 
they have to be first recognized and then eliminated.  
In a classical battle between two enemies, there are two crucial steps, information, and 
destruction of the enemy. In order to eliminate your enemy, you have to have better 
information (self-nonself discrimination) and available army to destroy your enemy. Thus, 
there must be two steps for direct or indirect antagonistic interaction suggesting that two steps 
for adaptation. As a result, arms races are performed in two steps; firstly, information 
exchange between two species (pathogen and host indicated by number 1 in figure 2 ) and 
second, is function of host effectors which induce the elimination of the pathogen (indicated 
by number 2 in figure 2) (Trowsdale and Parham, 2004) (Rausher, 2001a; Rausher, 2001b).  
Pathogens evolve to defend themselves by various mechanisms such as specialized 
mechanisms forming a high rate of diversification, by mimicking the host system, escaping 
the host recognition system (antigenic drift) and interfering with the host defense 
mechanisms. Host learns to get the information from the pathogen to distinguish self from 
nonself by using combination of highly variable recognition systems which leads to 
elimination of the pathogen by generating powerful and alternative destruction system 
thorough subsequent signaling pathways (Fig 2) (Berriman et al., 2005; Borst, 2002; Rausher, 
2001b; Trowsdale and Parham, 2004) (Charles A. Janeway  2005; Galan and Bliska, 1996). 
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Figure 2. Simplified scheme of the host-pathogen coadaptation at the molecular level. 
Arrows marked by number 1 indicates the recognition system and number 2 indicates the host effectors 
upregulated by recognition system (1). Pathogens are first recognized and the genes or gene families are induced 
by subsequent signaling pathways. Pathogen which is not recognized or destroyed by the host can multiply 
(blue). Whereas pathogen which is recognized or destroyed by the host cannot survive (red). By antagonistic 
direct interactions, host-pathogen coadaptation may occur as indicated in red colors for both pathogen and the 
host.  
A striking example of arms races between a virus and host immunity is the murine 
cytomegalovirus; In susceptible mice, to turn off host NK cells, murine cytomegalovirus 
expresses a substitute class I molecule, m157, that binds to inhibitory receptor Ly49i, whereas 
resistant mice encodes an activating receptor, Ly49h, providing a counter strategy. These two 
receptors are highly homologous to each other suggesting that they have common 
evolutionary origin and evolved in response to selective pressure imposed by the pathogen 
(Vivier and Biron, 2002).  
It is likely that the possession of a good destruction or invasion system for host and 
pathogen creates a high fitness cost under certain conditions. Otherwise one side would go to 
fixation, as is the case for fitness cost for having proper defense against pathogen  (Rigby et 
al., 2002), (Burdon and Thrall, 2003). For example, plasma membrane protein in A. thaliana, 
RPM1, is responsible for recognition of P. syringae (pathogen for plants). Susceptible 
inviduals lack the entire coding region of RPM1 and both susceptibility and resistance alleles 
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frequently occur together within natural populations. Tian et al., generated independent 
transgenic lines carrying RPM1 and showed that all the transgenic plants have fitness loss 
such as 9% reduction in total seed production (Tian et al., 2003). Similarly, Mx1 is resistance 
factor against variety of viruses in mouse such as influenza A and B (see below). The mouse 
carrying Mx1- allele is susceptible to influenza virus. The standard laboratory mouse strains all 
carry the Mx1- allele except A2G and SL/NiA mice. However, wild mice possess the Mx+ and 
Mx- alleles at roughly equal frequencies (Staeheli et al., 1988), (Haller et al., 1987), (Jin et al., 
1998a). This suggests that Mx1 gene like RPM1 might create high fitness cost. However, there 
is no direct evidence for the fitness cost specific to Mx1 gene in mice. 
The battle between host and pathogen is mainly carried out by molecular interactions. 
These interactions reflect the co-evolutionary balance that the host and pathogen must reach 
in order to secure their survival. Such interactions are usually maintained by the proteins 
which are encoded on single genes or gene family in one or multiple locus in both. The genes 
underlying the host defense includes the substantial proportion of the genome. It is estimated 
that in Arabidopsis, 14 % of the 21000 genes are directly related to pathogen resistance,  and 
in mice 50 loci distributed over 17 chromosomes are known to be involve in resistance against 
retroviruses alone. It is reported that at least 1000 genes are upregulated upon interferon 
stimulation in mouse (Bevan et al., 1998),(Bishop et al., 2000), (O'Brien, 1988), (Boehm et 
al., 1997).  
The fate of a gene sequence or gene family through evolutionary time is determined by 
a combination of processes. Random genomic events, mutation, recombination, duplication, 
transposition and loss under the selective processes whether neutral or natural, determine the 
trajectory of the sequence and its derivatives through the generations. Since neither the 
genomic processes, nor the selective fate of their derivatives are replicated in multiple 
evolving lineages, the representation of an ancient gene in modern descendent groups of 
organisms can be surprisingly various. This is extreme in immunity related genes whose 
products contribute to host pathogen resistance  
 
I.2.Immunity and Immunity Related Genes 
 
Immunity is the state of protection from infections and tumors. The recognition of the 
pathogen by the immune system results in the induction of defense mechanisms leading to the 
destruction of the infectious agents. The defense mechanism is highly dependent on the 
infectious agent, usually fast evolving, because of the short generation time and high adaptive 
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capacity. Therefore, immunity related genes are frequently rapidly evolving, resulting in 
formation of different mechanisms and complex systems to fight against infectious agents.   
Organisms especially the higher eukaryotes have generated two distinct types of 
immune systems. The effector immune mechanism, clearly first recognized by Janeway 
(Janeway, 1989) we call today as innate immunity. Recent studies reveal that some forms of 
innate immunity are present almost in all types of eukaryotes (Medzhitov and Janeway, 2000) 
(Hoffmann et al., 1999) (Janeway, 1989). Vertebrates have an additional highly sophisticated 
immune mechanism, generating adaptive immunity (Pancer et al., 2004), (Flajnik and Du 
Pasquier, 2004). In adaptive immunity, specified cell clones devoted to defense have an 
ability to recognize different subtypes of pathogens. Although, it is not possible to separate 
these two immune systems completely, the most striking difference between adaptive and 
innate immunity is in the generation of recognition systems. In the innate immune system 
recognition is mediated by germ line encoded receptors (e.g. TLR (Medzhitov and Janeway, 
1999) (Kimbrell and Beutler, 2001), NOD (Ogura et al., 2001), Scavenger Receptors 
(Pearson, 1996)). This means that the specificity of receptors is genetically predetermined. 
These receptors can recognize patterns that are general to pathogens such as lipopolysaccaride 
(LPS)/Pathogen associated molecular patterns (PAMPs). Therefore, pathogen recognition 
receptors (PRR) are essential players in innate immunity. However, the recognition systems of 
adaptive immunity are generated during the development of T and B cell populations by 
somatic recombination. This process leads to the generation of very large and extremely 
diverse cell populations, which varies from individual to individual (Kimbrell and Beutler, 
2001), (Flajnik and Du Pasquier, 2004).   
To emphasize the distinction between these two mechanisms, I would like to pose a 
question: “What were the evolutionary pressure that selected for the development of these two 
sets of receptors and the two distinct recognition mechanisms they employ?” (Janeway, 1989) 
The answer lies with the terms for coadaptation of host and pathogen. If your enemy has a 
high capacity to change its strategy (for example, to escape host immune response, the 
African trypanosomes regularly changes their coat (antigenic variation) (Borst, 2002) 
(Berriman et al., 2005) (Charles A. Janeway Jr., 2005)), you need to have such system to be 
ready for the new approach followed by your enemy. Host must have enough genetic 
variation so that the species can change as fast as the pathogen. As a rule for adaptation “if the 
genetic variation is inadequate, the species will become extinct (Lewontin, 1978).” It is 
impossible to code for such a wide variety of receptors genetically. Additonally, as mentioned 
earlier, the genes encoding receptors for adaptive immunity are assembled during the 
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development of T and B cells. The enormous amount of the varaible regions of these receptors 
could potentially recognize many very different molecules or proteins (antigen) which are 
usually specific to the pathogens. The adaptive immune response very specific when 
compared to innate immunity which is known as non-specifically acting immune mechanism. 
Therefore, to generate wide variety of receptor repertoire by somatic recombination must be a 
big advantage for the host to fight against pathogens, which usually have high evolving 
capacity. 
 A recent study shows that the adaptive system arose at two time points during the 
course of evolution (Beutler, 2005), (Pancer et al., 2004). Immunoglobulins (IGs) are the 
effector molecules of adaptive immune system. They occur either as membrane-bound cell 
surface receptors or as free antibodies. T cell (TCR) and B cell (BCR) receptors are generated 
using the IGs during the development of lymphocytes. However, receptor components of 
innate immunity are composed of leucine rich repeats (LRRs) which are germline encoded. It 
was shown by Pancer et al., that like the IGs, LRRs are used to generate variable receptors by 
somatic recombination in lamprey fish. This clearly shows that receptor components for 
innate immunity can be also used for adaptive immunity and it suggests that during the host 
pathogen coevolutionary process lamprey fish used another evolutionary trajectory to generate 
its adaptive immunity to get high level information.       
Innate immunity is present in all higher eukaryotes (Medzhitov and Janeway, 2000). 
Clearly, invertebrates and plants can survive without any adaptive immune mechanism 
(Hoffmann et al., 1999) and hence, innate immunity might be the most important immune 
system acting against pathogens in a wide range than adaptive immunity. One of the very well 
known families of innate immune receptors, which exist in vertebrates and invertebrates, are 
Toll like receptors (TLR). The Toll receptor was first discovered in a screen for dorso-ventral 
patterning in Drosophila (Anderson and Nusslein-Volhard, 1984). It took more than ten years 
to find out that in the adult fly the toll receptors have immune function especially to fungal 
infections (Lemaitre et al., 1996). Subsequently mammalian homolog, TLR was shown to be 
involved in immunity (Medzhitov et al., 1997). The analyses of genetic and physical mapping 
of LPS locus in C3H/HeJ and C57BL/10ScCr mice led to the discovery of TLR4 (Poltorak et 
al., 1998). Moreover, mice with a targeted deletion for the TLR4 gene were unresponsive to 
LPS (Hoshino et al., 1999) and it was shown that TLR2 and TLR4 play differential roles in 
the recognition of gram positive and gram-negative bacteria (Takeuchi et al., 1999). All 
members of the Toll family are single membrane-spanning proteins and their extracellular 
domains are composed of leucine rich repeats (LRR) which recognizes pathogen associated 
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molecular patterns (PAMPs) such as LPS, flagellin. So far, 23 members of the Toll family 
have been described both in vertebrates and invertebrates (Roach et al., 2005).  
The plant recognition systems use similar receptors. The plant recognition receptors 
are classified as nucleotide binding receptors and leucine rich repeats (NBS-LRRs) which 
show significant similarity to NOD receptors in mammals (Ausubel, 2005). For example, 
FLS2 corresponds functionally to TLR5 in mammals which is flagellin receptors but FLS2 
and TLR5 recognize different epitopes in flagellin protein. Similarly, RPM1, RPP5 (receptor 
proteins from Arabidopsis) are known to take part in immunity and have LRR containing 
domains (Staskawicz et al., 2001). However, the innate immune system in plants is more 
specialized than mammalia. As in the case of rice Xa21 gene, a transmembrane protein 
containing extracellular LRRs recognize species specific secreted molecule from 
Xanthomonas oryzae rather than broadly conserved PAMPs (Ausubel, 2005) (Fritig et al., 
1998) (Kimbrell and Beutler, 2001) (Kayihan et al., 2005). Innate immune system is the first 
system encounter for the pathogen (within first second to hours of entry) and is considered to 
be responsible for the induction of adaptive immunity (Medzhitov and Janeway, 1999) which 
takes several days longer.  
Cell autonomous immunity, an effector mechanism in innate immunity is a newly 
introduced term, describing the ability of individual cells (including non-immune cells) to 
destroy intracellular pathogens in a cell autonomous manner. In the first instance, the 
pathogens are recognized by the PRRs. Recognition mobilizes specific destruction systems by 
the activation of several signaling pathways within cells. A variety of molecules protect cells 
in different ways. The mechanisms for cell autonomous regulation has been described for  
PKR (Tanaka and Samuel, 1994), 2’-5’ Oligoadenylate synthesize (Mashimo et al., 2003), Mx 
(Schwemmle et al., 1995), IDO (Pfefferkorn, 1984),  iNOS (MacMicking et al., 1995), 
LRG47 (Collazo et al., 2001), gp91-phox (Nathan et al., 1983) which act intracellularly. 
These genes will hence be referred to as effector genes (EGs) see fig 2 and 3. 
These sets of EGs are either inducible by direct signaling events within the cell or by 
cytokines which activate signaling events in almost any type of cells in the host resulting in 
induction of EGs.  
Cytokines are proteins secreted by cells upon infection or tissue damage. Interferons 
are a class of cytokines responsible for managing host defense against pathogens by activating 
cells upon infection (Fig 3). They can be classified into three kinds, type I IFNs (ifn-α,β,ω,τ), 
type II IFNs (ifn-γ) and recently identified type III IFNs (ifn-λ) (Stark et al., 1998), (Kotenko 
et al., 2003), (Boehm et al., 1997), (David, 2002). While IFN γ is mainly secreted by natural 
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killer and activated T cells (Th1 and Tc1), the interferon receptors are expressed in nearly all 
types of cells. Differential screens and expression analysis indicate (Boehm et al., 1997) that 
thereby regulating more than 800 genes constituting a specific and complex defense 
protecting cells (Boehm et al., 1997) (Dar et al., 2005) . 
 
 
Figure 3. Simplified scheme for the type I and type II interferon signal transduction pathways. 
Cytokines bind to their respective receptors and trigger the signalling pathways via phosphorylation of Stat1, 
Stat2 by Jak1, Jak2, and Tyk2. Activated Stat1 and Stat 2 homodimerize (Type II signaling) or hetoridimerize 
(Type I signaling) and interact with p48 (IRF9) to form ISGF3 complex. Activation of subsequent genes occurs 
via binding of Stat1 homodimer or the ISGF3 complex to GAS and ISRE sequences, respectively. IFNs induce 
set of genes or gene families, that are involved in inhibiting intra- and/or extracellular propagation of virus, 
bacteria and protozoa. Modified after (Taylor, 2004) and (Stark et al., 1998).  
 
I.3.Interferon Inducible GTPases 
 
Among the plethora of interferon-inducible genes, the importance of the GTPases will be 
emphasized because of their abundance as well as their functions. These include the Mx 
family of GTPases (Lindenmann et al., 1963), Guanylate binding protein (GBP) family 
(Cheng et al., 1985), very large inducible GTPase (VLIG) (Klamp et al., 2003) and the p47 
GTPase family (Boehm et al., 1998). These GTPases have similar biochemical characteristics 
and functions to the dynamin family of GTPases. These proteins are characterized by their 
ability to oligomerize and can display oligomerization-dependent stimulation of GTP 
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hydrolysis (Warnock et al., 1996). Thus, here they will be grouped as dynamin like GTPases 
(Praefcke and McMahon, 2004). Though, their phylogenetic relationship is not resolved. 
 
I.4.Dynamin Family of GTPases 
 
Dynamins are GTPases with a molecular weight of about 100 kDa having an N-terminal GTP 
binding domain, a middle coiled coil domain, a pleckstrin homology (PH) domain involved in 
binding to phosphoinositides, a GTPase effector domain (GED) which is important for 
oligomerization, and a C-terminal proline rich domain (PRD) that interacts with SH3 domain 
containing proteins (Praefcke and McMahon, 2004), (Vestal, 2005), (Song and Schmid, 
2003). 
Dynamin and dynamin-like GTPases are involved in many processes in the cell. Dynamin1 
plays a major role in the endocytic pathway by the scission of clathrin-coated vesicles from 
the plasma membrane. They are generally classified as large GTPases since they differ in size 
and function from the small GTPases like the Ras superfamily (p21 ras, an oncogene, which is 
very well characterized with respect to its GTPase properties and function). However, the 
mechanism of action of dynamin has not been resolved. Dynamin functions either as 
mechanochemical enzyme or regulatory enzyme or both; dynamin behaves as 
mechanochemical enzyme using the energy of GTP hydrolysis to sever vesicles. It differs 
from the other regulatory GTPases such as ras which upon GTP binding, interacts with 
several effector molecules, thereby inducing and performing their respective functions in the 
cell. Dynamin uses the PH domain to bind to membranes, and through the SH3 domains, 
binds to several effector molecules essential for its endocytic function (Song and Schmid, 
2003). 
The members of the dynamin family are found in prokaryotes and eukaryotes. Its 
function diversifies within the cell from cell division to vesicle scission. Drosophila dynamin 
was the first dynamin to be described, recognized via a temperature sensitive mutant in a 
locus called “shibire”. Since then many members of the family with similar characteristics 
have been discovered. 
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Figure 4. Phylogeny of dynamin and dynamin-like GTPases 
Maximum Parsimony tree based on the G-domain of selected dynamin related proteins generated using  clustal-
X 1.83 (Matrix blosum) for multiple alignment, Mega3.1 for phylogenetic tree construction and bootstrap test. 
G-domain is defined according to Hs-Ras-1. Bootstrap values were indicated in black on the branch point. Black 
and green colored labels indicate the accession numbers and name of the gene, respectively. The blue highlighted 
genes are found to be inducible by interferon. The species names are abbreviated as Hs (Homo sapiens), Mm 
(Mus musculus), Bt (Bos taurus), Cf (Canis familiaris), Ss (Sus scrofa), Gg (Gallus gallus), Dr (Danio rerio), Xt 
(Xenopus tropicalis), Ce (Caenorhabditis elegans), Am (Apis mellifera), Dm (Drosophila melonogaster), Mt 
(Mycobacterium tuberculosis), Tr (Takifugu rubripes), Dd (Dictyostelium discoideum), Sc (Saccharomyces 
cerevisiae), Tb (Trypanosoma brucei), Ec (Escherichia coli), At (Arabidopsis taliana), Os (Oryza sativa). 
 
All P-loop GTPases are classified into two main groups: TRAFAC-(GTPase similar to 
translation factors) and SIMIBI-(GTPase similar to signal recognition particle) according to 
their relationship with translation and signal transduction respectively (Leipe et al., 2002). 
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The dynamin family belongs to the TRAFAC family of P-Loop GTPases according to the 
Leipe classification (Leipe et al., 2002). They also showed that the dynamin like subfamily of 
P-loop GTPases is represented early in the eukaryotic branch. The branch reaches to the 
LUCA (Last Universal Common Ancestor of the extant life forms) suggesting that they 
emerged at the beginning of eukaryotic evolution. Based on the similarity in the mechanism 
of action (see below), the origin of the dynamins can be linked to the septin family of 
proteins, important for cell division (Field et al., 1996), (van der Bliek, 1999). Septins are 
necessary for cytokinesis in budding yeast and drosophila. They have an N-terminal GTP 
binding domain and C-terminal domain which show similar functions to the dynamins (Field 
et al., 1996).  
The dynamin and dynamin like GTPases are also found in plants and invertebrates fig 4 
(Praefcke and McMahon, 2004). At least four members of this family are massively inducible 
by interferons: The guanylate binding protein (GBP), Mx, VLIG and the p47 (IRG) family of 
GTPases (light blue highlighted in phylogeny Fig 4.). Since the inducible dynamin-like 
GTPases are major players in cell autonomous immunity, there is no reason to believe that 
these proteins should not be present in invertebrates and one expects that these genes act in 
the same way they act in mammals. In fact, we know that members of the GBP family are 
present in invertebrates, and some of the representatives of Mx GTPases have also been found 
in plants (Hong et al., 2003) (Dombrowski and Raikhel, 1995). Interestingly, for the p47 
GTPases, no homologs have been found in invertebrates and plants (see discussion). It is most 
likely that genes evolved with the mechanism of immune response, under different selection 
pressures (coevolution) leading to their disappearance from some of the main branches of the 
eukaryotes.  
GBPs are induced by type I and type II interferons. The first GBP members cloned 
were HuGBP-1 and HuGBP-2 (Cheng et al., 1991). This family now comprises five members 
described in human and mouse. GBP-1 has a mass of about 67-kDa and has a unique property 
of binding to GMP, in addition to GTP and GDP (Cheng et al., 1985). hGBP1 has the 
canonical GTP binding motifs important for coordinating the binding of guanine nucleotides 
except for G4 motif, which is different from other GTPases (Praefcke et al., 1999). 
Biochemically, it has an ability to oligomerize upon binding to GTP (dimer), GDP-AlFx 
(tetramer) and shows at least eight fold increase in GTP hydrolysis upon multimerization 
(Prakash et al., 2000) (Praefcke et al., 1999). Recent analysis showed that hGBP-1 can target 
specifically to Golgi membrane in its GDP-AlFx bound form (Modiano et al., 2005). 
Although GBPs are massively induced by interferons, their function as resistance factors has 
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not been established. However, it has been reported that hGBP-1 shows an inhibitory effect 
(40-60%) on EMCV and VSV replication in cultured HeLa cells (Anderson et al., 1999). 
However, 35 out of 46 different mouse strains showed inability to express murine GBP-1 
upon induction by type I or type II interferon, and no viral susceptibility was observed 
between the expressing and non-expressing strains. Since the GBP family contains 5 
members, no viral susceptibility can be linked to redundant function of the individual GBP 
proteins (Staeheli et al., 1984) (Vestal, 2005). Additionally, it is reported that hGBP-1 has 
growth inhibitory effect on endothelial cells and alter the adhesive invasive properties of the 
cells (Guenzi et al., 2001).  
The Mx family of resistance GTPases, especially human MxA,  has been shown to be 
involved in resistance against a wide variety of viruses such as bunyaviruses, 
orthomyxoviruses, paramyxoviruses, rhabdoviruses, togaviruses, picornaviruses and hepatitis 
B virus  (Gordien et al., 2001; Haller and Kochs, 2002; Janzen et al., 2000; Kochs and Haller, 
1999). Mx proteins are mainly induced by type I interferon. The mouse Mx1 gene encodes 
interferon inducible nuclear protein. As mentioned above, only two lab mouse strains (A2G 
and SL/NiA) carry the Mx1+ allele and are resistance to the influenza virus. Whereas all the 
other laboratory mouse strains carry Mx1- allele and susceptible to influenza virus (Staeheli et 
al., 1988) (Jin et al., 1998a). In contrast to laboratory strains, it was shown by Haller et al., 
that wild  mice carry the both alleles at equal frequencies (Haller et al., 1987). This suggests 
that Mx proteins are under the control of balancing selection which can possibly be explained 
by general fitness cost for resistance genes (Rigby et al., 2002). Like GBP-1, Mx proteins also 
contain an N-terminal GTP binding domain, middle domain and C-terminal domain which has 
GED activity. It has low affinity to GTP when compared to ras like GTPases and high rate of 
GTP hydrolysis following general characteristics of  dynamin-like GTPases (Haller and 
Kochs, 2002; Schumacher and Staeheli, 1998). It has also been shown that human Mx1 and 
MxA protein can form higher oligomeric structures (Melen et al., 1992) (Kochs et al., 2002a). 
However, for the antiviral activity of MxA, formation of large oligomeric structures is not 
necessary (Janzen et al., 2000). Recent studies show that MxA specifically recognizes and 
sequesters the LaCrosse viral (LACV) N protein into large perinuclear complexes and 
oligomeric MxA/N complexes are formed in close association with COP-I-positive vesicular-
tubular membranes (Kochs et al., 2002b),(Reichelt et al., 2004).  
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I.5.The Family of p47 GTPases 
 
 The p47 GTPases are a family of GTPases which is massively induced by interferon gamma 
(Boehm et al., 1998). The proteins have an N-terminal region, GTP binding domain and 
highly variable C-terminal region, which might be important for intracellular localization and 
oligomerization (see discussion). The GTP binding domain of the p47 GTPases has all three 
classical GTP binding motifs (Fig 5). Apart from G domain, p47 GTPases have no homology 
to other GTPases. Both N and C-terminal region have characteristic features which 
distinguish this family from other P-loop GTPases (Fig 4, 5 and  see below). IRG 47, isolated 
as a cDNA from B cells, was the first member to be described (Gilly and Wall, 1992). So far, 
six of the members have been studied in some detail (Boehm et al., 1998) (Taylor, 2004). At 
least four of them have been analyzed functionally by targeted gene knockout experiments 
(Table 1) (Taylor et al., 2000) (Collazo et al., 2001) (Parvanova, 2005) (Taylor, 2004). 
Targeted gene knock-out experiments revealed that the p47 GTPases family is indeed 
involved in resistance against wide variety of pathogens in a non-redundant way (see Table 1) 
(Taylor, 2004). The phenotype of the knock out mice for LRG47 and IGTP were very 
striking, showing early death upon infection by Toxoplasma gondii (within first 10 days p.i.) 
suggesting that these p47 resistance proteins may be the strongest resistance system in mouse. 
They can be grouped into two structural subfamilies, named GMS and GKS, based on a 
remarkable substitution in the G1 motif (Fig 4 and 5). The GMS proteins LRG47, IGTP and 
GTPI (GMS subfamily) carry methionine instead of lysine in their G1 motif. This substitution 
is a unique feature of the p47 GTPases family. All the P-Loop GTPases have the canonical 
lysine important for the coordination of the phosphates in the nucleotide. The GMS subgroup 
of p47 GTPases also contains 12 additional specific amino acid  substitutions in their G-
domain relative to the members of the GKS subfamily; IIGP1, TGTP1, IRG47 (Fig 5). 
Biochemical analysis of recombinant IIGP1 shows low affinity to GTP, slow rate of GTP 
hydrolysis, co-operative GTP hydrolysis with ability to form oligomers in a GTP dependent 
manner (Uthaiah et al., 2003). The crystal structure of IIGP1 (Fig 6) (Ghosh et al., 2004) 
shows three N-terminal α-helices followed by a G-domain, which is structurally similar to 
GTPase domain of Ras. The G-domain is linked to the C-terminal domain by a short  linker 
helix (αE) and the C-terminus contains seven α helices. Based on homology within the family 
and analysis by secondary structure prediction programs, we can clearly say that IIGP1 is 
likely to be structurally representative of all p47 GTPases. Granted, the similarity in the 
biochemical characteristics, and sequence analysis, the p47 GTPase family can be grouped 
into the dynamin like GTPases. The p47 GTPases are emerging as important cell autonomous 
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resistance molecules. LRG-47 deficient mice (LRG-47-/-) have increased susceptibility to M. 
tuberculosis. Moreover, Macropahges isolated from LRG-47-/- mice showed arrested 
maturation of phagosomes containing M. tuberculosis (MacMicking et al., 2003). Recently, 
Martens et al., reported that astrocytes isolated from IIGP1 deficient mice have increased 
susceptiblity to T. gondii (Martens S, 2005). In the resting level, LRG-47 localizes to the 
Golgi apparatus and is recruited to the plasma membrane upon phagocytosis whereas IIGP1 is 
an endoplasmic reticulum associated protein in fibroblast, hepatocyte and macrophages 
(Martens et al., 2004). Recent analysis showed that upon infection by T. gondii TGTP, IIGP1, 
IRG47, GTPI and IGTP are accumulated on the parasitophous vacuole (Martens S, 2005). 
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                    1        10        20        30        40        50        60 
                    |        |         |         |         |         |         | 
IIGP1      1 ---------------MGQLFSSPKSDENNDLPSSFTGYFKKFNTGRKIISQEILNLIELRMRKGNIQLTNSAISDALKEI 
TGTP1      1 ----------------------------MAWASSFDAFFKNFKRESKIISEYDITLIMTYIEENKLQKAVSVIEKVLRDI 
IRG-47     1 ----------MDQFISAFLKGASENSFQQLAKEFLPQYSALISKAGGMLSPETLTGIHKALQEGNLSDVMIQIQKAISAA 
GTPI       1 -------MPTSRVAPLLDNMEEAVESPEVKEFEYFSDAV-FIPKDGNTLSVGVIKRIETAVKEGEVVKVVSIVKEIIQNV 
IGTP       1 MDLVTKLPQNIWKTFTLFINMANYLKRLISPWSKSMTAGESLYSSQNSSSPEVIEDIGKAVTEGNLQKVIGIVKDEIQSK 
LRG-47     1 -------MKPSHSSCEAAPLLPNMAETHYAPLSSAFPFVTSYQTGS-SRLPEVSRSTERALREGKLLELVYGIKETVATL 
H-Ras-1    1 -------------------------------------------------------------------------------- 
 
 
  
 
                70        80        90         100       110       120             130 
                              |          |         |          |        |         |               |        
IIGP1     66 DSSVLNVAVTGETGSGKSSFINTLR-GIGNEEEGAAKTGVVEVTMERHPYKH-PNIP----NVVFWDLPGIGSTNFPPNT 
TGTP1     53 ESAPLHIAVTGETGAGKSTFINTLR-GVGHEEKGAAPTGAIETTMKRTPYPH-PKLP----NVTIWDLPGIGTTNFTPQN 
IRG-47    71 ENAILEVAVIGQSGTGKSSFINALR-GLGHEADESADVGTVETTMCKTPYQH-PKYP----KVIFWDLPGTGTPNFHADA 
GTPI      61 SRNKIKIAVTGDSGNGMSSFINALR-LIGHEEKDSAPTGVVRTTQKPTCYFS-SHFP----YVELWDLPGLGATAQSVES 
IGTP      81 SRYRVKIAVTGDSGNGMSSFINALR-FIGHEEEESAPTGVVRTTKKPACYSSDSHFP----YVELWDLPGLGATAQSVES 
LRG-47    73 SQIPVSIFVTGDSGNGMSSFINALR-VIGHDEDASAPTGVVRTTKTRTEYSS-SHFP----NVVLWDLPGLGATAQTVED 
H-Ras-1    1 -MTEYKLVVVGAGGVGKSALTIQLIQNHFVDE----YDPTI-----EDSYRKQVVIDGETCLLDILDTAGQEEY---SAM 
                      GXXXXGK/MS          SWI                    DXXG/SWII 
                           G1                      G2                            G3 
  
 
 
                  150       160      170       180       190       200       210        
                          |         |               |         |         |        |         |         
IIGP1    140 YLEKMKFYEYDFFIIISATRFK------KNDIDIAKAISMMK-KEFYFVRTKVDSDITNEADGKPQTFDKEKVLQDIRLN 
TGTP1    127 YLTEMKFGEYDFFIIISATRFK------ENDAQLAKAIAQMG-MNFYFVRTKIDSDLDNEQKFKPKSFNKEEVLKNIKDY 
IRG-47   145 YLDQVGFANYDFFIIISSSRFS------LNDALLAQKIKDAG-KKFYFVRTKVDSDLYNEQKAKPIAFKKEKVLQQIRDY 
GTPI     135 YLEEMQISIYDLIIIVASEQFS------LNHVKLAITMQRMR-KRFYVVWTKLDRDLSTS------TFPEPQLLQSIQRN 
IGTP     156 YLEEMQISTFDLIIIVASEQFS------SNHVKLAITMQRMR-KRFYVVWTKLDRDLSTS------TFPEPQLLQSIQRN 
LRG-47   147 YVEEMKFSTCDLFIIIASEQFS------SNHVKLSKIIQSMG-KRFYIVWTKLDRDLSTS------VLSEVRLLQNIQEN 
H-Ras-1   68 RDQYMRT--GEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVE----------------SRQ 
                       N/TKXD                                                  
                                          G4                                         
 
 
 
              220       230       240       250       260       270       280       290 
                  |         |         |         |         |         |         |         |  
IIGP1    213 C-VNTFRENGIAEPPIFLLSNKNVCHYDFPVLMDKLISDLPIYKRHNFMVSLPNITDSVIEKKRQFLKQRIWLEGFAADL 
TGTP1    200 C-SNHLQESLDSEPPVFLVSNVDISKYDFPKLETKLLQDLPAHKRHVFSLSLQSLTEATINYKRDSLKQKVFLEAMKAGA 
IRG-47   218 C-VTNLIKTGVTEPCIFLISNLDLGAFDFPKLEETLLKELPGHKRHMFALLLPNISDASIELKKHFLREKIWLEALKSAA 
GTPI     202 I-RDSLQKEKVKEHPMFLVSVFKPESHDFPKLRETLQKDLPVIKYHGLVETLYQVCEKTVNERVESIKKS-IDEDNLHTE 
IGTP     223 I-RENLQQAQVRDPPLFLISCFSPSFHDFPELRNTLQKDIFSIKYRDPLEIISQVCDKCISNKAFSLKEDQMLMKDLEAA 
LRG-47   214 I-RENLQKEKVKYPPVFLVSSLDPLLYDFPKLRDTLHKDLSNIKCCEPLKTYGTY-EKIVGDKVAVWKQR-IANESLKNS 
H-Ras-1  130 A-QDLARSYGI---PYIETSAKTRQGVEDAFYTLVREIRQHKLLNPPDESGPGCMSCKCVLS------------------ 
                                SAK 
                                 G5 
 
 
                  
                       300       310       320      330        340        350           360   
                     |         |         |         |         |          |             |     
IIGP1    292 VNIIPSLTFLLDSDLETLKKSMKFYRTVFGVDETSLQRLARDWEIEVDQVEAMIKSPAVFKPT-----DEETIQERLSRY 
TGTP1    279 LATIP-LGGMISDILENLDETFNLYRSYFGLDDASLENIAQDLNMSVDDFKVHLRFPHLFAEH-----NDESLEDKLFKY 
IRG-47   297 VSFIPFMTFFKGFDLPEQEQCLKDYRSYFGLDDQSIKEIAEKLGAPLADIKGELKCLDFWSLVK-----DNSIIAQATSA 
GTPI     280 FG-IS--------DPGNAIEIRKAFQKTFGLDDISLHLVALEMKNKHFNT--SMESQETQRYQQ----DDWVLARLYRTG 
IGTP     302 VS-SE-------DDTANLERGLQTYQKLFGVDDGSLQQVARSTGRLEMGSR-ALQFQDLIKMDR---RLELMMCFAVNKF 
LRG-47   291 LG-VR--------DDDNMGECLKVYRLIFGVDDESVQQVAQSMGTVVMEYKDNMKSQNFYTLRREDWKLRLMTCAIVNAF 
H-Ras-1      -------------------------------------------------------------------------------- 
 
 
 
       
               370       380  390       400     410       
                |         |         |         |         |                   
IIGP1    367 IQEFCLANGYLLPKNSFLKEIFYLKYYFLDMVTEDAKTLLKEICLRN---------------- 
TGTP1    353 IKHISSVTGGPVAAVTYYRMAYYLQNLFLDTAANDAIALLNSKALFEKKVGPYISEPPEYWEA 
IRG-47   372 AEAFCAVKGGPESSAFQALKVYYRRTQFLNIVVDDAKHLLRKIETVNVA-------------- 
GTPI     345 TRVGSIGFDYMKCCFTSHHSRCKQQKDILDETAAKAKEVLLKILRLSIPHP------------ 
IGTP     370 LRLLESSWWYGLWNVVTRYFRHQRHKLVIEIVAENTKTSLRKALKDSVLPPEIH--------- 
LRG-47   362 FRLLRFLPCVCCC------LRRLRHKRMLFLVAQDTKNILEKILRDSIFPPQI----------     
H-Ras-1      ---------------------------------------------------------------    
 
Figure 5. Sequence Alignment of identified p47 GTPases. 
Sequences of 6 mouse p47 GTPases IIGP1 (AJ007971), TGTP1 (L38444), IRG47 (M63630), LRG47 (U19119), 
GTPI (AJ007972), IGTP (U53219) H-Ras-1 (P01112) showing close homology extending to the C-terminus, 
aligned on the known secondary structures of  IIGP1 (Ghosh et al., 2004). The unusual methionine residues in 
the G1 motif of GMS proteins are highlighted in green and GMS specific a.a. substitutions are indicated with 
green arrow. Canonical GTPases motifs are indicated in red boxes. 
 
N αC αA 310 αB
S1 H1 S2    S3 H2A 
H3 S5 H4 S4 αdH2 H2B 
H5 αE αFS6 
αH αI αJ αK αG 
αL CαK 
H4 
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Table 1. Summary of phenotype observed to different intracellular pathogens in mice lacking p47 
GTPases. 
S and R indicate susceptible and resistance respectively. N.D.: not determined. * The susceptibility effect was 
only observed in cultured cell lines (astrocytes) (Martens S, 2005) and (Parvanova, 2005). Modified after 
(Taylor, 2004) 
 
 
 
Figure 6. Crystal structure of IIGP1 in GDP bound form shown by ribbon presentation (Ghosh et al., 
2004) 
IIGP1 contains three domains, The N-terminal domain (cyan), G-domain (light blue) and C-terminal domain.  
The GTPase domain shows very similar features to the G-domain of H-Ras-1.    
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I.6.The Aim of This Study 
 
Host-pathogen interactions generate powerful evolutionary forces. Therefore, genes or 
gene families related with immunity are known to be fast evolving. Involvement of interferon 
inducible large GTPases in immunity has been described. p47 GTPases, described above, is 
one of the interferon inducible large GTPases family thought to be involved in providing cell 
autonomous immunity in mouse. Detailed analysis of six of the family members revealed that 
p47 GTPases are indeed one of the most important resistance mechanisms of the mouse 
against variety of vacuolar pathogens. Having such resistance mechanism must be a big 
advantage for an organism. However, there are no reports of p47 GTPases in man. Hence, the 
importance of p47 GTPases as a resistance mechanism in mouse is a critical theme to be 
analyzed. The analysis of six p47 GTPases working in a non-redundant way as a family led us 
to analyze the evolution of p47 GTPases. Elucidation of the functional relationship between 
the species especially for mouse seemed imperative. 
Detailed analysis of the whole p47 GTPases family was carried out both 
phylogenetically and experimentally. The conclusions reached were unexpected, to be 
presented and discussed in detail in the following sections. 
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II.MATERIALS AND METHODS  
 
II.1.CHEMICALS, REAGENTS AND ACCESSORIES 
 
All chemicals were purchased from Aldrich (Steinheim), Amersham-Pharmacia 
(Freiburg), Applichem (Darmstadt), Baker (Deventer, Netherlands), Boehringer 
Mannheim (Mannheim), Fluka (Neu-Ulm), GERBU (Gaiberg), Merck (Darmstadt), 
Pharma-Waldhof (Düsseldorf), Qiagen (Hilden), Riedel de Haen (Seelze), Roth 
(Karlsruhe), Serva (Heidelberg), Sigma-Aldrich (Deisenhofen). DNA size standards from 
Gibco-BRL (Eggenstein), electrophoresis chambers from FMC Bioproducts (Rockland Maine 
US), developing and fixing solutions for Western Blot detection from Amersham Pharmacia 
(Freiburg), Luminol from Sigma Aldrich (Deisenhofen), Coumaric acid from Fluka (Neu-
Ulm). Deionised and sterile water (Seral TM) was used for all the buffers and solutions, Ultra 
pure water from Milli-Q-Synthesis (Millipore). 
 
II.1.1.Enzymes/Proteins 
 
Restriction Enzymes and T4 DNA polymerase from New England Biolabs (Bad Schwalbach)  
“Complete Mini” protease inhibitor cocktail from Boehringer (Ingelheim). 
Pyrococcus furiosus (Pfu) DNA polymerase from Promega (Mannheim) 
Shrimp Alkaline Phosphatase (SAP) from Amersham 
Thrombin from Serva, (Heidelberg) 
RNase A from Sigma 
1Kb ladder for Agarose gels from Gibco 
Rainbow –Molecular weight marker-Precision protein standardsTM ( Biorad) 
Page Ruler Protein Marker from Fermentas 
Wide Range Protein Marker from Sigma 
 
II.1.2.Reagent Kits 
 
Plasmid Mini and Midi kit from Qiagen 
Sequencing Kit from ABI PRISM 
Total RNA and mRNA isolation kit from Qiagen 
 
II.1.3.Vectors 
 
PGW1H from British Biotech (Oxford, England) 
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pGEX-4T-2  from Amersham Pharmacia (Freiburg) 
pMALp2E from New England Biolabs (Bad Schwalbach)  
pBlueScript II KS+ from stratagene 
pGEMTeasy from Promega 
pET28b+ from Novagen 
pRSET (A,B,C) from invitrogen 
 
II.1.4.Materials for Protein Isolation 
 
Ni-NTA Superflow from Qiagen 
Amylose Resin from New England Biolabs  
GST beads from Amersham 
 
II.1.5.Media 
 
Luria Bertini (LB) Medium 
10 g Bacto Tryptone, 5 g Yeast Extract, 10 g Nacl, Distilled water to 1Litre 
LB Plate Medium 
10 g Bacto Tryptone, 5 g Yeast Extract, 10 g Nacl, 15 g Bacto Agar, Distilled water to 1Litre 
Terrific Broth (TB) Medium 
12 g Bacto Tryptone, 24 g Yeast Extract, 0.17 mM KH2PO4, 0.072 mM K2HPO4, 4 ml 
Glycerol, Distilled water 1 Litre 
IMDM (Iscove’s Modified Dulbecco’s Medium) from Gibco 
10% FCS, 2 mM 1-Glutamine, 1 mM Sodium pyruvate, 100 U/ml Penicillin,100 µg/ml 
Streptomycin, 1x non-essential amino acids. Media mainly used for the growth of L929, T2 
IRF9-/-, MEF and Hela cells. 
DMEM (Dulbeco’s Modified Eagle Medium) from Gibco. 
10% FCS, 2 mM 1-Glutamine, 1 mM Sodium pyruvate, 100 U/ml Penicillin,100 µg/ml 
Streptomycin, 1x non-essential amino acids. Media mainly used for the growth of Hek293, 
HepG2, MCF-7, SW480, and Primary Foreskin Fibroblast (HS27) cells. 
RPMI 1640 + L-Glutamine from Gibco. 
10% FCS, 100 U/ml Penicillin,100 µg/ml Streptomycin, 1x non-essential amino acids. 
Media mainly used for the growth of Thp1, primary foreskin fibroblast (HS27), and IRF 8 -/- 
(50uM 2ME, 6ng/ml GM-CSF, 6ng/ml M-CSF additionally required) cells. 
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II.1.6.Antibiotics 
 
Ampicillin from Roth was prepared as a stock solution of 100 mg/ml in water, used as final 
concentration of 100 μg/ml and stored at 4°C. Kanamycin from Sigma stock solution was 
prepared as 30 mg/ml in water, used as final concentration of 30 μg/ml and stored at -20°C. 
Chloromphenicol from Sigma was prepared as 30 mg/ml in EtOH, used as final concentration 
of 30 μg/ml and stored at -20°C. Penicillin/Streptomycin from Gibco 
 
II.1.7.Bacterial Strains 
 
E. coli XL1-Blue: recA1, end A1, gyrA96, thi-1, hsdR17, supE44, relA1, lac, 
[F’, pro AB, lacIqZ∆M15, Tn10 (Tetr)] 
E. coli DH5α: 80dlacZ ∆Μ15, recA1, endA1, gyrA96, thi-1, hsdR17 (rB- mB+), supE44, 
relA1, deoR, ∆(lacZYA-argF)U169 
E. coli BL-21: E. coli B, F-, omp T, hsd S (rB- mB-), gal, dcm 
E. coli NB42: (Cicchetti et al., 1999) kindly provided by Ralf Max Leonhardt 
 
II.1.8.Eukaryotic Cell Lines 
 
Hela (Human cervix Carcinoma) 
MEFs (Mouse embryonic fibroblasts) 
L929 (Mouse fibroblast cell line) 
Thp1 (Human monocytic Leukumia) 
GS293 (Human embryonic kidney) 
HepG2 (Human primary liver cancer) 
MCF7 (Human breast adenocarcinoma) 
T2 (Lymphoblastoma cell line) 
Hs27 (primary foreskin fibroblast) 
IRF8 -/- (CL2 cells (Macrophage like cell lines)) 
IRF3 -/- (MEFs) 
IRF9 -/- (MEFs) 
MDCK II (Madin-Darby canine kidney cells) 
 
II.1.9.Antibodies 
 
Primary antibodies and antisera 
α4181, human IRGM recombinant protein, Rabbit polyclonal antibody, dilution 1:5000 for IB 
(Immunoblot), 1:500 for IF (immunoflourescence), generated in this study (see below) 
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Ctag-1 (Natasa Papic personal communication), peptide (KLGRLERPHRD), Rabit polyclonal 
antibody, dilution 1:5000 for IF and IB, from Eurogentec. αIGTP, mouse IGTP (283-423), 
mouse mono clonal antibody in a concentration 0,25 μg/ml, dilution 1:250 for IF from BD 
Transduction Laboratories. A19, mouse LRG47 (N-terminal), goat polyclonal, IF dilution 1-
100 from Santa Cruz.  
  
II.1.10.Secondary Antibodies and Antisera 
 
For westernblot; 
IgG anti-Mouse Horseradish peroxidase coupled from Goat (Pierce) 
IgG anti-Rabbit Horseradish peroxidase coupled from Donkey (Amersham) 
For immunofluorescence; 
Goat anti-mouse 1-2000 Alexa 488/546 from Molecular Probes, Donkey anti rabbit 1-2000 
Alexa 488/546 from Molecular probes and DAPI (Sigma) 
 
II.2.MOLECULAR BIOLOGY 
 
II.2.1.Culture of Eukaryotic Cells 
 
Cell lines (see above) were grown in 75cm2 polystrene tissue culture flasks (Sarstedt) with 5% 
CO2 at 37°C in a humidified incubater with suitable media appropriate for each cell line (see 
above). When the cells reached 80% confluency medium was removed and the cells were 
washed once in 1XPBS then detached from the plastic by trypsinisation (1X Trypsin). To 
prepare frozen stocks, cells were resuspened in freezing medium (FCS with 10 % di-methyle 
sulfoxide (DMSO)) in a final cell number (>106 cells/ml) then cells were kept over night at -
20°C and next morning transferred to -80°C for longer storage cells transferred liquid 
nitrogen. Transient transfection was performed in Hela, MEFs, L929 and  Hek293 cells. Cells 
were grown up to 80 % confluence in 60mm dishes and transfection with Fugene (FuGENETM  
Roche applied sciences) was performed according to manufacturer conditions; 6 μl of fugene 
mixed with 90 μl of serum free medium, appropriate amount of DNA was added (minimum 
1μg of DNA) mixture incubated at room temperature for 15min- 45min and added to the cells 
in drop wise manner. 
 
II.2.2.Preparation of IRGM(a) Specific Polyclonal Antisera (α4181)  
 
A rabbit antiserum against IRGM(a) protein was prepared, The rabbit was immunized 
subcutaneously with 200 µg purified recombinant MBP-IRGM(a) fusion protein (Figure 21) 
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which was diluted in up to 500 μl PBS in equal amount of complete Freund’s adjuvant 
(DifcoLab., Detroit, MI). 2nd injections with same protein were given subcutaneously after 
four weeks with 200 µg in same conditions. Two weeks later 2° bleed was collected and 
tested versus pre-immune serum by westernblot. 3rd injection was performed after 4 months in 
same conditions but the preparation of recombinant IRGM(a) protein was different; The 
MBP-IRGM(a) fusion protein was digested over night with thrombin (see above). The 
digested protein was subjected to Gel-filtration column. The IRGM(a) containing fractions 
were collected, concentrated with Vivaspin (Vivascience) centrifugal concentrator with 10000 
MW cut off and redisolved with 500 μl of resuspension buffer (6M GnCl, 50mM Hepes, 
4mM DTT, pH:7.5). Resuspended IRGM(a) recombinant protein was subjected to Gel-
filtration coloumn. The fractions were collected and dialyzed against PBS in a volume ratio 1 
to 500 over night. Dialyzed fractions were checked on the gel and stored at -80°C.  4th 
injection was performed after 4 months in the same conditions above. Amount of the protein 
were determined using the Bradford assay.  Antisera from all the bleeds, the pre-bleed prior 
immunisation, first, second, third, and the fourth bleeds kept at room temperature for over 
night and next morning were obtained by centrifugation of the clotted blood at 3000g for 7 
min at 4°C and stored at -20°C. Western blots were done on transfected and un-transfected 
cell lysates using different dilutions of the pre-bleed, and partially depleted 2nd, 3rd and 4th 
bleed to check the specificity for pre-bleed control.  
 
II.2.3.Western Blot Analysis 
 
Proteins were run on SDS-PAGE gel and transferred to nitrocellulose membrane by 
electroblotting. Ponceau-S (0.1% Ponceau-S (w/v) (Sigma), in 5% acetic acid) staining was 
used to define the place of the proteins on nitrocellulose membrane. Membrane was blocked 
with 5% milk powder, 0.1% Tween 20, for 15 hours at 4°C. Antisera/antibody was diluted in 
PBS, 10%FCS, 0.1 Tween20, and protein bands visualized using the enhanced 
chemiluminescence (ECL) substrate.  
 
II.2.4.Immunofluorescence 
 
Appropriate cell lines (see above) grown on 22X22 mm coverslips in 6 well plates were 
induced, left uninduced with interferon γ or transfected with GTPase constructs. After 24 
hours medium was removed. The cells were washed with 2ml of PBS and fixed with 2 ml of 
PBS/3%Paraformaldehyde for 20 min at RT. Cells were washed 3times with PBS and washed 
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with 2 ml PBS/0.1% Saponin incubated for 10min at RT. Wash buffer was removed and 
immediately cells were blocked by adding PBS/0.1 %saponin/3% BSA and incubated for 
1hour at room temperature in 6 well plates. Coverslips were incubated with 100 μl of PBS/0.1 
%Saponin/3% BSA  which contains appropriate antibody dilution (see above) on parafilm in 
humid environment for 1 hour at RT temperature or over night at 4°C. Coverslips were put in 
to the 6 well plates and washed with 3X 5 ml of PBS/0.1% Saponin. Coverslips incubated 
with 100 μl of PBS/0.1 %Saponin/3% BSA which contains appropriate secondary antibody 
dilution (see above) or dapi (1:1000) on parafilm in humid environment for 30 min at RT 
temperature in dark conditions. Coverslips were put into the 6 well plates and washed with 3X 
5 ml of PBS/0.1% Saponin. Finally, coverslips were put on to the slide with 20 μl of ProLong 
Gold antifade reagent (Molecular Probes). After over night incubation cells were observed 
with a Zeiss Axioplan II fluorescence microscope equipped with a cooled CCD camera 
(Quantix) using the Metamorph software (version 4.5r3, Universal Imaging Corp.) 
 
II.2.5.Oligonucleotides 
 
Oligonucleotides were designed using the programs, primer3 (http://frodo.wi.mit.edu/cgi-
bin/primer3/primer3_www.cgi),Netprimer 
(http://www.premierbiosoft.com/netprimer/netprlaunch/netprlaunch.html). 
All oligonucleotides were from invitrogen, nucleotides were supplied as powder and 
resuspended to a final concentration 100pmol/μl then diluted 1 in 10 to 10pmol/μl as final 
concentration. For each reaction 1μl was used.   
 
          
Gene Primers 5’ to 3’ 
GCCTCTAGCTGCTGGGACCTGTCTCAGGTCACATCTGAG Irgc 
GCGGGTGGCCGCCAGATCCTCGTCCACC 
GGAGATCCTATCAGTGGGGAGAGTGTGAGGGIRGC (human) 
CCTCTCTGAAGCCCGACGGCCG 
CTGTATCCGGAAATTCTTCCCAAAGGBP-1 (human) 
CTTCAATGGCCTCTCTCTCACTGTC 
ATGACAACTTTGGTATCGTGGAAGG
GAAATGAGCTTGACAAAGTGGTCGT
GAPDH (human) 
ATATTTCTGGGCCTTGTGGAATTCAC 
AAAGTTCTACTTTGTCCGAACCAAGATAGATCAAGAT Irgb1-3-8 
 CTCTTCCTTATTAAGGAGAGACTTGGCATCACTTG 
GGTACATACAACCACTGAGAGAACACCATACACTTACA Irgb2-5-9 
 ATGGTATGGTAGCCCATGCTCTTGGCA 
TCTACTTTGTCAGAACCAAGATAGACAGCGACTTAGA Irgb6 
 GCCATGCGATAGTAAGTGACTGCAGCG 
TCATTATTGTCTCTGCTGGACGCATTAAACATIrgb7 
 TTAGAGACTAAGAAGACTGGAGGCTCCTGGTG 
Irgb8 CGCTTATCTAGACCAAGTGGGATTTGCCA
List of Primers  
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CAACCACTATGTTAAGGAACTGTGTGCGCC 
CGGAATCAAGGAGACTGTGGCAACATTGIrgm1 
TCCTGGGCAACTAAGAAAAGCATGCGTT 
GATCTCGGATCCGGGTAACGCGATIrgm2 
TAACAGAACTTCCTTGGCTTTGGCAGCAG 
CTGGAGGCAGCTGTCAGCTCCGAGIrgm3 
GTCCTTTAGAGCTTTCCTCAGGGAGGTCTTG 
TGCTGCCTTGACAGACATTGAGAAAGCCIrgb10 
GCTGCGTTAGCATTCTGCAGATTCTTTACAC 
TTCCCTTGTCAATGTGGCTGTCACTGGIrga1 
AGAAAGGTCAGTGAAGGTATGATAGTAGCACACCAG 
CACAGGTGGACTCTGACTTAAGAAATGAAGAGGATT Irga2 
ACTTTCTAAGAAGAAGCTCAGTAGCCCATCTGC 
AGCTATGCTTGAAAAGGGGGGACTTTCAGIrga3 
TATGGGCAAAATGAGTTTGAGCCGCTT 
GCTGAAGTTGGAGTAATAGAGACAACTATGAAGAGAACTTCT Irga4 
TGTGTCAAGGATATGAAGTTGTAAATAATAGATTGCAGG 
CTGACACTAGGAGATGTTCAGCAAGCAAATAATG Irga5 
AAGGAAAAGAAGTGGTAAGTAAAAGGCTTTCTCCATATA 
ATCAGTGATGCATTAAAAGAAATCGATAGTAGTGTGC Irga6 
GTCAGAGAAGGGATGATATTCACTAGGTCAGCAG 
CACAATTTTATGCTTTCTCTGCCTGGCATTIrga7 
TCAGCAAATGAGGGGACTTCATTATTTCTTTTACTT 
GAGTTATGCCTGAAGAAGGGGGACATTCAIrga8 
TGAGTTTGAGCTATTTTTTTGAATATGCCTCTTTAAGG 
GCTGGCAAGTCCTCCCTCATCAACIRGC 
GAGAGGTTGGACACGAGGAAGATGC 
TCCTTTCTCAGGAGGCCATCACTTCIRGB2 
GCCAGTTGTGCATCATTGATTGTGA 
GAAAAGGCATTGGGAGATGGGAAGTIRGM5 
AACCTTTTCCCCTGTCTTTGGATGG 
GAGAGAGCATCCAGTGTCCCATTGAIRGM6 
GATGGGTTCGAAAACCCTCTCCTTC 
ACCCAGTCCCTTCACACTCCATCACIRGM4 
TAGCAAGTGGGAATCTGGGTGGTTC 
CAGGACACCAGTTAACATCACTATGIRGMs1-r1 (human) 
GATTTTCCAGGACATTTTCTCTGAT 
IRGM-rGMS 
(human) 
ATATTTCTGGGCCTTGTGGAATTCAC 
 
GAGAAAGCCTCAGCAGATGGGAACTTG IRGM(b-e) 
f10-r60 GCACTGGCTAGCTAGCTGTTGAATATCCTGA 
GGACTCTGGCAATGGGATGAACACCTTCATCAGTGCCCTTCG IRGMmn 
CGAAGGGCACTGATGAAGGTGTTCATCCCATTGCCACAGTCC 
IRGM5’(HindIII) CCCCCAAGCTTATGAATGTTGAGAAAGCCTCAGCAG 
IRGMctag1(EcoR1) CCCCCGAATTCTTAGTCACGATGCGGCCGCTCGAGTCGACCTAGTTTG
TATTCACATACCCGCTCCTTCTGG 
IRGMhistag(EcoR1) CCCCCGAATTCTTAATGATGATGATGATGATGGTATTCACATACCCGC
TCCTTCTGG 
IRGM(b)3’ 
(HindIII) 
GCGCAAGCTTCTAGCTGTTGAATATCCTGAGCAGATTTAC 
5’ Anc GGCCACGCGTCGACTAGTACGGGIIGGGIIGGGII
Est Stop CCCCCAAGCTTCAGGATCCTTTCAGCAAGCAAGAGG 
IRGMr1 (human) GATTTTCCAGGACATTTTCTCTGAT 
5’(1-2) CCCCCGGATCCATGAATGTTGAGAAAGCCTCAGC 
AP GGCCACGCGTCGACTAGTAC(T)17
AUAP GGCCACGCGTCGACTAGTAC
UAP (CUG)4GGCCACGCGTCGACTAGTAC
GTCTACATGTTCCAGTATGACTCCACTCACGGGAPDH (mouse) 
GTTGCTGTAGCCGTATTCATTGTCATACCAGG 
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II.2.6.Preperation of mRNA and cDNA synthesis 
 
Oligotex mRNA isolation kit (Qiagen) was used to isolate mRNA from total RNA (isolated 
by using total RNA isolation kit Qiagen). mRNA was stored at -80°C. cDNA synthesized 
using the mRNA obtained by SuperScript First Strand Synthesis System (Invitrogen) 
according to manufacturers instructions. Synthesis was primed by Olig-dT primers. 1µl of 
cDNA is used for each reaction. 
 
II.2.7.RT-PCR on Cells and Tissues 
 
Mouse L929 fibroblasts or appropriate cell lines were stimulated for 24 h with 200U/ml IFN-γ 
or 200U/ml IFN-β (R&D and Calbiochem respectively). Human cell lines (Hela, HEK293, 
HepG2, T2, THP1, MCF-7, SW-480, Primary foreskin fibroblast-HS27) were stimulated for 
24 h with 2000 U/ml Interferon-β or 200 U/ml Interferon-γ (PBL Biomedical laboratories and 
Peprotech respectively).Total RNA was extracted from tissues and cells using the “RNeasy 
mini kit” (QIAGEN, Hilden, Germany), except for testis, where the “RNeasy Lipid Tissue 
Kit” (QIAGEN) was used. Poly (A) RNA was isolated from total RNA using the Oligotex 
mRNA kit (QIAGEN). Total RNA from human tissues was purchased from Biochain 
(Hayward, CA, USA). cDNA was generated from mRNA and total RNA using the “Super 
Script First-Strand Synthesis System for RT-PCR” (Invitrogen, Carlsbad, CA, USA). The 
generated cDNAs were screened for the presence of p47 GTPase transcripts by PCR. The 
amplified fragments were confirmed by sequencing. 
 
II.2.8.5’and 3’ RACE (Rapid amplification of cDNA ends) PCR  
 
5’RACE PCR; cDNA synthesized using the IRGM-rGMS primer (see above), after 
preparation of cDNA, cDNA made single stranded and purified using the rapid PCR 
purification kit (Boehringer). Terminal deoxy transferase Rection maintained on the purified 
cDNA, (16.5µl cDNA, 5µl TdT + Reaction buffer (Amersham), 2.5µl dCTP (2mM)) 
incubated for 3min at 94°C, 1µl of Tdt was added and incubated for 15min at 37°C, fallowed 
by inactivation step for 5 min 65°C. PCR reaction was performed on the (cDNA+polyC) 
using the primer 5’Anc. PCR product was purified by using the rapid PCR purification kit and 
second round nested PCR was performed using the primers UAP and IRGMr1. 1.7 kb PCR 
product was cloned to PGEM-T easy and positive clones were determined by sequencing (1.6-
5’Race-hGMS and 3.6-5’Race-hGMS).  
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3’RACE PCR; cDNA synthesized using the AP primer (see above), after preparation of 
cDNA, cDNA made single stranded and purified using the rapid PCR purification kit 
(Boehringer). First PCR was performed using the primers Hgms5’(1-2) and UAP. PCR 
product was prufied by using the rapid PCR purification kit and second round nested PCR 
was performed using the primers IRGMr1 and AUAP. The PCR product was double digested 
with HincII and SpeI (50µl purified PCR product, 7µl digestion buffer (NEB), 3µl HincII, 3µl 
SpeI, 0.7µl BSA, 6.3µl H2O incubated at 37°C for 10hour) and same time pBlueScript II KS+ 
was double digested with HincII and SpeI (6µl pBlueScript II KS+ (200 ng/ml), 1µl digestion 
buffer (NEB), 0.1µl BSA, 1µl HincII, 1µl SpeI, 0.9µl H2O incubated at 37°C for 10 hours). 
After restriction digestion, both products were purified and ligated (1µl digested purified 
pBlueScript II KS+, 7µl purified PCR product, 1µl T4 DNA ligation Buffer(10X),  1µl T4 
DNA ligase and incubated 15 hours at 16C). Positive clones were screened by sequencing and 
named (3’-9.5-Race-hGMS,  3’-9.6-Race-hGMS, 3’-9.8-Race-hGMS, 3’-R.1-Race-hGMS, 3’-
R.6-Race-hGMS, 3’-R.9-Race-hGMS, 3’-R.3-Race-hGMS) 
  
II.2.9.Site Directed Mutagenesis 
 
Site directed mutagenesis was carried out with the modification of “QuickChangeTM XL 
Site-Directed Mutagenesis”  Kit from strategen. Modifications; amount of plasmid used as 
template 20-60µl, amount of primers 100-125ng, DpnI digestion at least four hours.  
 
II.2.10.Real-Time-PCR on Cells 
 
Mouse L929 fibroblasts were stimulated for 24 h with 200U/ml IFN-γ or 200U/ml IFN-β 
(R&D and Calbiochem respectively). The induction ration between induced and uninduced 
p47 GTPases (Irgm1 and Irga6) was detected by a quantitative PCR assay using the 
LightCycler System (Roche). cDNA synthesized using the mRNA prepared from the induced 
and un-induced cells was used as a template. The amount of measured transcripts was 
normalized to the amount of the mouse GAPDH transcript in the probes. The sequences of all 
primers are listed in List of primers (see above). The reaction performed using Quantitect 
SYBR Green (Qiagen, Hilden) according to the manufacturer instructions with the 
modifications; addition of extra 1U taq polymerase (Rita Lange personal communication) and 
PCR program (95°C,  3 min denaturation step.). Melting curve analysis was performed after 
each run to analyse specificity of primers. To generate regression curve as standard for 
calculation of molucules, pGEMT-easy+Irgm1 and pGEMT-easy+Irga6 were used in serial 
dilutions. 
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II.2.11.Quantification by UV Spectroscopy 
 
DNA concentrations were determined by using UV/Vis Spectrophotometer (Biomate 3 
Thermo spectronic). 1 μl of genomic DNA was diluted in 1 ml of TE buffer (pH: 7,5) and 
DNA quantification was done at 260 nm and 280 nm wavelengths. 260 nm wavelengths show 
the concentration of nucleic acid in the sample. 1 OD (Optic Density) at 260 nm 
approximately is equal to 50μg/ml double helical DNA in the sample. The ratio of two values 
that were read at 260 nm and 280 nm measures the purity of the nucleic acids. The ratio of 
OD260/OD280 must be between 1.8 and 2.0. This ratio is drastically decreased if protein or 
phenol remains in the solution.  
 
II.2.12.Checking the Presence of DNA on Agarose Gel Electrophoresis 
 
Agarose gel electrophoresis was used for qualitative analysis of extracted DNA. Agarose gels 
were prepared in respective percentage (0.6%- 1%) by boiling agarose in 1X TAE or 
0.5XTBE buffer. The gel was poured onto an electrophoresis plate and gel was left in room 
temperature for 30 minutes for polymerization. 1.0 μl of genomic DNA, 6.0 μl of 6X 
bromophenol blue dye and 6.0 μl of dH2O mixed (for PCR products DNA quantities were 
varied from 5μl to 20μl according to experiment) and the gel was run at 70-120 V for 60-30 
minutes respectively, and stained in 0,5μl/ml ethidium bromide (EtBr) solution. It was 
visualised under UV light. The quality of DNA was determined by looking at the migration 
patterns of the bands on the gel and the presence or absence of smears. 
 
II.2.13.Preparation of Competent Cells I 
 
The preparation was started with 5 mL overnight culture of E. coli cells in a LB medium 
which contains 0.02M MgSO4, 0.01M KCl at 37°C with 180rpm. Next day it was inoculated 
in a ratio 1:10 in fresh LB with same contents above up to approx. OD600 = 0.1 and incubated 
until reaching OD600 = 0.45 at 37°C with 180rpm. The flask was put on ice or in cold room for 
10 min. Cells were pelleted at 5000 g for 10 min, 4 °C. pellet was resuspended in 100 mL cold 
TFB I and incubated on ice for 10 min, Cells again spun down at 4000 g for 5min, 4 °C. The 
cells were resuspended carefully in 20 mL TFB II. Finally, the cells were aliquoted into 
precooled 1.5 mL tubes (100-300μL/tube) and frozen in liquid nitrogen, finally aluquots were 
transferred to -80 °C. 100 μL/ is used for transformation. 
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Buffers: 
TFBI: 30 mM KOAc; 50 mM MnCl2; 100 mM KCl; 10 mM CaCl2; 15 % (w/v) Glycerin. 
TFBII: 10 mM Na-MOPS pH 7.0; 75 mM CaCl2; 10 mM KCl; 15 % (w/v) Glycerin. 
 
II.2.14.Preparation of Competent Cells II 
 
5-10 E. coli DH5α colonies were inoculated into 250ml of LB + 50mM MgCl2 and incubated 
at 24°C (optimal 18°C) to OD600 = 0.450-0.600 (it takes 10 to 12 hour at 24°C several days at 
18°C). Cells were cooled on ice for 10 min and pelleted by centrifugation 8min at 4500g at 
4°C in 50ml tubes. Cells were resuspended with 80ml ice-cold TB buffer (total) and incubated 
for 10 min on ice. The cells were centrifuged for 4500g for 5 min. and pellet was resuspended 
again in 20 ml ice-cold TB buffer. DMSO (room temperature) was added to 7% final 
concentration and incubated on ice for 10min. The cells were aliquoted in pre-cooled 
eppendorf tubes and shock frozen in liquid nitrogen. Competent cells were kept in -80°C.  
TB buffer 
10mM Pipes, 55mM MnCl2, 15mM CaCl2, 250mM KCl everything added except MnCl2 
adjusted to PH:6.7 with KOH. Finally, MnCl2 is added and stored at 4°C. 
 
 II.2.15.E. coli Transformation 
 
Cells were thawed on ice for 10 min. then plasmid DNA or ligation reaction was mixed with 
100 μl competent cells in 1.5 ml tube (usually to 5/10 μl of ligation reaction used). Competent 
Cells and DNA mixture was incubated on ice for 20 min. followed by heat shock at 42 °C for 
2 min. in water bath. 500 or 1000 μl of fresh LB was added and incubated on rotater for 45-60 
min. then plated 250 - 500 μl on selection plate. 
 
II.2.16.Prufication of IRGM(a) Protein, N-Terminally Fused to GST Protein 
 
With this method it was possible to get low amount (approx. 100μM) of IRGM(a) N-
terminally fused with GST protein which was going to the inclusion bodies. 
Construct= PGEX 4T-2 + hGMS 
Bacteria= E.Coli (BL-21) 
(1). A 20 ml over night culture was incubated at 37 °C, 180 rpm (2). The O/n incubated 
culture was diluted 1:100 in 200 ml Terrific Broth, Amp100μg/ml and incubated at 37 °C, 180 
rpm around 2 hours until the growth reaches between 0.200 and 0.400 (3). The E. coli culture 
was stored at cold room (4 °C) around 1 hour to cool down temp. before the induction with 
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IPTG, and was induced with 50μM IPTG (10 μl from 1M to 200ml) (4). Incubation was 
maintained over-night at 18 °C, 180 rpm. (5). The culture was separated into 100ml 
centrifugation tubes (250ml) and centrifuged at 5000g, 15min. at 4 °C .After this step 
everything was maintained on ice (6). Each pellet was weight (for my case=1.390gr) and 
washed 1time with Pre-Washing Buffer, (Resuspending by pipetting up and down slowly) (7). 
Centrifuged at 5000g, 15min. at 4 °C, supernatant was removed and samples were 
immediately frozen in Liquid Nitrogen (-80) (8). Each frozen pellet was resuspended in 20 ml 
Sonification Buffer by pipetting up and down slowly.1 tablet of Protease inhibitor Tablet was 
added in 20ml solution (Before adding Sonification buffer, Tubes were kept in room 
Temperature for 10min.) (9). When two pellet completely resuspended, each solutions were 
mixed together (40 ml) before sonification (10). Total 40 ml Solution was sonificated 15 
times 30sec. with 30sec. break on ice. (Sonifier 450= Output Control (5), Duty Cycle 
(Constant), Timer (0)) (Bramson TM2= Time (max.), Temp (max.), 1X) (During the 
sonification, temperature was always checked to keep sample cold, some times was waited 
longer then 30sec.) After this step everything was maintained in Cold Room (11). An equal 
volume (40ml) of 20% Glycerol + sonification buffer was added on sonificated culture in drop 
wise (Using Gravity Column with flow rate 1ml/min) by slowly stirring. (12). The sonificated 
culture was centrifuged at 100.000g (25000rpm in Beckmann Class H with SW 41 Ti rotor), 
for 30min, at 4 °C. (13). The supernatant was directly added on Gravity Column containing 
3ml of GST beads which were previously prepared by washing with 10% Glycerol + 
sonification buffer several times of column volume. The flow rate was adjusted to 1ml/min. 
(14). The GST-beads was washed with 3times 10% Glycerol+sonication buffer and each wash 
fractions were collected to check on SDS-PAGE. (15). The column was washed with 2times 
wash buffer and each wash were collected to check on SDS-PAGE (16). 2ml of 20mM 
reduced glutathione (In Wash Buffer) was added on the column with 5 ml glass pipet and 
pipetted several times to mix GST beads with glutathione solution properly. (17). Elution of 
recombinant protein was further performed with additional 4times, 2ml of reduced glutathione 
in a same way above. (In each step 5min incubation is made to elute protein) (18). GST beads 
were washed with 2 times with 20 ml of wash buffer and 2times of 20ml water (19). 10ml of 
6M Guanidium Cloride was added to the column and washed extensively 2times in a 100ml 
of volume (20). GST-beads were stored in 30% EtOH + water 
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Solutions 
 
Pre-Washing Buffer 
50mM Hepes-NaOH  10ml  (0.5 M PH:8.0) 
100mM NaCl   10ml  (1M) 
H2O  to final Conc.   100ml   PH adjusted to 7.5 
 
Sonificatin Buffer 
50mM Hepes-NaOH  10ml  (0.5 M PH:8.0) 
100mM NaCl   10ml  (1M) 
5mM DTT   500μl  (1M) 
5mM MgCl2   500μl  (1M) 
30μM GDP   100μl  (30mM) 
H2O  to final Conc.   100ml   PH adjusted to 7.5 
 
20% Glycerol + Sonificatin Buffer 
50mM Hepes-NaOH  10ml  (0.5 M PH:8.0) 
100mM NaCl   10ml  (1M) 
5mM DTT   500μl  (1M) 
5mM MgCl2   500μl  (1M) 
30μM GDP   100μl  (30mM) 
20% Glycerol   20ml  
H2O  to final Conc.   100ml   PH adjusted to 7.5 
 
10% Glycerol + Sonificatin Buffer 
50mM Hepes-NaOH  10ml  (0.5 M PH:8.0) 
100mM NaCl   10ml  (1M) 
5mM DTT   500μl  (1M) 
5mM MgCl2   500μl  (1M) 
30μM GDP   100μl  (30mM) 
10% Glycerol   10ml  
H2O  to final Conc.   100ml   PH adjusted to 7.5 
 
 
 
Wash Buffer 
50mM Hepes-NaOH  10ml  (0.5 M PH:8.0) 
100mM NaCl   10ml  (1M) 
1mM DTT   100μl  (1M) 
5mM MgCl2   500μl  (1M) 
30μM GDP   100μl  (30mM) 
10% Glycerol   10ml  
H2O  to final Conc.   100ml   PH adjusted to 7.5 
 
 
II.2.17.Prufication of IRGM(a) Protein, N-Terminally Fused to MBP Protein 
 
After cloning the gene into the expression vector pMAL-p2E + Thrombin digestion site, 
clones for expression of the fusion protein were incubated overnight 24°C in NB42. The 
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MBP-IRGM(a) fusion protein was purified from a bacterial lysate by binding to an amylase 
resin. After washing the resin of bacterial impurities, the fusion protein was eluted off the 
amylase resin with 10 mM maltose. Using this method more then 10mg/ml MBP-IRGM(a) 
fusion protein was purified. (This protocol was adapted from original protocol of Donald Ria, 
University of California Berkeley, Bio reagents and Chemicals) 
Construct= pMAL-p2E +Tr+hGMS 
Bacteria= E.Coli (NB-42) 
(1). A 6L of rich media was inoculate with 10ml/L (1 to 200) of an overnight culture with 
strain expressing the MBP-IRGM(a) fusion protein. The culture was incubated at 37°C 
temperature until culture reaches to an optical density of 0.5 at 600nm (OD600 of 0.5) approx 3 
to 4 hour. (2). Culture was induced with 400μl of 0.5 M IPTG (0.1 M IPTG for final 
concentration) for over night at 24°C. (3). The culture was centrifuged for 15 min. by using 
Beckmann 1L rotor at 6000 rpm (5000g) at 4°C (4). The supernatant was removed and the 
cell pellet was resuspended in 20 ml of ice-cold lysis buffer. 1X Protease inhibitor cocktail 
was added on pellet and the tablet was solubulized together with pellet. (2 tablet from 1 to 10 
Complete mini Roche). (5). The cell suspension was transferred to 15 ml falcon tubes and was  
snap frozen in liquid nitrogen. (6). The cell suspension was thawed in cold water. (7). The 
thawed cell suspension was sonicated by using the 30 second burst with 30 second break at 
setting of 5 with the tip of a cell sonicator probe in 120 ml beher. (Be sure to minimize 
foaming, sample should be kept in ice water bath during sonication )The sonication bursts 
were repeated until no more protein was released. The protein release was mnitored by 10 μl 
aliquots of the lysate by bradford assay (2ml). (8). The cell suspension was centrifuged at 4°C 
for 30 min at 50 000 g. (9). At the same time, the amylase resin column was prepared by 
pouring 60 ml of resin into 1 g coloumn 2.5 cm in diameter. The capacity was expected to be 
3 mg of maltose binding protein/ml resin in theory but for IRGM(s) fused protein capacity 
was around 1.5 mg/ml. (10). The column was equlibrated by lysis buffer with 2-5 column 
buffer (column buffer should be around 35 ml). (11). The flow rate was adjusted to 1ml/min 
but this flow rate was reduced during the process. (12). the sample was loaded and the flow 
though was collected and kept at 4°C so that it can be used again to load the column several 
times. Because it is observed that there was always protein not bound to the coloumn. (13). 
Once loaded, the column was washed with 10 column volumes of elution buffer. (14). MBP-
IRGM(a) fusion protein was eluted by elution buffer with 5 column volume, 5 ml each 
fractions. Usually within first 3 fractions elution of MBP-IRGM(a) protein should be 
observed . This was very much depends on how old  the column material was. (15). A 50 μl 
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of thrombin (5 unit/ml) was added to each elution fractions containing 10ml of highly 
concentrated protein (average 2mg/ml protein) and kept at 4°C o/n for complete digestion. 
(16). The digested protein was concentrated by using Vivaspin centrifugal concentrator  with 
10000MW cut off with 20 ml capacity up to appropriate volume. (17). The concentrated 
protein was subjected to gel filtration column (Hi-Load 26/60 superdex 75 prep grade, 
resolution 3000-70 000 or ).  
 
Solutions 
 
Elution Buffer 
20 μl of (GDP, GTP or GTPγS) 
5mM MgCl2  
200mM NaCl (No difference is detected between 150-300mM) 
50mM Tris-HCl, PH:8.0 
2mM Na2S2O5 (Sodium metabisulfide) 
10mM Maltose 
1 mM DTT 
10% (v/v) Glycerol 
PH: 8.0 
Add the DTT and Na2S2O5 fresh before use 
 
Wash Buffer  
1mM PMSF 
5mM MgCl2  
300mM NaCl  
50mM Tris-HCl, PH:8.0 
2mM Na2S2O5 (Sodium metabisulfide) 
10mM Maltose 
1 mM DTT 
10% (v/v) Glycerol 
PH: 8.0 
Add the DTT, PMSF and Na2S2O5 fresh before use 
 
 
Lysis Buffer 
1mM PMSF 
5mM MgCl2  
1 M NaCl  
100mM KCl 
50mM Tris-HCl, PH 8.0 
10mM Maltose 
0. 5 mM DTT 
PH: 8.0 
Add the DTT, PMSF and protease inhibitor cocktail fresh before use 
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II.3.EVOLUTIONARY AND PHYLOGENETICS ANALYSIS 
 
II.3.1.Use of Database Resources 
 
All available public databases were extensively screened by BLAST and related searches for 
sequences belonging to the IRG family. In the case of the mouse, transcript sequences derived 
from the C57BL/6 strain were given preference over sequences of other and undefined strain 
origin and compared in all cases with genomic sequence available via the ENSEMBL and 
NCBI. A systematic study of polymorphism has not yet been completed, but it is already clear 
that nearly all IRG sequences derived from the CZECHII cDNA libraries (Mus musculus 
musculus) differ from C57BL/6 sequences. These differences make allocation of many 
CZECHII sequences to individual clade members of the C57BL/6 mouse problematical. 
Identification of certain Irg sequences with recognised gene symbols was achieved through 
the Mouse Genome Initiative web resources at http://www.informatics.jax.org/.  
 Human and dog IRG sequences were identified from the available public databases 
(ENSEMBL, NCBI) and confirmed wherever possible by multiple sequence comparisons at 
transcriptional and genomic level. Fugu material was obtained and analysed through the 
BLAST server at http://fugu.hgmp.mrc.ac.uk/ and ENSEMBL web site at 
http://www.ensembl.org/Fugu_rubripes/. Tetraodon sequence was initially assembled from 
the GSS sequence database at NCBI and subsequently from the UCSC compiled genome 
database via the BLAST server at http://genome.ucsc.edu/cgi-bin/hgGateway. Zebrafish 
sequence was obtained from zebrafish genome resources at 
http://www.sanger.ac.uk/Projects/D_rerio and analysed in an Acedb database using the 
Spandit annotation tool.  
 Chromosomal locations and synteny analysis of mouse and human chromosomes was 
initiated through http://www.ensembl.org/Mus_musculus/syntenyview. Further details were 
obtained through http://www.sanger.ac.uk/Projects/M_musculus/publications/fpcmap-
2002/mouse-s.shtml. Protein molecular weight calculations is maintain by using available free 
calculation program at (http://bioinformatics.org/sms/prot_mw.html) 
 
II.3.2.Phylogeny and Alignment Protocols 
 
Routine sequence analysis and local sequence database management was handled 
using DNA-Strider 1.3f12, Vector-Nti and MacVector 7.2. The identity and similarity matrix 
of protein and nucleotide sequences (Table 2) are based on GeneDoc version (# 2.6.0002). 
Phylogenetic analysis was conducted using the neighbor-joining (NJ) method (Saitou and Nei, 
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1987), as implemented in the MEGA2 program (Kumar et al., 1994). We used p-distances for 
constructing the phylogenetic trees. Reliability of the NJ trees was examined by the bootstrap 
test (Felsenstein, 1985). 
 Alignments were performed via the BCM multiple alignment programme suite 
(http://searchlauncher.bcm.tmc.edu/multi-align/multi-align.html) and EBI-Clustalw 
(http://www.ebi.ac.uk/clustalw/) using the default options and manipulated according to the 
crystal structure of IIGP1 (Ghosh et al., 2004). Shading of alignments was performed with 
Boxshade (http://www.ch.embnet.org/software/BOX_form.html) and additional sequences 
were shaded manually according to the default options of Boxshade. Contig assembly was 
performed either by using the TIGEM, Cap3 
(http://fenice.tigem.it/bioprg/interfaces/cap3.html) or Infobiegen 
(http://www.infobiogen.fr/services/analyseq/cgi-bin/cap_in.pl).The ests for contigs were 
edited for sequences error when necessary. Ka/Ks (codon based selection test) analysis was 
performed using the program K-Estimator 6.0 (Comeron, 1999).  
 
II.3.3.Identification of Transcription Factor Binding Sites 
 
Promoter regions (2 kb upstream of putative transcription start point) were screened 
for putative transcription factor binding sites with the Transcription Element Search System 
(TESS, http://www.cbil.upenn.edu/tess) and the results were further analysed and confirmed 
manually (Schug and Overton, 1997). Additional promoter analysis of Irgc (mouseCinema) 
and IRGC (humanCINEMA) was performed with ConSite (Lenhard et al., 2003) based on 
phylogenetic footprinting (http://www.phylofoot.org). 
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III.I.RESULTS I. 
 
III.I.1.Genomic organization of the p47 (IRG) GTPase genes of the C57BL/6 mouse. 
 
Using a combination of screens and supplementary analysis (see Materials and 
Methods), the following genomic representation for the p47 GTPases of the C57BL/6 mouse 
was established. The p47 (IRG) GTPases form a well-defined family of 23 members 
distributed on mouse chromosomes 7, 11 and 18:  
 
 
A general nomenclature on phylogenetic principles is introduced for the p47 GTPases, 
based on the stem name IRG (immunity-related GTPases). The sources of all Irg sequences in 
database and assignment of genes with previously published names are listed in appendix 
table 1. However, from now on, the name “p47 GTPases or p47 GTPase family” will be used 
to describe the family considering historical reason. ORFs of individual members of p47 
GTPases can be found in our p47 GTPases database (http://www.genetik.uni-
koeln.de/groups/Howard/index.html). From the open reading frames of these genes protein 
sequences were predicted and aligned in fig. 7 (see below). Among the 23 p47 homologous 
genes, two are putatively pseudogenes based on criterion of inability to code for a functional 
GTPase domain. Irga5 is highly degraded pseudogene resulting in putative loss of coding full 
length p47 GTPases and this appears to be a recent event. Irga1 has a perfect open reading 
frame from the putative initiator methionine until residue 298 of the sequence and runs out of 
frame through a 4 base pair deletion followed by a single base loss (See Fig. 7). Although 
transcribed, Irga1 appears to be further damaged by an unexplained failure to splice correctly 
from exon 1 to exon 2. Both donor and recipient splice sites appear normal (see below). Thus, 
Irga1 is expected to be expressed normally in the cell based on the information both from 
general principles and from homology to closely related p47 genes such as Irga2 and Irga6. 
However only a single correctly spliced transcript is found in the Est database (BI658674). 
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Irga8 is assigned pseudogene status in C57BL/6 mice because of a single base insertion at 
position 204 in the second exon, resulting in a frame shift at amino acid lysine (K) (see Fig 7). 
The strongest evidence for this insertion to be a recent event is the presence of an intact 
version of Irga8 in the closely related mouse species, Mus musculus musculus, represented by 
the Czech II strain for which an extensive EST database is available. With this exception of a 
single base insertion, the open reading frame of Irga8 is complete and shows close homology 
to other p47 GTPases. In the p47 gene clusters on chromosome 11, Irgb7 is identified as a 
pseudogene on the bases of a single base change which mutates residue glutamine (Q) of the 
putative open reading frame to a stop codon (X) (Fig 7). In addition, no transcript of Irgb7 has 
yet been found either as an EST or by RT-PCR studies (see below). Irgb10, is another 
truncated p47 GTPase despite being transcribed and interferon-inducible, because its ORF 
terminates shortly after those regions homologous to other p47 GTPases, breaking off at 
amino acid 232. Additionally, no homologous sequence is to be found in the underlying DNA. 
Thus, Irgb10 appears to be a relatively recent 5‘gene fragment coding only for the G-domain 
of p47 GTPases. The remaining 19 p47 genes appear to be intact in the open reading frame. 
Thus, a minimum estimate of the number of potentially functional p47 GTPases in mouse is 
not just six, as previously described, but rather 20. 
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Irga6 
Irga1 
Irga2 
Irga4 
Irga7 
Irga5ψ 
Irga3 
Irga8 
Irgd 
Irgm1 
Irgm2
Irgm3
Irgb3
Irgb4
Irgb8
Irgb1 
Irgb6 
Irgb10 
Irgb2 
Irgb7ψ 
Irgb5 
Irgb9 
Irgc 
H-Ras-1 
N
S5 H4 αE S6 αG αF αd H3 H5 
1 ---------------MGQLFS----SPKSD-ENNDLPSSFTGYFKKFNTGRKIISQEILN 
1 ---------------MGQLFS----LLKN--KCQFLVSSVAEYFKKFKKIVIIILQEVTT 
1 ---------------MGQLFS----SRRS--EDQDLSSSFIEYLKECEKGINIIPHEIIT 
1 ---------------MGQLLS----DTSKTEDNEDLVSSFNEYFKNIKTE-KIISQETID 
1 ---------------MDQLLS----DTSKNEDNDDLVSSFNAYFKNIKTENKIISQETID 
1 ---------------MGQLFS----GTSK---SEALCSSFTEYFQKFKVENKIISQEIST 
1 ---------------MGQLFS----HIPKDEDKGNLESSFTEYFRNYKQETKIISEETTR 
1 ---------------MGQLFS----NMPKDEDKGILESSFTEYFRNYKQETKIISEETTR 
1 ---------------MDQFISAFLKGASENSFQQLAKEFLPQYSALISKAGGMLSPETLT 
1 ---------MKPSHSSCEAAPLLPNMAETHYAPLSSAFPFVTS---YQTG-SSRLPEVSR 
1 -------------MPTSRVAPLLDNMEEAVESPEVKEFEYFSDAVFIPKDGNTLSVGVIK 
1 -----MDLVTKLPQNIWKTFTLFINMANYLKRLISPWSKSMTAGESLYSSQNSSSPEVIE 
1 -------------------------------MAQLLVFSFENFFKNFKKESKILSEETIT 
1 -----------QHPPLHTATCQPSSSRPSRLTAQLLVFSFENFFKNFKKESKILSEETIT 
1 -------------------------------MAQLLVISFENFFKNFKKESKILSEETIT 
1 -----------QHPPLNTATCQTSTGRTSQITAQLLEFNFKNFFKNFKKESKILSEETIT 
1 ---------------------------------MAWASSFDAFFKNFKRESKIISEYDIT 
1 ---------------MGQSSS------KPDAKAHNMASSLTEFFKNFKMESKIISKETID 
1 ---------------MGQTSS----STSPPKEDPPLT---------FQVKTKVLSQELIA 
1 -----------XPFWFVPPLGTIDICQDWVKLPLLHPLQRRILLLTFQMKTKILSQELIT 
1 ---------------MGQTSS----STPPPKEDPDLTSSFGTNLQNFKMKTKILSQELIA 
1 ---------------MGQTSS----STLPPKDDPDFIASFGTNLQNFKMKTKILSQELIA 
1 -------------------------------------MATSRLPAVPEETTILMAKEELE 
1 ------------------------------------------------------------ 
 
LIELRMRKGNIQLTNSAISDALKEIDSSVLNVAVTGETGSGKSSFINTLR-GIGNEEEGA 
SIELDMKKENFQEANSAICDALKEIDSSLVNVAVTGETGSGKSSFINTLR-GIGHEEEGA 
SIEINMKKGNIQEVNSTVRDMLREIDNTPLNVALTGETGSGKSSFINTLR-GIGHEEGGA 
LIKLYLNKGNIHGANSLIRDMLREIDNTPINIAVTGESGAGKSSLINALI-GIGPEEEGA 
LIELHLNKGNIHGANSLIREALKNIDNAPINIAVTGESGVGKSSFINALI-GTGPEEEGA 
LIELYLTLGDVQQANNAITYALRXLARTPQNVALIGESGRGKYSFINVFR-GLDMKRKM- 
SIELCLKRGDFQRANSVISDALKNIDNTPINIAVTGESGAGKSSLINALR-EVKAEEESA 
SIELCLKKGDIQRANSIISDALKNIDNAPINIAVTGESGAGKSSLINALR-EIKAEEESA 
GIHKALQEGNLSDVMIQIQKAISAAENAILEVAVIGQSGTGKSSFINALR-GLGHEADES 
STERALREGKLLELVYGIKETVATLSQIPVSIFVTGDSGNGMSSFINALR-VIGHDEDAS 
RIETAVKEGEVVKVVSIVKEIIQNVSRNKIKIAVTGDSGNGMSSFINALR-LIGHEEKDS 
DIGKAVTEGNLQKVIGIVKDEIQSKSRYRVKIAVTGDSGNGMSSFINALR-FIGHEEEDS 
LIESHLEDKNLQGALSEISHALSNIDKAPLNIAVTGETGTGKSSFINALR-GVRDEEEGA 
LIESHLEDKNLQGALTEISHALSNIDKAPLNIAVTGETGTGKSSFINALR-GVRDEEEGA 
LIESHLEDKNLQGALSEISHALSNIDKAPLNIAVTGETGTGKSSFINALR-GVRGEEEGA 
LIESHLENKNLKEALTVISHALSNIDKAPLNIAVTGETGTGKSSFINALR-GISSEEKDA 
LIMTYIEENKLQKAVSVIEKVLRDIESAPLHIAVTGETGAGKSTFINTLR-GVGHEEKGA 
SIQSCIQEGDIQKVISIINAALTDIEKAPLNIAVTGETGAGKSTFINALR-GIGHEESES 
SIESSLEDGNLQETVSAISSALGDIEKVPLNIAVMGETGAGKSSLINALQ-GVGDDEEGA 
FIELYLEDGNLXETVSAISSALGDIEKVPLNIAVMGETGAGKSSLINALQ-GTGADEDGV 
FIESSLEDGNLQETVSAISSALGGIEKAPLNIAVMGETGAGKSSLINALQ-GVGDDEEGA 
FIESSLEDGNLRETVSAISSALGGIEKAPLNIAVMGETGAGKSSLINALQ-GVGDDEEGA 
ALRTAFESGDIPQAASRLRELLANSETTRLEVGVTGESGAGKSSLINALR-GLGAEDPGA 
--------------------------MTEYKLVVVGAGGVGKSALTIQLIQNHFVDE--- 
 
A-KTGVVEVTMERHPYKH-PNIP----NVVFWDLPGIGSTNFPPNTYLEKMKFY-EYDFFI 
A-KTGVVEATMERHPYKH-PNMP----NVVFWDLPGIGSTKFPPKTYLEKMKFY-EYDFFI 
A-HTGVTDKTKERHPYEH-PKMP----NVVFWDLPGTGSEDFQPKTYLEKMKFY-EYDFFI 
A-EVGVIETTMKRTSYKH-PKIE----TLTLWDLPGIGTQKFPPKTYLEEVKFK-EYDFFI 
A-EVGVIETTMKRNFYKH-PKIE----TLTLWDLPGIGTQKFPPKTYLEEVKFK-EYDFFI 
A-TVGVVETTMNRTPYRN-PNIP----NVIIWDLPGIGTTNFPPKHYLKKMQFYVMYDFFI 
A-EVGVTETTMKVSSYKH-PKVK----NLTLWDLPGIGTMKFQPKDYLEKVEFK-KYDFFI 
A-EVGVTETTMKVYSYKH-PKVK----NLTLWDLPGIGTKKFPPKTYLETVEFK-KYDFFI 
A-DVGTVETTMCKTPYQH-PKYP----KVIFWDLPGTGTPNFHADAYLDQVGFA-NYDFFI 
A-PTGVVRTTKTRTEYSS-SHFP----NVVLWDLPGLGATAQTVEDYVEEMKFS-TCDLFI 
A-PTGVVRTTQKPTCYFS-SHFP----YVELWDLPGLGATAQSVESYLEEMQIS-IYDLII 
A-PTGVVRTTKKPACYSSDSHFP----YVELWDLPGLGATAQSVESYLEEMQIS-TFDLII 
A-PTGVVETTMKRTPYPH-PKLP----NVTIWDLPGIGSTTFPPQNYLTEMKFG-EYDFFI 
A-PTGVVETTMKRTPYPH-PKLP----NVTIWDLPGIGSTTFPPQNYLTEMKFG-EYDFFI 
A-PTGVVETTMKRTPYPH-PKLP----NVTIWDLPGIGSTNFQPQNYLTEMKFG-EYDFFI 
A-PTGVIETTMKRTPYPH-PKLP----NVTIWDLPGIGSTNFPPQNYLTEMKFG-EYDFFI 
A-PTGAIETTMKRTPYPH-PKLP----NVTIWDLPGIGTTNFTPQNYLTEMKFG-EYDFFI 
A-ESGAVETTKDRKKYTH-PKFP----NVTIWDLPGVGTTNFKPEEYLKKMKFQ-EYDFFL 
AASTGVVHTTTERTPYTY-TKFP----SVTLWDLPSIGSTAFQPHDYLKKIEFE-EYDFFI 
TAPVGVVYTTIEKKSYPY-AKFP----SAILWELPAIGFHHFQPHDYLKKIKFE-EYDFII 
AASTGVVHTTTERTPYTY-TKFP----SVTLWDLPGIGSTAFQPHDYLKKIEFE-EYDFFI 
AASTGVVHTTTERTPYTY-TKFP----SVTLWDLPGIGSTAFQPHDYLKKIEFE-EYDFFI 
A-LTGVVETTMQPSPYPH-PQFP----DVTLWDLPGAGSPGCSADKYLKQVDFG-RYDFFL 
--YDPTI-----EDSYRKQVVIDGETCLLDILDTAGQEEY---SAMRDQYMRT---GEGFL 
 
153 IISATRFK------KNDIDIAKAISMMK-KEFYFVRTKVDSDITNEADGKPQTFDKEKVL 
152 IISATCFK------KNDIDLAKAISMMK-KEFYFVRTKVDTDLRNEEDFKPQTFDKEKVL 
152 IISATRFK------KNDIDLAKAIGIMK-KEFYFVRTQVDSDLRNEEDFKPQTFDREKVL 
153 IVSATRFT------KLELDLAKAITNMK-KNYYFVRTKVDIDVENERKSKPRTFEREKAL 
154 IVSSTRFT------KHELDLAKAIGIMK-KNYYFVRTKVDIDLENERKSKPRTFDREKTL 
151 IVSATCFR------KNDIDLSKAVVMIK-KKDFLLRTKEDIDIENENX------------ 
154 IVSSSRFT------KLELDLAKATRIMK-KNYYFVRSKVDCDLDNEKKSKPRNFNRENTL 
154 IVSATRFT------NHEIELAKAIRIMK-KNYYFVRSKVDFDLYNEEKSKPRNFNRKNTL 
158 IISSSRFS------LNDALLAQKIKDAG-KKFYFVRTKVDSDLYNEQKAKPIAFKKEKVL 
160 IIASEQFS------SNHVKLSKIIQSMG-KRFYIVWTKLDRDLSTS------VLSEVRLL 
159 IVASEQFS------LNHVKLAITMQRMR-KRFYVVWTKLDRDLSTS------TFPEPQLL 
168 IVASEQFS------SNHVKLAITMQRMR-KRFYVVWTKLDRDLSTS------TFPEPQLL 
142 IISATRFK------EIDAHLAKTIEKMN-TKFYFVRTKIDQDVSNEQRSKPRSFNRDSVL 
162 IISATCFK------EIDAHLAKTIEKMN-TKFYFVRTKIDQDVSNEQRSKPRSFNRDSVL 
142 IISATRFK------EIDAHLAKAIAKMN-TKFYFVRTKIDQDVSNEQRSKPKSFNRDSVL 
162 IISATRFK------EIDAHLAKAIAKMN-IKFYFVRTKIDQDISNEQRSKPKSFNRDSVL 
140 IISATRFK------ENDAQLAKAIAQMG-MNFYFVRTKIDSDLDNEQKFKPKSFNKEEVL 
152 IISSARFR------DNEAQLAEAIKKMK-KKFYFVRTKIDSDLWNEKKAKPSSYNREKIL 
146 IVSAIRIK------QSDIELAKAIVQMN-RGLYFVRTKTDSDLENEKLCNPMRFNRENIL 
162 VS-AGRIK------HSDVELAKAIVQMN-RGLYFNRTKTDIDLKNEKLYNPMRFNRENTL 
155 IVSSGRFK------HNDAELAKAIVQMN-RSFYFVRTHTDLDLMVVKRSNPRRFNRENTL 
155 IVSSGRFK------HNDAELAKAIVQMN-RSFYFVRTHTDLDLMVVKLSDPRKFNKENIL 
136 LVSPRRCG------AVESRLASEILRQG-KKFYFVRTKVDEDLAATRSQRPSGFSEAAVL 
 79 CVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVE------------- 
 
QDIRLNCVNTFRENGIAEPPIFLLSNKNVCHYDFPVLMDKLISDLPIYKRHNFMVSLPN 
QDIRLNCVNTFKENGIAEPPIFLISNENVCHYDFPVLMDKLISDLPDYKRHNFMLSLPN 
QDIRLNCVNTFRENGIAEPPIFLISNKNVCHYDFPVLMDKLISDLPVFKRQNFMFSLPN 
KQIQSYSVKIFNDNNMAVPPIFLISNYDLSDYDFPFLVDTLIKELHVQKRHNFMLSLPN 
KQIQSYAMNTFSDNNMAIPPIFMVSNYDLSKYDFPVMMDTLIKDLHAEKRHNFMLSLPG 
----------------------------------------------------------- 
NQVRNSYLDTFRESKIDEPQVFLISNHDLSDYDFPVLMDTLLKDLPAEKRQNFLLSLPN 
NQIRNSYLDTFRESKIDEPQVFLISNHDLSDYDFPVLMDTLLKDLPAEKRHNFLLSLPN 
QQIRDYCVTNLIKTGVTEPCIFLISNLDLGAFDFPKLEETLLKELPGHKRHMFALLLPN 
QNIQENIRENLQKEKVKYPPVFLVSSLDPLLYDFPKLRDTLHKDLSNIRCCEPLKTLYG 
QSIQRNIRDSLQKEKVKEHPMFLVSVFKPESHDFPKLRETLQKDLPVIKYHGLVETLYQ 
QSIQRNIRENLQQAQVRDPPLFLISCFSPSFHDFPELRNTLQKDIFSIRYRDPLEIISQ 
KKIRDDCSGHLQKALSSQPPVFLVSNFDVSDFDFPKLETTLLRELPSHKRHLFMMSLHS 
KKIRDDCSGHLQKALSSQPPVFLVSNFDVSDFDFPKLETTLLRELPAHKRHLFMMSLHS 
KKIRDDCSGHLQKVLSSQPPVFLVSNFDVSDFDFPKLENTLLRELPAHKRHLFMMSLHS 
KKIKDECLGLLQKVLSSQPPIFLVSNFDVSDFDFPKLETTLLKELPAHKRHLFMMSLHS 
KNIKDYCSNHLQESLDSEPPVFLVSNVDISKYDFPKLETKLLQDLPAHKRHVFSLSLQS 
EVIRSDCVKNLQNANAASTRGFL-SLKLX------------------------------- 
KSIRICLSSNLKERFQQEPPVFLVSNFDVSDFDFPKLESTLLSQLPAYKHQIFMSTLQV 
KSLQICISSNLKECFHQEPPVFLVSNFDVSDFDFPKLESTLLSQLPAYKHQIFMRTLQV 
KQIRHTISSMLKEVTHQEPPVFLVSNFDVSDFDFPKLESTLLSQLPAYKHHMFMLTLPI 
EQIRNSISNILKEVTHQEPPVFLVSNFDVSDFDFPNLESTLLSQLPAYKHHMFMLTLPI 
QEIRDHCTERLRVAGVNDPRIFLVSNLSPTRYDFPMLVTTWEHDLPAHRRHAGLLSLPD 
---SRQAQDLARSYGI---PYIETSAKTRQGVEDAFYTLVREIRQHKLRKLNPPDESGP 
 
 
ITDSVIEKKRQFLKQRIWLEGFAADLVNIIPSLTFLLDSDLETLKKSMKFYRTVFGVDET  
ITDSVIETKRQSLKQRHWLQGFAGVLLSYLH----------------------------- 
ITDSVIEKKRNFLRWKTWLEGFADGLL------SFFLESDLETLEKSMKFYRTVFGVDDA 
FTDQAIDRKYKATQQFIWLEAFKIGVVAIFPVLGNLRNKDMKKIKNTLNYYQKIFGVDDE 
ITEAAIDRKHKATQQIVWLEAFNVGLLANFPVTGILGDNDVKKLEKSLNYYRKIFGVDDE 
------------------------------------------------------------ 
ITEAAIQKKYNSTKQIIWLQATKDGLLATVPVVGILKDLDKERLKKRLDYYRDLFGVDDE 
ITEAAIQKKYNSTKQFIWLQAMKDGLLATVPVVGILKDLDKERLKRSLDYYRDLFGIDDE 
ISDASIELKKHFLREKIWLEALKSAAVSFIPFMTFFKGFDLPEQEQCLKDYRSYFGLDDQ 
TYEKIVGDKVAVWKQRIANESLK----------NSLGVRDDDNMGECLKVYRLIFGVDDE 
VCEKTVNERVESIKKSIDEDNLH----------TEFGISDPGNAIEIRKAFQKTFGLDDI 
VCDKCISNKAFSLKEDQMLMKDLEA--------AVSSEDDTANLERGLQTYQKLFGVDDG 
VTETAIARKRDFLRQKIWLEALKAGLWATIPL-GGLVRNKMQKLEETLTLYRSYFGLDEA 
VTETAIARKRDFLRQKIWLEALKAGLWATIPL-GGLVRNKMQKLEETLTLYRSYFGLDEA 
VTETAIDRKRDFLRQRIWLEALKAGVWTTIPL-GGLVRDKMQKLEETLTLYRSYFGLDEA 
VTETTIARKRDFLRQKIWLEALKAGLWATIPL-GGLVRDKMQKLEETLTLYRSYFGLDEA 
LTEATINYKRDSLKQKVFLEAMKAGALATIPL-GGMISDILENLDETFNLYRSYFGLDDA 
----------------------------------------------------------- 
VINAIVDRKRDMLKQKIWKESIMPRAWATIPS-RGLTQKDMEMLQQTLNDYRSSFGLNEA 
VINAIVDWKRDMLKQKVWKESTTPRAWATIPS-LGLTQKDMEMLQQTLNDYRSSFGLDEA 
VTDSTIDRKRDMLKQKVWKESTMPRAWATIPS-LGLTQKDMEMLQQTLNDYRSSFGLDEA 
VTDSTIDRKRDMLKQKIWKESIMPRAWATIPS-RGLTQKDMEMLQQTLNDYRSSFGLDEA 
ISLEALQKKKDMLQEQVLKTALVSGVIQALPVPGLAAAYDDALLIRSLRGYHRSFGLDDD 
GCMSCKCVLS-------------------------------------------------- 
 
Irga6 
Irga1 
Irga2 
Irga4 
Irga7 
Irga5ψ 
Irga3 
Irga8 
Irgd 
Irgm1 
Irgm2 
Irgm3 
Irgb3 
Irgb4 
Irgb8 
Irgb1 
Irgb6 
Irgb10 
Irgb2 
Irgb7ψ 
Irgb5 
Irgb9 
Irgc 
H-Ras-1 
GXXXXGK/MS
    G1 
SWI
G2 DXXG/SWIIG3
N/TXXD
G4 
SAK
G5 
S2αA 310 αC H2B H1 S3αB H2 H2AS1 S4 
S4 
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αH αI αJ αK αL C
Irga6 
Irga1 
Irga2 
Irga4 
Irga7 
Irga5ψ 
Irga3 
Irga8 
Irgd 
Irgm1 
Irgm2 
Irgm3 
Irgb3 
Irgb4 
Irgb8 
Irgb1 
Irgb6 
Irgb10 
Irgb2 
Irgb7ψ 
Irgb5 
Irgb9 
Irgc 
H-Ras-1 
325 SLQRLARDWEI-EVDQVEAMIKSPAVFKPTDEETIQERLSRYIQEFCLANGYLLP----- 
    ------------------------------------------------------------ 
318 SLQRLARAWEIDQVDQVRAMIKSPAVFTPTDEETIQERLSRYNQEFCLANGYLLP-----  
325 SLELVAKDFQV-PVEQVKKTMKTPHLLKKYREETFRNDFKKLVSTFG----RLL------ 
326 SLELVAKDFQV-PVEQVKEIMKSPHLLKTNGKETLGEKLLKYLEKFETATGGLL------ 
    ------------------------------------------------------------ 
326 SLMFMAKDAQV-PVELLIKNLKSPNLLKCK-EETLEELLLNCVEKFASANGGLL------ 
326 SLMFIAKDAQV-PVELLKIKLKSPYLLELE-EETLGGLILNCVEKFASANGGLL------ 
330 SIKEIAEKLGA-PLADIKGELKCLDFWSLVKDNSIIAQATSAAEAFCAVKGGPES----- 
316 SVQQVAQSMGTVVMEYKDNMKSQNFYTLRREDWKLRLMTCAIVNAFFR-LLRFL------ 
316 SLHLVALEMKNKHFN--TSMESQETQRYQQDDWVLARLYRTGTRVGSIGFDYMK------ 
327 SLQQVARSTGRLEMGSRALQFQDLIKMDRRLELMMCFAVNKFLRLLESSWWYGLWN---- 
333 SLENIAKDFNV-SVNEIKAHLRFLQLFTKNNDMSFKEKLLKYIEYISCVTGGPL------ 
314 SLENIAKDFNV-SVNEIKAHLRSLQLLTKNNDMSFKEKLLKYIEYISCVTGGPL------ 
313 SLENIAKDFNV-SVNEIKAHLRSLQLLTKNNDMSFKEKLLKYIEYISCVTGGPL------ 
333 SLENIAKDFNV-SVNEIKAHLRSLQLLTKNNDMSFKEKLLKYIEYISCVTGGPL------ 
311 SLENIAQDLNM-SVDDFKVHLRFPHLFAEHNDESLEDKLFKYIKHISSVTGGPV------ 
    ------------------------------------------------------------ 
317 SLENIAEDLNV-TLEELKANIKSPHLFSDEPDTSLTEKLLKYIGNP--------------  
332 SLKNIAEDLNV-TLEELKANIKSPHLLSDEPDTSLTEKLLKYIGNP--------------  
326 SLENIAEDLNV-TLEELKANIKSPHLLSDEPDTSLTEKLLKYIGNP--------------  
326 SLENIAEDLNV-TLEELKANIKSPHLLSDEPDTSLTEKLLKYIGNP--------------  
308 SLAKLAEQVGK-QAGDLRSVIRSPLANEVSPETVLRLYSQSSDGAMRVARAFERGIPVFG 
    ------------------------------------------------------------ 
 
----KNSFLKEIFYLKYYFLDMVTEDAKTLLKEICLRN------------------------------- 
--------------------------------------------------------------------- 
----KN-HCREILYLKLYFLDMVTEDAKTLLKEICLRN------------------------------- 
---AVGLYFPAIYYLQLHILDTVTEDAKVLLRWKYSKPRSNSTYP------------------------ 
---AVGLYFRKTYYLQLHFLDTVTEDAKVLLRWKYSKPRSNSTYP------------------------ 
--------------------------------------------------------------------- 
---AAGLYFRKTYYLQFHFLDTVAEDAKVLLKAAQTHFAHSF--------------------------- 
---AAGLYFRKTYYLQFHFLETVAEDAKVLLKEAY---------------------------------- 
----SAFQALKVYYRRTQFLNIVVDDAKHLLRKIETVNVA----------------------------- 
----PCVCCCLRRLRHKRMLFLVAQDTKNILEKILRDSIFPPQI------------------------- 
---CCFTSHHSRCKQQKDILDETAAKAKEVLLKILRLSIPHP--------------------------- 
---VVTRYF--RHQRHKLVIEIVAENTKTSLRKALKDSVLPPEIH------------------------ 
---ASGLYFRKTYYWQSLFIDTVASDAKSLLNKEEFLSEKPGSCLSDLPEYWETGMEL----------- 
---ASGLYFRKTYYWQSLFIDTVASDAKSLLNKEEFLSEKPGSCLSDLPEYWETGMEL----------- 
---ASGLYFRKTYYWQSLFIDTVASDAKSLLNKEEFLSEKPGSCLSDLPEYWETGMEL----------- 
---ASGLYFSKTYYWQSLFIDTVASDAKSLLNKEEFLSEKPGSCLSDLPEYWETGMEL----------- 
---AAVTYYRMAYYLQNLFLDTAANDAIALLNSKALFEKKVGPYISEPPEYWEA--------------- 
--------------------------------------------------------------------- 
-------YFSKVFHLQNYFIDTVASDAKIILSKEELFTEQVSSFNSKASPYREESVGKVFPVSPGSTFL 
-------YFSKVFHLQNYFIDTVASDVKIILSKEELFTEQVSSFNSKASPYREESVGEVFPVGPGSTFL 
-------YFSKVFHLQNYFIDTVASDVKIILSKEELFTEQVSSFNSKASLYREESVGKVFPVGPGSTFL 
-------YFSKVFHLQNYFIDTVASDVKIILSKEELFTEQVSSFNSKASPYWEESVGKVFPVGPGSTFL 
TLVAGGISFGTVYTMLQGCLNEMAEDAQRVRIKALEEDEPQGGEVSLEAAGDNLVEKRSTGEGTSEEA---
--------------------------------------------------------------------- 
 
---------------------------------- 
---------------------------------- 
---------------------------------- 
---------------------------------- 
---------------------------------- 
---------------------------------- 
---------------------------------- 
---------------------------------- 
---------------------------------- 
---------------------------------- 
---------------------------------- 
---------------------------------- 
---------------------------------- 
---------------------------------- 
---------------------------------- 
---------------------------------- 
---------------------------------- 
---------------------------------- 
FHFFEMFQSDSDKLCHVHVLLLLTSWGLSGETVT 
FHFFEMFQSDSDKLCHVHVLLLLTSWGLSGETVT 
FHFIEMFQSDSDELCHVHVLLLLTSGGLSSETVT 
FHFFEMFQSDSDKLCHVHVLLLLTSWGLSGETVT 
PLSTRRKLGLLLKYILDSWKRRDLSEDK------ 
---------------------------------- 
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406 
416 
421 
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417 
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421 
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467 
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Figure 7. Amino acid alignment of the mouse Irg GTPases.  
Sequences of all 23 mouse Irg GTPases showing the close homology extending to the carboxyl-terminus, are aligned on the secondary structure of Irga6 (indicated by 
the secondary structure elements drawn in blue above the sequence alignment). The sequences of notional products of the two pseudo-genes Irga5 and Irgb7 have been 
partially reconstructed; premature terminations are indicated in red. In the C57BL/6 mouse, the sequence of the Irga8 gene is altered by an adenine insertion, indicated 
by the red highlighted lysine (K) at position 204. (The sequence after this position is given after correcting the frameshift, and is identical to that of the CZECHII (Mus 
musculus musculus) sequence BC023105 that lacks the extra adenine.) The turquoise-highlighted M in M1 and M2 are initiation codons that are dependent on alternative 
splicing (also see Figure 9); the unusual methionine residues in the G1 motif of GMS proteins are highlighted in green. The blue background Q residue of Irgb5 and 
Irgb2 at positions 405 and 396 represents the point at which tandem splicing occurs to Irgb4 and Irgb1, respectively. Canonical GTPase motifs are indicated by red 
boxes. The nucleotide and amino acid sequences themselves can be obtained in the p47 (IRG) GTPase database from our laboratory website (http://www.genetik.uni-
koeln.de/groups/Howard/index.html). 
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Analysis of the relationship between the p47 GTPases based on nucleotide sequence 
delivers suggestive clues to understand phylogenetic events that generate complexity in gene 
families. The multiplex block of 13 genes on chromosome 11 contains most divergent 
sequences, including all three representatives of the GMS GTPases, LRG-47 (Irgm1), 
IGTP(Irgm3) and GTPI (Irgm2), and the singlet sequence for IRG-47 (Irgd), as well as the 
previously isolated TGTP (Irgb6) sequence now accompanied by 8 further representatives. 
Fig 8a shows a phylogeny generated from the full length nucleotide alignment of the p47 
GTPases and  Fig 8b shows an alignment generated from the G domains alone (according to 
structure of IIGP1(Irga6)). The deep roots connecting the p47 GTPases on chromosome 11 
suggests that this cluster is relatively ancient. In contrast, all eight genes clustered on 
chromosome 18 show a degree of homogeneity, suggesting relatively recent divergence, with 
a plausible ancestral relationship to a member of the TGTP (Irgb6) cluster on chromosome 11. 
In contrast, the isolated p47 gene on chromosome 7 seems to represent an ancient root with no 
obvious systematic relationship to any of the other subfamilies. Within the chromosomal 
clusters, more recent duplication events are apparent, thereby linking Irga1, Irga2 and Irga6, 
Irgb1, Irgb3, Irgb4 and Irgb8, Irgb2, Irgb4, Irgb7 and Irgb9. The open reading frame of the 
adjacent sibling pair Irgb3 and Irgb4 differ only by nine nucleotides. Table 2 gives the 
nucleotide and protein sequence identities across the aligned open reading frames of the 23 
complete genes of the p47 family, in order of dissimilarity, showing the wide evolutionary 
divergence between the more distant branches of the tree. The pattern of divergence in the p47 
tree suggests a relatively old gene family that has undergone a succession of 
duplication-divergence cycles over time, a pattern of evolution, which is still actively 
continuing in several of the subfamilies (see discussion).  
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Figure 8. Phylogenetic relationship of mouse Irg GTPases. 
 (a) Unrooted tree (p-distance based on neighbour-joining method) of nucleotide sequences of the G-domains of 
the 23 mouse Irg GTPases, including the two presumed pseudogenes Irga5 and Irgb7. (b) Phylogenetic tree of 
the amino acid sequences of the G-domains of 21 mouse Irg GTPases rooted on the G-domain of H-Ras-1 
(accession number: P01112). The products of the two presumed pseudo-genes Irga5 and Irgb7 are excluded from 
the analysis. 
 
 
Table 2.Nucleotide and amino acid identities based on the G-Domain of the mouse Irg family.  
Identity matrix of pairwise aligned nucleotide (gray background) or amino acid (white background) sequences of 
mouse Irg family members. Matrix was generated using the GeneDoc program. Pseudogenes, Irgb7 and Irga5 are 
excluded from protein analysis.  
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III.I.2.The structure of p47 GTPase genes and their splicing patterns. 
 
The genes of the p47 family have a distinctive signature common to the whole family (Fig 9). 
The entire open reading frame is encoded on a single long exon with the initial ATG close to 
the splice acceptor site for one or more untranslated 5‘ exons. All the splicing acceptor and 
donors are listed in appendix table 2. In two cases (LRG47 and one of the splice forms of 
GTPI), the methionine is encoded at the 3‘ end of the previous exon, giving 3 or 4 N-terminal 
amino acid residues encoded by the upstream exon. In the case of GTPI, a second methionine 
classically positioned at the 5‘ end of the long exon 3 is used as the initiator codon in the most 
common form splicing directly from exon 1 to exon 3. Three genes of the chromosome 18 
cluster have unusual genomic structures. The strongly expressed Irga6 (IIGP1) gene has two 
alternative untranslated 5‘exons (exon 1A and exon 1B) each independently furnished with a 
functional promoter (see below).    
 
Figure 9. Genomic structure of mouse Irg GTPases.  
Genomic structure of mouse Irg genes. Green blocks indicate coding exons and blue blocks indicate 
5’-untranslated exons. Orange arrows identify putative promoter regions. Stars represents exons shown to be 
excluded in alternative splice forms. The scale bar is measured in base pairs up to the first base of the long 
coding exon. Note the presence of two promoters for Irga6 and Irgd. 
 
 The close homologues Irga1 and Irga2 are closely related to each other (Fig. 7 and 
Table 2) and exon 1 of Irga1 is used as the first exon of Irga2, entailing an intron length of 35 
kb containing the Irga1 putative pseudogene as well as the completely intergenic interval 
between Irga1 and Irga2. A genomic sequence apparently homologous to exon 1 of Irga1 is 
present 7 kb upstream of the coding exon 2 of Irga2 but is not apparently provided with an 
adequate promoter and has not yet been observed in a cDNA. Exon 1 of Irga1 also splices to 
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acceptors upstream of the coding exon of Irga1, but only a single cDNA is recorded where the 
correct 5‘splice acceptor site is used (BI658674). A recorded Est of Irga1 contain long 
genomic sequences upstream of the coding exon resulting in multiple starts in incomplete 
reading frames (BG915086). 
 A further splicing anomaly found in the public database connects Irgb1-Irgb2 and 
Irgb5-Irgb4 which is indicated in fig 9 and 10a. These genes are adjacent and in the same 
polarity on chromosome 11, with Irgb2 upstream of Irgb1 and Irgb5 upstream of Irgb4. The 
only transcripts seen containing Irgb1 are tandem structures in which the long exon 2 of Irgb1 
is preceded in frame by the long exon 2 of Irgb2. This appears to result from sporadic use of a 
cryptic splice donor site near the termination codon of Irgb2 resulting in splicing with the 
splice acceptor site of the long coding exon of Irgb2. RT-PCR analysis using primers from the 
5‘ end of Irgb1 and the 3‘ end of Irgb2 results in an amplification of a long, interferon-
inducible cDNA consistent with a fusion transcript (Fig 10b). A full-length cDNA 
representing the Irgb2-Irgb1 tandem sequence derived from “Mammary tumor metastatized to 
lung” is present in the NCBI public databases. The corresponding tandem sequence was 
amplified and shown to be inducible by interferon γ on the cDNA synthesized using RNA 
prepared from L929 cells (Figure 10b). Since no ESTs of Irgb1 alone have been reported so 
far and due to inability to detect Irgb1 without the Irgb2 tandem, it may perhaps be reasonable 
to consider Irgb1 simply as a second long coding exon of Irgb2 rather than as a gene by its 
own right. However, the situation is different for Irgb5-Irgb4 tandem, since single Est 
AK037088 can be found in public databases, which does not splice into Irgb4, thus Irgb5 can 
exist as a single gene or as a tandem gene together with Irgb4 (See Fig 9 and 10a). In my RT-
PCR analysis, Irgb4 (or Irgb3, these two sequences only differ by nine nucleotides from each 
other especially in 5’ prime region) is constitutively transcribed in mouse L929 cells. 
However, it is not clear whether Irgb4 is transcribed alone or only the second long exon of the 
Irgb5 because the amplification product of RT-PCR was specific to long coding exon of Irgb4 
and in database, there is no Est available for Irgb4. Therefore, Irgb4 was considered as an 
alternative splicing form of Irgb5. Rat Irgb13 and Irgb14 represents same structure with Irg2-
Irgb1 and Irgb5-Irgb4 tandems, therefore Irgb14 and Irgb13 are considered to be transcribed 
as tandem. However, there is no Est was reported in public rat databases either for tandem or 
for individual Irgb13 and 14.  
Furthermore, new type of tandem gene formation has been identified in rat, which 
apparently contains rat Irgb10, Irgm2, Irgm3, encoding the three GTPases together on a single 
transcript, AY321344 (Fig 10 and Appendix Table 3). These genes are adjacent and have the 
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same polarity on BAC AC097938.6 localized to chromosome 10 in rat. This corresponds to 
the homologous Irgm2, 3 and Irgb10 in the same order as on the mouse chromosome 11 (see 
above). Alignment of the triple gene with individual rat Irgb10, Irgm2 and Irgm3 is shown in 
appendix fig. 1. After five times splicing by having short peptides which is unrelated to p47 
GTPases, the triple gene starts with a GKS like GTPase characteristics-Irgb10 sequence with 
a classical myristoylation signal MGxxxS. After coding the whole N-terminal, G domain and 
C-terminal region of rat Irgb10, the triple tandem splices into one of the GMS type GTPase 
(rat Irgm3). Finally, the tandem ends with another GMS type GTPase (rat Irgm2) which is 
linked to the previous GTPases by three splicing with short peptides. End of the third gene 
codes classical C-Terminal sequence of GMS type GTPase (Irgm2) and splice into short 
sequences, which has a putative stop codon and is unrelated to any known p47 GTPase. 
Analysis of all splicing acceptors and donors together with the structure of the triple gene is 
shown in appendix table 3. Since Ests for rat Irgm3 and rat Irgm2, not splice into triple 
tandem, have been reported (Ests for rat Irgm2 CO388297, CB544546, CO566274 and for rat 
Irgm3 CK841941,CK841941). It is reasonable to consider the triple tandem formation simply 
as an alternative splicing form of rat Irgm3 and Irgm2. However, no Est was detected for 
Irgb10 alone indicating that rat Irgb10 is only transcribed as first long exon of the triple 
tandem AY321344.  
 
Figure 10. Triple and tandem gene formations in p47 GTPase family. 
(a) All possible higher structure formations detected in mouse, rat and zebrafish in p47 GTPases are illustrated. 
Light blue shading indicates the GKS type GTPase, light green coloring indicates the GMS type or a Quasi  
GTPase. (b)  An RT-PCR experiment showing interferon inducibility of mouse Irgb2-Irgb1 tandem. L929 cells 
were induced with 200 u/ml interferon γ for 24 hour (+) and uninduced (-).  
 
Another tandem formation was detected in the zebrafish database forming irgg1-irgq1 which 
is located on chromosome 16. Like mouse tandems, irgg1and irgq1 are adjacent with the same 
polarity, with irgg1 positioned upstream of irgq1. There are two Ests available in databases, 
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BQ481364 and BQ481122. The tandem starts with irgg1 and splice into irgq1, however both 
GTPases code for the N-terminus and G-domain of p47 GTPases and irgq1 is considered to be 
a quasi GTPase which has valine (V) instead of lysine (K) in  G1 motif (see below, Fig 10a 
and Maria Leptin personal communication) 
 
III.I.3.The coding sequences of the p47 GTPases 
 
A multiple alignment of the predicted translation products of the coding sequences of the 21 
intact mouse p47 GTPase genes is shown in fig 7. Superimposed on the alignment is the 
known secondary structure of IIGP1 derived from the recently determined high-resolution 
crystal structure (Ghosh et al., 2004). The full alignment confirms a number of major features 
already apparent from the previously published alignment of six family members fig 5. The 
proteins are largely co-linear, with minor insertions or deletions. The GTP binding domain is 
rather strongly conserved in all proteins, with key elements for nucleotide binding being 
highly conserved. The previously noted abnormal methionine in the G1 motif (GMS instead 
of GKS) is found only in the three GMS proteins previously described. The many new genes 
described here are all of the conventional GKS type. Outside the nucleotide binding sites there 
is considerable sequence variation, especially in the C-terminal region, interspersed between 
highly conserved features common to the entire family. From the crystal structure of IIGP1, it 
can be tentatively predicted that the most highly divergent regions in the alignment 
correspond to extended loops between helical regions which vary in length. However 
confirmation for this interpretation depends on further structural information for other 
members of this family. A majority of the proteins, including all chromosome 18 gene 
products and some of chromosome 11 gene products Irgb10, Irgb2, Irgb5, Irgb9 carry the N-
terminal myristoylation signal MGxxxS. It has been documented that IIGP1 is indeed 
myristoylated in cells, and, as expected, favors binding of the protein to membranes (Uthaiah, 
2002), (Martens et al., 2004). It is therefore predictable that the putative myristoyl motifs of 
the other gene products may be active. No other membrane attachment sequences or lipid 
modification motifs are apparent elsewhere in the sequences, despite the documented 
attachment of several of these proteins to membranes. Several of the new gene products have 
C-terminal extensions up to about 65 residues compared with the canonical IIGP1 sequence. 
This is the case for the group of Irgb2, Irgb5, Irgb7ψ, Irgb9 proteins as well as for Irgc. 
However, C-terminal extension of Irgb2 and Irgb5 are largely excluded from the tandem 
sequences because of the splicing on the glutamine (Q) a.a residue (indicated as blue in Fig. 
4). 
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III.I.4.Identification of interferon response elements and characterization of the putative 
promoter of mouse p47 GTPase genes. 
 
The p47 GTPases are regulated by interferon gamma (Boehm et al., 1998). Therefore, it is 
essential to know the signature of the promoter elements used in the upregulation of these 
GTPases at the transcriptional level. The basis for interferon-inducible expression of the p47 
GTPases has been investigated in a reporter assay only for Irgd (IRG47) (Gilly et al., 1996). 
In this study, Gilly et al., identified a classical ISRE sequence, upstream of the putative 
transcription start point. My analysis explored the generality of this observation, not just for 
the five other previously defined p47 genes but also for all the known transcribed p47 genes 
(Boehm et al., 1998). Fig 11 summarizes the essential findings superimposed on the genomic 
structure. The analysis indicated that there is another putative promoter region exists for irgd, 
in addition to that found by Gilly. It is also identified that there exist two promoter regions for 
IIGP1. Both promoters are used apparently in all tissues in which IIGP1 is expressed except 
the liver. In liver basal activity of Irga6(p2) is significantly higher than the Irga6(p1) 
((Parvanova, 2005) and Jia Zeng personal communication). All known transcribed p47 genes 
possess the interferon inducible signature motifs, ISRE and GAS elements in characteristic 
clusters. Both the putative promoters of Irga6 and Irgd have intact interferon-inducible 
elements. Interestingly, infection with L. monocytogenes experiments revealed that Irga6(p1) 
driven expression is strongly upregulated while Irga6(p2) showed no or slight level of 
increase in upregulation in liver, spleen and lung (Parvanova, 2005). The positions relative to 
the putative transcription start site and the sequences as well as orientations of these elements 
are itemized in table 3. No systematic differences were apparent between the interferon 
inducible elements of any of the p47 genes except for Irgc. A more detailed search was done 
10 kb upstream of the putative transcription start, also failed to reveal either clustered or 
isolated ISRE or GAS elements in the putative promoter region.  
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Figure 11. Promoter structure of mouse Irg GTPases. 
Interferon response elements in the promoter regions of mouse Irg genes. γ-Activated sequences (GAS; pale blue 
blocks) and interferon-stimulated response element (ISRE; red blocks) sequences were identified in the 
promoters shown in panel a (also see Additional data file 7). Dark blue blocks downstream of each promoter 
represent the most 5’ exon. The yellow block identifies a putative Sox1 transcription factor binding site in the 
proximal promoter region of Irgc. The scale bar is measured in base pairs from the first base of the 5’ exon. 
Please note that Irga1 and Irga2 is the same promoter. 
 
These data strongly indicated that interferon response elements for 14 uncharacterized p47 
genes, and all except Irgc might therefore be inducible by interferon. To validate the 
importance of the identified interferon response elements, RT-PCR analysis was carried out. 
L929 cells were either stimulated or not stimulated with interferon γ (200 U/ml) for 24 hours 
and the results of induction were analyzed by RT-PCR. Of the 14 new p47 genes, eight of 
them showed clearly inducible transcription (Fig. 12a). As anticipated from the promoter 
analysis, Irgc showed no induction in fibroblasts, and in mice infected with Listeria 
monocytogenes (Christophe Rohde personal communication). Interestingly, there was lack of 
interferon-inducible transcription of Irga5 even though it shows perfect interferon-inducible 
upstream elements correctly positioned relative to the putative transcriptional start.   
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Gene name Distance GAS Distance ISRE 
Irga1 -133 GTTCTTGGAA -148 AGTTTCACTTTCCT(+) 
 -188 CTTCTTTGAA   
Irga2 -119 GTTCTTGGAA -134 AGTTTCACTTTCCT(+) 
 -174 CTTCTTTGAA   
Irga3 -142 CTTCTTTGAA -156 TGTTTCACTTTCAT(+) 
 -207 TTTCTGCCAA   
Irga4 -141 CTTCTTTGAA -156 TGTTTCACTTTCAT(+) 
 -184 GTTTCTGGAA   
Irga6(p1)* -162 CTTCTTTGAA -176 TGTTTCACTTTCAT(+) 
 -226 TTTCTTGCAA -235 CCTTTCTCTTTCTG(+) 
 -312 GTTCCATTAA   
Irga6(p2)* -170 CTTCTTAGAA -130 AGTTTCACTTTCCT(+) 
Irga8 -30 CTTCTTTGAA -45 GGTTTCACTTTCAT(+) 
 -93 TTTCTGCCAA   
Irgb2 -87 TTTCCAGGAA -77 AGAAAGTGAAACCT 
Irgb4   -381 AGAAAGAGAAAGAC 
   -627 TCAAAGAGAAAGTT 
Irgb6 -96 TTTCCAGGAA -86 CGAAACCGAAACCT 
Irgb9   -223 AGAAAGAGAAAGAA 
   -562 TCAAAGAGAAAGTT 
   -665 TCAAAGAGAAAGAC 
Irgb10 -61 ATTACTGGAA -47 ACTTTCAGTTTCAC(+) 
   -93 GCTTTCAGTTTCT   
(+) 
Irgd(p1)* -821 TTTCTGTGAA -301 ACTTTCTCTTTGAA(+) 
Irgd(p2)* -21 TTTCCTGCAA -35 AGTTTCACTTTTGT(+) 
 -80 TTTCCTGGAA   
Irgm1 -64 TTTCAAGAAA -54 AGAAACCGAAACTG 
 -1061 TTTCCGGTAA -1050 AGAAAGAGAAAGCC 
Irgm2 -95 TTTCCAGGAA -85 TGAAACTGAAAGCT 
Irgm3 -108 TTTCTAGGAA -98 TGAAACTGAAAGCT 
   -825 TGAAAATGAAAGAC 
Table 3: ISRE (Interferon stimulated Response Element) and GAS (Gamma activated sequences) elements 
of mouse Irg family genes.  
Values in the distance column denote the position of ISRE and GAS element relative to the putative transcription 
start site. Black and gray shading indicates optimal and sub-optimal binding sites respectively. *(p1) alternative 
upstream promoter, (p2) alternative downstream promoter. ISRE and GAS elements marked as (+) have the same 
orientation relative to the putative transcription start site. 
 
No additional elements such as an NFkB site which is frequently associated with the 
ISRE/GAS motifs were found. However the ISRE and GAS sites described in table 3 showed 
internal variation suggesting that they were not recently derived from a common ancestor. The 
relative positions of the GAS and ISRE elements varied from promoter to promoter and 
moreover both sites were not consistently present in all elements and the relative orientations 
of both components were variable. 
Furthermore, to compare the number of fold induction of p47 GTPases by IFN γ, real 
time PCR was carried out. Classical p47 GTPases like Irga6 (IIGP1) and Irgm1 (LRG47), 
which have been characterized by in vivo and in vitro methods, were selected. Irgm1 shows 
50 and 23 fold inducible transcription upon stimulation by IFN γ and β respectively. In 
contrast, Irga6 showed 215 and 23 fold induction by IFN γ and β respectively.  
                                                                                                                                                                      Results I 
 49
 
Figure 12. Interferon responsiveness of mouse and human p47 (IRG) GTPase.  
(a) IFN γ inducibility of eight newly identified Irg genes. Induction was performed for 24 hours with IFN γ in 
L929 fibroblasts and was detected by RT-PCR. D refers to a positive control genomic DNA template; O refers to 
a negative control of the same genomic template after DNAse1 treatment; and + and – refer to RT-PCR on 
DNAse1-treated RNA templates from IFN-γ-induced and IFN-γ-noninduced cells, respectively. The sibling 
genes of the Irgb series could not be individually amplified because of their close sequence similarity. The 
identities of the amplified genes responding to interferon induction, indicated by vertical arrows, were 
subsequently established by sequencing of multiple clones from the PCR product. (b) Real-Time PCR analysis 
of the induction of Irga6 and Irgm1 in L929 fibroblasts induced for 24 hours with IFN-γ or β (also see (Boehm et 
al., 1998)). Demonstration of Interferon γ and β induction of Irga6 and Irgm1 in L929 fibroblasts, GAPDH was 
used as positive control (left). O refers to a negative control of the RT-PCR. γ, β and – refer to RT-PCR on 
DNAse1-treated RNA templates from IFN-γ/IFN-β induced and noninduced L929 cells, respectively. The 
detected induction ratio for Irga6 and Irgm1 by real-time PCR are illustrated (right). Numbers on the top of the 
box indicate the exact value of fold induction. Real-Time PCR was normalized using GAPDH. PGEMT-Easy 
containing ORF of Irga6 and Irgm1 was used as a reference for detection of the copy number of cDNA.   
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The reason for detected difference between Irga6 and Irgm1 in induction is probably 
due to chromosomal distribution of Irg genes (Fig 12b). It is detected that the promoters of the 
Irg genes, localized to the chromosome 11, have generally higher basal level of activity than 
the promoters of the Irg genes localized to chromosome 18 (Fig 12 and see above).  
 
III.I.5.Identification of interferon response elements and characterization of the 
putative promoter of fish p47 GTPase genes. 
The identified fish and dog p47 GTPases were analyzed for either interferon inducibility or 
existence of ISRE and GAS elements. Among the seven identified full-length dog p47 
GTPases, four of them showed clearly inducible transcription upon IFN-γ stimulation in cell 
culture (see below). Preliminary analysis indicates that indeed ISRE and GAS elements are 
exist in the promoter regions of fish p47 GTPases. This is true especially in the case of irge3 
and irge4 of which expression are derived from the same promoter like Irga1 and Irga2 (Fig 
13 and 11). The fish p47 GTPases, irge3 and irge4 have perfect ISRE elements in the putative 
promoter region. The putative promoter region is identified using the Ests AW233145, 
CK142408 and analyzed according to supplementary analysis described in material and 
methods (Table 4). Identified putative promoter region of irge3 and irge4 is probably the 
representative of other irge like p47 GTPases because it has microsatellite repeats in its 
promoter region and the microsatellite spreads through Danio rerio BAC sequence 
(AL935330). The pattern of distribution of microsatellites is consistent with the distribution of 
fish irge genes which is located on the same BAC indicating that multiple genomic 
duplication events were responsible for generation of new irg genes with their promoter 
regions. Further analysis of promoter region of other fish p47 genes revealed that indeed p47 
GTPases in fish have ISRE and GAS sites in their promoter region (Maria Leptin personal 
communication).     
These properties strongly suggested that the association of the interferon-inducible 
elements with the p47 GTPase genes is old and their sequences are retained in position 
subsequently and are maintained in a working order by natural selection for a considerable 
period of time against the disruptive forces of spontaneous genome evolution. 
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Gene name Species Distance ISRE Reference 
s HLA-A3 H. sapiens  AGAAA-AGAAACT (Friedman and Stark, 1985) 
s 2’,5’ AS H. sapiens -88 AGAAA-CGAAACC (Benech et al., 1987) 
as2’,5’ AS H. sapiens -140 GGAAACTGAAACT (Floyd-Smith et al., 1999) 
s Isg 20 H. sapiens -39 AGAAACTGAAACA (Gongora et al., 2000) 
s Isg 15 H. sapiens -95 GGAAACCGAAACT (Reich et al., 1987) 
s Isg 54 H. sapiens -91 GGAAAGTGAAACC (Reich et al., 1987) 
s IFNα1 H. sapiens -73 AGAAATGGAAACT (Ryals et al., 1985) 
s PKR H. sapiens  GGAAAACGAAACT (Kuhen and Samuel, 1997) 
as MxA H. sapiens -91 AGAAA-CGAAACC (Chang et al., 1991) 
s PKR M. musculus  GGAAAACGAAACA (Tanaka and Samuel, 1994) 
as Mx1 M. musculus -120 AGAAA-CGAAACT (Hug et al., 1988) 
as Mx1 G. gallus -50 AGAAA-CGAAACT (Schumacher et al., 1994) 
s Mx1 O. mykiss -88 TGAAAGTGAAACA (Collet and Secombes, 2001) 
s Mx1 D. rerio  AGAAA-TGAAACT (Altmann et al., 2004) 
as Irga6(p1)* M. musculus -176 TGAAAGTGAAACA Present study 
as Irga6(p2)* M. musculus -130 GGAAAGTGAAACT Present study 
s Irgb6 M. musculus -86 CGAAACCGAAACC Present study 
s Irgm1 M. musculus -54 AGAAACCGAAACT Present study 
s Irgm2 M. musculus -85 TGAAACTGAAAGC Present study 
s Irgm3 M. musculus -98 TGAAACTGAAAGC Present study 
as Irge3, irge4 D. rerio -76 GGAAA-CGAAACT Present study 
Table 4: Comparison of ISRE (Interferon Stimulated Response Element) elements representing Irg family 
genes with the known ISRE elements of other IFN inducible genes.  
Values in the distance column denote the position of ISRE element relative to the putative transcription start site. 
Black and gray shading indicates optimal and suboptimal binding site respectively. *(p1) alternative upstream 
promoter, (p2) alternative downstream promoter. ISRE and GAS elements marked as (as) antisense, (s) sense. In 
the presence of two or more ISRE element  in the respective promoter region, the one that is closest to the 
transcription start site has been used. The table was originally prepared by (Collet and Secombes, 2001) and 
updated using recent reports. 
 
Figure 13. Promoter and genomic structure of irge3 and irge4  
Dot plot matrix analysis using irge genes (irge3 vertical-represented by light blue and irge4 vertical represented 
by dark blue) and Danio BAC sequence (AL936330) matrix covers the 11000bp (from 175000 to 186000) of 
AL936330. Putative promoter region was identified using the 5’Ests (AW233145 for Irge3 and CK142408 for 
Irge4) (highlighted in green). Identified ISRE sequence on the promoter region of irge3/4 was indicated with red 
arrow. Black arrows indicate the microsatellites repeats.  
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III.I.6.The p47 GTPases in other rodents 
 
Using a combination of screens on available databases, evolutionary analysis of p47 
GTPases was extended to other rodentia species. Analysis was carried out using 
bioinformaticc approaches for the Czech II mouse strain (Mus musculus musculus) and Rat 
(Rattus norvegicus). 
 Either blastn or tblastn searches in NCBI blast server were used yielding 82 Ests from 
Czech II mouse showing significant homology to p47 GTPase. All collected Ests were used to 
generate contigs. A total of ten contigs was assembled using the supplementary analysis 
described in Material and Methods. Further search analysis was performed to confirm contigs 
association to p47 GTPases and putative full length transcript was extracted whenever 
possible. Nucleotide sequences of these genes were edited to get putative open reading 
frames, and were aligned (Fig. 14a and see below). 10 representative of the p47 GTPase 
family were recovered from the Czech II Est database, with a complete ORF. Irgm1 could 
only be partially constructed from collected Ests by contig generation and alignment of all 
p47 GTPase in Czech II mouse is shown in appendix fig 2. The phylogenetic analysis showed 
that there are sequence variations indicating recent diversification. In the phylogeny the 
branch containing Irga9 and Irga10 represent recently duplicated version of p47 GTPase 
family in Czech II mouse (Fig 14a). Irga8 is encoding full length p47 GTPase in Czech II 
mouse whereas it is truncated in C57BL/6 mice (see above). It would be of interest to 
elucidate whether there are any patterns of polymorphism of p47 GTPases in Czech II mouse 
leading to diversification of the family members by positive selection. 
 The rat genome was also screened for analyzing p47 GTPase homologue genes using 
the available database for Norway Rat (Rattus norvegicus). Fifteen p47 genes were recovered 
from the rat genome of which two are incapable of coding full length p47 GTPases (see 
above). Therefore it is concluded that Irga14 and Irga16 are pseudogenes since they do not 
encode full length p47 GTPases and have accumulated multiple null mutations. In contrast 
previously reported pseudogenes in mouse Irga5 and truncated p47 GTPase Irgb10, which is 
encoding only the G-domain of classical p47 GTPases, are encoding functional full length p47 
GTPases in rat (Fig 14b). Multiple alignments of mouse p47 GTPase with their rat homolog 
show that every feature of p47 GTPases are also present in rat (Appendix Fig 3). Topology of 
the phylogeny of rat p47 GTPases generated together with mouse homologs reveals that 
diversity of p47 GTPases is protected here in rat as well. Each branch of phylogeny has at 
least one member of the rat p47 GTPase. Additionally, the branch containing Irga11, Irga12 
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and Irga13 (IIGP1), further diversified in the rat genome (Fig 14b) suggesting that 
diversification of the Irga genes probably is expanded by recent genomic duplication (see 
above).  
 
Figure 14. Phylogeny of other rodents (Czech II and rat) with C57BL/6 mice Irg GTPases 
(a) Phylogeny of Czech II (blue) and C57BL/6 mice (green). (b) Phylogeny of rat (red) and C57BL/6 mice 
(green). For both phylogenic tree constructions, Nj tree based on nucleotide sequences was generated by using 
Mega3.1. The nucleotide and amino acid sequences themselves can be obtained in the p47 (IRG) GTPase 
database from our laboratory website (http://www.genetik.uni-koeln.de/groups/Howard/index.html).   
 
Ests were identified for all rat p47 GTPases described above, except for Irgb14 and Irgb13 
showing that family is indeed actively transcribed in rat as well. As mentioned above, triple 
gene formation was detected in the rat genome at transcriptional level. There is a special 
mRNA (AY321344) exist in the rat database encoding triple p47 GTPases in tandem which 
was reported as liver specific regeneration gene (see above and appendix table 3). 
 
III.I.7.The p47 GTPase genes of the human genome. 
 
An extensive analysis of the human genome databases was initiated to identify the p47 
GTPase gene family members in humans. By both transcriptome and genome analysis only 
two sequences, both transcribed, corresponding to p47 GTPases were found, on chromosome 
19, and chromosome 5 respectively. Analysis of these two sequences showed that, IRGC is 
closely homologous at both nucleotide and amino acid level, to the isolated mouse gene, Irgc. 
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The second sequence, IRGM, encodes a G-domain of p47 GTPases, which begins downstream 
of the typical start sites in the mouse p47 GTPases and terminates in the region of the α-
helixH in IIGP1. 3‘of this point all recognizable homology at nucleotide or amino acid level 
in all five reading frames was lost. By a number of criteria, including the defining methionine, 
the IRGM transcribed gene fragments is a human homologue of the GMS subfamily of p47 
GTPases (Fig 17). By exploring the human and mouse synteny maps, it was possible to locate 
the syntenic cluster containing mouse Irgc, accurately to an identical syntenic cluster on 
human chromosome 19. The human IRGC shows more than 90% identity at the amino acid 
level and more than 85% at the nucleotide level with the syntenic human gene. Thus, we 
concluded that IRGC gene in human is a true orthologue of the irgc gene in mouse.  
 Using various syntenic loci, it was possible to map unambiguously the region in the 
human genome corresponding to both mouse p47 GTPase clusters to the proximal long arm of 
human chromosome 5. The mouse chromosome 11 cluster, itself divided by a 10 Mb gap, is 
also divided in its syntenic relation to the human chromosome. The region corresponding to 
the 10 genes from Irgd (IRG-47) at one end Irgm1 (LRG-47) at the other is accurately located 
in a 30 kb interval between the two human marker loci HINT1 and TRIM7. The mouse 
chromosome 18 p47 GTPase cluster maps immediately centromeric to the human marker gene 
DCTN4 (Fig. 15). The synteny results strongly suggest that the interferon-inducible p47 
GTPases were formerly encoded in a single cluster ancestral to the human chromosome 5 
region. This ancestral block was subsequently broken down in the mouse lineage into two 
clusters located on chromosomes 11 and 18 respectively, while the p47 genes in the 
chromosome 5 cluster in the human species were progressively lost until the only trace of 
their former existence is the unique GMS fragment (see below). 
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Figure 15. Synteny relationships between the human and mouse IRG genes 
a.  Synteny between mouse chromosome 7 and human chromosome 19 in the region of the IRGC and IRGQ 
genes. The figures indicate distances from the centromere in megabases. The locations of three further syntenic 
markers are given. Gene orientation is given by black arrows. b. Complex synteny relationship between human 
chromosome 5 and mouse chromosomes 11 and 18 in the regions containing the mouse Irg genes. Figures 
indicate distances from the centromere in megabases. The locations of IRG genes are shown in the yellow panels.  
Positions of diagnostic syntenic markers are also indicated. Syntenic blocks are given in full color, the rest is 
shaded. (courtesy of Julia Hunn) 
 
III.I.8.The p47 GTPase genes of the dog genome. 
 
Is the mouse (Order Rodentia) or the human (Order Primata) the exception? IRG genes in a 
third order of mammals, the Carnivora was screened. Totally, nine IRG genes from the public 
genome database of the dog, Canis familiaris, were recovered, (Fig 17, 18 and Appendix Fig. 
4). Of these, one (AACN010088820) is a pseudogene by a number of criteria, another is 
clearly a dog IRGC, while the partial sequence (AACN010048557) is novel but most closely 
related to IRGC. The remainder assort into segments of the phylogeny already established for 
the interferon-inducible mouse IRG genes. Both GMS and GKS genes are represented and are 
inducible by interferon in dog MDCK II epithelial cells (Fig 16). The three dog GMS genes 
                                                                                                                                                                      Results I 
 56
seem to have diversified independently from the mouse GMS genes as represented in main 
vertebrate phylogeny (Fig 18). As in man and mouse, dog IRGC gene was not induced by 
IFN-γ. At least in dog, therefore, the absence of the interferon inducible p47 GTPase Ests in 
the databases can reflect a tighter control of transcription than in mouse, and the same 
argument could also be used for the other mammalian groups. Overall, the IRG gene status of 
dog clearly resembles that of mouse rather than that of human. 
 
 
Figure 16. Inducibility of Dog (Canis familiaris) GTPases 
Epithelial MDCK II cells were induced (+) or not induced (-) with 10 ng/ml dog interferon for 24 hours, D refers 
to 30 ng of genomic DNA as positive control, 0 refers to no DNA as negative control. 
 
III.I.9.The p47 GTPase family in other vertebrates. 
 
The public databases (ENSEMBLE and NCBI) for homologues of the p47 GTPases was 
screened in other taxonomic groups. Among the other mammals, p47 GTPase like genes have 
been identified in pig, hamster, and cow (Appendix Table 4). Examination of these sequences 
reveals that they have indeed characteristic features of p47 GTPases. Both pig and dog have 
Cinema (IRGC) as well as a Cinema like p47 GTPase. The degree of divergence of this 
second sequence from pig and dog Cinema (IRGC) suggests a relatively old duplication rather 
than a recent event. When mammalian lineage is considered, these results suggest that the 
absence of inducible p47 GTPases seen in man might be an unique case outside the murine 
rodents. 
 The p47 GTPases are present in several non-mammalian vertebrates (Appendix Table 
1). There is p47 GTPase-like sequence available for Xenopus (Xenopus tropicalis). However, 
no p47 GTPase gene was detected for chicken (Gallus gallus)  (Appendix Table 4). In 
addition, the completion of the two of the ray finned fish genomes has allowed us for a 
detailed analysis in these fish (Zebrafish, fugu, Tetraodon). The alignment given in fig. 17 
shows conclusively that these are p47 GTPase genes, with all the characteristic sequence 
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features identified in the mammalian representatives present. Fish p47 GTPases fall in to two 
clades (f and e) in vertebrate phylogeny (Fig. 18) showing that diversification of the p47 
GTPase family is probably expanded by an early genomic duplication event (Hoegg and 
Meyer, 2005) (Christoffels et al., 2004). Including quasi GTPases, 14 intact members of the 
p47 GTPase family were detected in zebrafish. However, the family was represented only 
with 2 members in Fugu and Tetraodon, respectively. No members of the GMS subfamily are 
present in these fish genomes. Exceptionally, the Tetraodon, fugu and zebrafish (only for Irgf) 
genes appear to be divided by a short intron positioned as indicated by the blue in Fig. 17. 
This is inferred from the alignment of the sequences with mammalian sequences, the presence 
of stops in all reading frames in the putative introns except fugu, the positioning of perfect 
splice donor and acceptor sites and available Ests in databases (CA589084 for Fugu irgf5). 
They show no significantly greater similarity to the highly conserved mouse CINEMA (Irgc) 
gene than to the variety of interferon-inducible genes. Thus, it can be concluded that fish p47 
GTPase family, its own evolutionary trajectory probably related to diversification after 
species-specific multiple genomic duplications resulting in different complexity of p47 
GTPases in Fugu, Tetraodon and Danio. 
 
III.I.10.The p47 GTPase genes in invertabrates. 
 
It is possible to identify p47 GTPase-like genes outside the vertebrates. Although no 
homologue of p47 GTPases were detected in Drosophila, the results of the recent database 
search show that C. elegans has p47 GTPase like proteins; (C46E1.3) which is encoded as 
tandem and additional single gene (W09C5.2) (Appendix Table 1). It could be argued from 
the alignment that W09C52 is much closer to p47 GTPase then C46E1.3 especially in N-
terminus (Appendix Fig 5). However, validity of these genes as a member of p47 GTPase 
remains to be answered. Phylogenetic and bioinformatic analysis is not enogh to link these 
genes to family of p47 GTPases. Biochemical or structural studies are necessary to clarify the 
validity of these genes as a member of p47 GTPases.  
A series of 45-50 kDa GTPases of unknown function are recognizable in a number of 
cyanobacterial species, including common pathogens which show a plausible homology to the 
vertebrate GTPases in the G-domain. The G-domains of these enzymes are located within the 
protein at roughly the same position as in the p47 GTPases as a general characteristics of p47 
GTPases. These observations raise the possibility that the vertebrate p47 GTPases may have 
been horizontally acquired from a microbial genome although it must immediately be 
conceded that no homology can be discerned outside the G domain however secondary 
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structure predictions analysis indicates that bacterial p47 GTPase like proteins have similar 
secondary structure to IIGP1 (Jonathan C. Howard personal communication). 
 
III.I.11.IRG homologues with divergent nucleotide-binding regions: the quasi-GTPases 
 
The mouse, human, xenopus and zebrafish genomes encode proteins homologous to the IRG 
GTPases but radically modified in the GTP-binding site. These modified GTPases, which are 
named here as “quasi IRG“ proteins, thus IRGQ, have characteristic features of p47 GTPases. 
Human and mice contain a single IRGQ gene closely linked to IRGC. The zebrafish genome 
contains three IRG homologues with more or less modified GTP-binding motifs (irgq1-q3), 
(Fig 17 and Fig 18). The homology of the fish irgq genes to IRG genes is stronger than that of 
human and mouse IRGQ genes but their function as GTPases is doubtful. irgq1 is clustered on 
a single BAC clone with 4 apparently normal irge genes and immediately downstream of a 
truncated p47 gene, irgg, with which irgq1 is transcribed as the C-terminal half of a tandem 
transcript (Maria Leptin personal comunication). Thus the hypothetical protein product would 
be a C-terminally truncated p47 GTPase, linked at its C-terminus to a similarly truncated p47 
homologue probably without GTPase function (see above).  
 IRGQ sequences reveal their phylogenetic relationship to the IRG proteins, but are 
nevertheless more or less radically modified, primarily in the nucleotide binding site. In view 
of the substantial divergence between the IRGQ genes and functional p47 GTPases, it was 
unexpected not to find close homologues of the Danio irgq sequences in either the Fugu or 
Tetraodon genomes. The evolution and diversity of the Danio irgq genes is apparently linked 
to the evolution and diversity of the p47 GTPase family.  
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FPVLMDKLISDLPIYKRHNFMVSLPNITDSVIEKKRQFLKQRIWLEGFAADLVNI-IPSLT
FPKLETKLLQDLPAHKRHVFSLSLQSLTEATINYKRDSLKQKVFLEAMKAGALAT-IPLGG 
FPKLEETLLKELPGHKRHMFALLLPNISDASIELKKHFLREKIWLEALKSAAVSF-IPFMT 
FQSLETTLLKELPAHKRHIFMQYLPNITESAIDRKRDSLRQKVWLEAVKAGASAT-IPFMG 
FQSLETTLLRELPSHKRHIFMQYLPIVTEATIDRKRDCLRQKVWLEAIKAGASAS-IPLVG 
FPRLEETLLKELPVHKRHIFALLLPNLSYTSIEMKRAFFKEKIWLDALKSSALSF-IPFMA 
FPKLRDTLHKDLSNIRCCEPLKTLYGTYEKIVGDKVAVWKQRIANESLK-----------N 
------------------------------------------------------------- 
FPELRNTLNRDISDIRYCGPLKNLSHTYEKVISDKVTMFRGKIASKSF------------D 
FPELRDALNRDISDIRYCGPLENLSDTCEKIINDKVTSFQEQIGSKTFQ-----------D 
FPELRKSLHRDISNIGYRGHLENLTHTCEKVINGKVTTLQGQIGSKSFQ-----------D 
FPMLVTTWEHDLPAHRRHAGLLSLPDISLEALQKKKDMLQEQVLKTALVSGVIQA-LPVPG 
FPTLVSTWEHDLPSHRRHAGLLSLPDISLEALQKKKAMLQEQVLKTALVLGVIQA-LPVPG 
FPLLMSTWEHDLPAHRRHAGLLSLPDISLEALQKKKDMLQEQVLKTALVSGVIQA-LPVPG 
FQKFISTFKDEVFKIRAEEFSGFLDKMLHGGWLKAR------------------------- 
FQKLVNTLEEELPKNKRFALIQSLPVYSLETLTKKITYFKKLIWLNAVGAGVGAF-PPIPG 
FQKLVNTLEEELPKNKRFALIQSLPVYSLEALTKKITYFKKLIWLNAVGAGVGAI-APIPG 
FEELQNTLAEELPVHKRNALLQAWPVCSAASLEMKIKMFEGVIWAASLASAGIAV-VPLPG 
FN-LVGTLESELSDQKGFALVQSVPVYSLAMLEKKKALLEKFIWLAALASSACTL-VPNQF 
FQTFVDTLEKQLPDHKRDALILSLPIYSSKILEEKIEIFMKQTWSAAVASGSVAV-VPVPG 
FQTFVDTLEKQLPDHKRDALILSLPIYSSKILEEKIEIFMKQTWSAAVASGSVAV-VPVPG 
LNLLQDRMEKELPQHKRRVLMLALPNITLEINEKKKKALEENIRKVAFLSACVAL-FPLPG 
LNLLEEKMEEELPQHKRRVLLLALPNITQEINEKKKEALGQNIGKVAILSACVAA-VPIPG 
LNLLQEMMEKEILKCKRILLKSALLNVKQEVIEQRKDTLKRNIERVTEQSVAITD-VHLPG 
FQLLQERMETELPLHKRRVLMLALPNVSLDVIKKKKEVLEKDIAKVAFISATVSA-VPIPG 
FLTFLEVMRGDLPEIRAHALLLALPTFSSSLVTQKKDAFKALVWAAASLSGGVSA-IPVPL 
FVSLESALSSDLNTIRTSAFAYYIARTVKENL----------------------------- 
LFLVSANYPETLDLAKLKGMLKAAIPSHKKVALARYVSKQLDEDVFWKRSDSCKFM----- 
FHETHETLERELPEHKRNVLLVAMPNISLEIIEKKKEAFKSKIPLWAFVSAAGAV-VPVPG 
FHLLYETLEREFPEHQRDVLLVAMSNISLEINGKKKEAFKSKIPYWALVSSVGAL-VPVPG 
FHRLHATLERELPEHKRDALLFAMPNMSLEIIEKKKEAFKSKIPHYAFVSAACAA-VPVPG 
FHRLHATLERELPEHKRDALLVSLANMSLEIIKKKKEAFKSKIPHYAFVSAACAA-VPLPG 
LPGLGTWLQHALPTAQAGALLLALPPASPRAARRKAAALRAGAWRPALLASLAAAAAPVPG 
LPGLCEWLRRALPPAQAGALLLALPPASPSAARTKAAALRAGAWRPALLASLAAAAAPLPG 
DAFYTLVREIRQHKLRKLNPPDESGPGCMSCKCVLS------------------------- 
 
DIRLNCVNTFRENGIAEPPIFLLSNKNVCHYD 
NIKDYCSNHLQESLDSEPPVFLVSNVDISKYD 
QIRDYCVTNLIKTGVTEPCIFLISNLDLGAFD 
KIRNDCITQLQNVKVCDPQVFLVSNLDLSSYD 
KIRNDCVKHLMEANMSDAQVFLVSSFELSDYD 
QIRDNCLANLSNIGVPEPCIFLVSNFDLDDFD 
NIQENIRENLQKEKVKYPPVFLVSSLDPLLYD 
-IRENVLENLQKERVCEY-------------- 
NIQENIQENLQKERVFEPIIFLVSSFEPLLHD 
NIWENIQETLQKVGVCEPIIFLVSSFEPLLHD 
NIRENIRETLHKEGVCEPIIFLVSSFNPFLHD 
EIRDHCTERLRVAGVNDPRIFLVSNLSPTRYD 
EIRDHCAERLREAGVADPRIFLVSNLSPARYD 
EIRDHCAERLRVAGMTDPRIFLVSNLSPARYD 
QMRQDCEKYLKEKKLD-PHIFLVSTHDTHNYE 
KIREDCKVNLLK--LNISKIFLISSFHLERYD 
KIREDCKVNLLK--VRISKIFLISSFHLERYD 
TIREDCLKNLKQ--LGDPKVFLISSFDLEKYD 
AIREDCYRNLKE--VGNPKVFLISSFDLRKYD 
HIRENCHRNLKD--IDDPHAFLICSFELHKYD 
HIREDCHRNLKD--MDDPHAFLICSFELHKYD 
SIRKDCINGLRKIGIEDPIVFLISGWELSKYD 
VIREDCVNGLRKIGIEDPVVFLISNFELGKYD 
SIREDCENGLRKIGIEYPVVFLISGWDLGKYD 
NIRDKCKSELSKI-VKDPAVFLISCNELNKYD 
AKKAASLDVLKAEGVPLPKVFLVQPSALEKLD 
GLRAQYTQELQREKLSEQQMFLINSQDRSAFD 
VISMVDLIEDKAVEEVRQWTEKVLSKLDIQQS 
RIRDNCKKGLLNAGVQA-QVFVLSNFELQRYD 
LIRENCKRGLLNAGLQA-QVFLLSSFELQRYD 
LIRENCKEGLLKEGVQAPQVFLLSNFELRRHD 
LIRENCKEGLLKEGVQAPQVFLLSNFELRRHD 
DSGCTAARSPEDELWEVLEEAPPPVFPMRPGG 
DSERAAALSPEDETWEVLEEAPPPVFPLRPGG 
--SRQAQDLARSYGI---PYIETSAKTRQGVE 
154 ISATRFK------KNDIDIAKAISMMK-KEFYFVRTKVDSDITNE--ADGKPQTFDKEKVLQ
141 ISATRFK------ENDAQLAKAIAQMG-MNFYFVRTKIDSDLDNE--QKFKPKSFNKEEVLK 
165 ISSSRFS------LNDALLAQKIKDAG-KKFYFVRTKVDSDLYNE--QKAKPIAFKKEKVLQ 
154 ISSTRFT------INDAQLATAIRKMK-KNFYFVRSKVDSDLYNL--KRTKPSDFNKDEILL 
155 ICATRFK------INDVQLATAIKKMK-KNFYFVRSKVDSDLYNL--KRIKPREFNKDEILQ 
156 ISSSRFS------LNDALLAQNIKEIG-KKFYFVRTKVDNDLYNE--EKSKPMSFKRERVLQ 
161 IASEQFS------SNHVKLSKIIQSMG-KRFYIVWTKLDRDLSTS--------VLSEVRLLQ 
117 VASAQFS------MNHVMLAKTAEDMG-KKFYIVWTKLDMDLSTG--------ALPEVQLLQ 
130 IASEQFS------MNLVKLAKAIQVLG-KRFYIVWTKLDRDLSTS--------ALLKERLLQ 
149 IASEQFS------MNLVKLVKAIQRQG-KRFYIVWTKLDRDLSTR--------VLPEEQVLQ 
149 IASEQFS------MNLVKLVKSIQGQG-KRFYIVWTKLDRDLSTC--------VLSEEQLLR 
137 VSPRRCG------AVESRLASEILRQG-KKFYFVRTKVDEDLA--ATRSQRPSGFSEAAVLQ 
139 VSPRRCG------AVETRLAAEILCQG-KKFYFVRTKVDEDLA--ATRTQRPSGFREAAVLQ 
139 VSPRRCG------AVETRLASEILRQG-KKFYFVRTKVDEDLA--ATRTQRPSGFSEAAVLQ 
132 VISERVR------ENNMLLVDEIDKRK-KPFYFIRTKIDNDVKSQRR----KSKFSETQALE 
148 VTSERFR------ENDIELAKAINKSN-KLFYFIRTKIDNDVR----AESNKRNFDERVLLD 
146 VTSERFR------ENDIELAKAIKKSN-KLFYFIRTKIDNDVR----AESYKRNFDEPMLLD 
123 LNSERFM------QNDVMLAKEIRKQK-KNFYFVRSKIDNDIS----AEQRKKTFDEQRVLC 
126 ISSERFK------ENDVYLAKEIQKKQ-KRFYFVRNKIDNDIC----SVANGK-INEQQLLC 
158 ISSERFK------ENDIMLANAIKERK-KLFYFLRSKIDNDIH----AESHRKDFDEQKVLS 
157 ISSERFK------ENDIMLANAIKERK-KLFYFLRSKIDNDIH----AESHRKDFDEQKVLS 
130 IASDRFR------ECHTQLAKEIMRMG-KKFYFVRSKIDASIT----AEKKKKNFDQKKTLD 
130 IASDRFK------ECHTHLAKEIMRMG-KKFYFVRSKIDASIT----AEKRKKNFDLKKTLD 
130 IASDRFR------ECHTQLAKGIMRMG-KKFYFVRSKIDASIT----AEKKKKNFDQKKTLD 
128 ISSDRFK------EHHSLLAEEIVRLR-KTFYFVRSKIDQSID----SEKYKKTFDQEKMLD 
122 LTSTDRP------SANSVAVWKEVRSL-QKETVYFVLLAS-------------VKDTEKSLE 
133 IVSDWEK------VRHVKLAKEVEKLR-KHYLLVQTKVDSCLQTQG-----DLCCEETEILD 
135 SLSANAF------SSSEGQQVASVLAL-CDVYILVSPLRVRLRTIQL-LQQASSMGKECYL- 
149 ISDTCFR------KNDVKLAKEIQKMG-KKFYFVRSKVDDDLLN---AQRSQRDFDPEQTLS 
122 ISETRFR------ENDVKLAKEIQKMG-KKFYFVRSKVDNDLQS---EQRYQRDFDPEKTLS 
160 ISATRFR------ENDVKLAKEIQKMG-KKFYFVRSKVDNDLQN---AQRSQRNFDAEQTLA 
160 ISATRFR------ENDVKLAKEIQKMG-KKFYFVRSKVDNDLQN---AQRSQRNFDAEQTLA 
169 APTEENWAQVRSLVSPDAPLVGVRTDGQGEDPPEVLEEEKAQNASDGNSGDARSEGKKAGIG 
170 APTEKDWAQVQALLLPDAPLVCVRTDGEGEDPECLGEGKMGPGKAGSEGLQQVVGMKKSGGG 
 80 VFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAART--VE-------------- 
AKTGVVEVTMERHPYKH-PNIP----NVVFWDLPGIGSTNFPPNTYLEKMKFYEYDFFII-- 
APTGAIETTMKRTPYPH-PKLP----NVTIWDLPGIGTTNFTPQNYLTEMKFGEYDFFII-- 
ADVGTVETTMCKTPYQH-PKYP----KVIFWDLPGTGTPNFHADAYLDQVGFANYDFFII-- 
APIGAVETTFDRTEYKH-RKFP----NVTLWDLPGVGTTTFHPQEYLEKMKFREYDFFII-- 
APTGPVETTFLRKAYKH-PKFP----NVTFWDLPGIGTTSFQPQDYLEKMVFREYDFFII-- 
ASVGVVETTMKKTPYQH-PKYP----KVTFWDLPGTGTPNFHPHEYLEMVEFATYDFFII-- 
APTGVVRTTKTRTEYSS-SHFP----NVVLWDLPGLGATAQTVEDYVEEMKFSTCDLFII-- 
PPTELVKATQRCASYFS-SHFS----NVVLWDLPGTGSATTTLENYLMEMQFNRYD-FIM-- 
APTGVVKTTQIPTCYSY-PHFP----NVELWDLPGTGAGTQSLENYLEEMKFSWYDLFII-- 
APTGVVRTTQVPTCYSS-SHFP----YMELWDLPGTGTGTQSLENYLEKIHFSQYDLFII-- 
APTGVVRTTQIPTCYSF-SDIP----NVELWDLPGTGAATQNLETYLEEMQFSKYDLFII-- 
ALTGVVETTMQPSPYPH-PQFP----DVTLWDLPGAGSPGCSADKYLKQVDFGRYDFFLL-- 
ALTGVMETTMQPSPYPH-PQFP----DVTLWDLPGAGSPGCPADKYLKQVDFSRYDFFLL-- 
ALTGVVETTMQPSPYPH-PQFP----DVTLWDLPGAGSPGCPADKYLKQVDFGRYDFFLL-- 
AQTGAIETTKQATMYQQ-SNLP----HIRLWDLPGMGTPSFASKSYVKMMNFDLYDMFMV-- 
ASTGTTETTMKPNMYEH-PFMP----NVKIWDLPGIGSPKFRAKKYLKDVNFHMYDFFLI-- 
AFTGTTETTMKPNMYEH-PFMP----NVKIWDLPGIGSPKFRAKKYLKDVNFHMYDFFFI-- 
APTGVTETTMEPNMYEH-PAMP----NVKIWDLPGIGSPNFKADKYLKDVKLKNYDFFII-- 
APTGLTETTKKATMYTH-PTKP----NVRLWDLPGIGTPNFKANQYLKDVKFETYDFFII-- 
APTGVTETTLVPTMYRH-PTMP----NIELWDLPGTGSPKFKAKKYLKDVKLETFDFFII-- 
APTGVTETTLVPMMYKH-PTMP----NVELWDLPGTGSPKFKAKKYLKEVKLETFDFFII-- 
AETGPVETTMEPEVYIH-PKYH----NVKVWDLPGIGTPNFKADEYLELVEFERYDFFII-- 
AETGVVETTMEPKAYNH-PKIQ----HVKVWDLPGIGTPNFKADEYLQQVEFERFDFFII-- 
AKTSSVVTTAEPEVYFH-PKYE----NVKLWDLPGIGTPNFKADKYLELVEFERYDFFII-- 
AETGFEETTMEPKDYIH-PNFK----NVRLWDLPGIGTPNFKAKDYLKLVKFERYDFFII-- 
AQNPPSAAPEELAVFTN-PKHP----DFRLWDLPPISSDANFKPEDYIERFKATRYNAII-- 
AGASISNPALS-------PVYP----DVRFWDISGIEAV-MDYSVFEMKQAMKCYDFYII-- 
ALTGVTETTKEAVEYAL-PDSH----NIRFWDLPGLGKIG-----------------DLS-- 
APVGVVETTVDVKEYPH-PDYP----NVSLWDLPGIGTTKFPADEYLKLVGFEKFDFFII-- 
APVGVVETTAEVKEYPH-PNYP----NVSLWDLPGIGTTKFPADEYLKLVGFEKFDFFII-- 
APTGVVETTTEVRAYPH-PSYP----NVTLWDLPGIGTTRFPADQYLKHVGFERFDFFII-- 
APTGVVETTTEVRAYPH-PSYP----NVTLWDLPGIGTTRFPADQYLKHVGFERFDFFII-- 
APTGPTP-------YPA-PERP----NVVLWTVPLGPTATSP--AVTPHPTHYDALILVTPG 
VPTAPTP-------FPA-PERP----NVVLWTVPLGHTGTATTAAAASHPTHYDALILVTPG 
-YDPTI-----EDSYRKQVVIDGETCLLDILDTAGQEEY---SAMRDQYMRT--GEGFLC-- 
 
LIELRMRKGNIQLTNSAISDALKEIDSSVLNVAVTGETGSGKSSFINTLR-GIGNEEEG-A
LIMTYIEENKLQKAVSVIEKVLRDIESAPLHIAVTGETGAGKSTFINTLR-GVGHEEKG-A 
GIHKALQEGNLSDVMIQIQKAISAAENAILEVAVIGQSGTGKSSFINALR-GLGHEADE-S 
SIEKSLKEGNLQKAVSDINKALKDIDNAPLSIAVTGESGTGKSSFINALR-GVGHDEEG-A 
TIQSHLEKGDLQSAFSAINDALRDIDNAPLNIAVTGESGTGKSSFINALR-GMGHDEEG-A 
RIQAALKEAKLKDVADIIEESLVAAENAPLDVAVIGESGTGKSSFINALR-GLSYEEEG-S 
-TERALREGKLLELVYGIKETVATLSQIPVSIFVTGDSGNGMSSFINALR-VIGHDEDA-S 
NVEKASADGNLPEVISNIKETLKIVSRTPVNITMAGDSGNGMSTFISALR-NTGHEGKA-S 
NIEKALGGRKLLEVVPMVRETLERASSVPLRIAVTGDSGNGMSSFINALR-GIGHDEED-S 
NIEKALGDGKLLEVVSMIRETLETVSSAPVSIAVTGDSGNGMSSFINALR-EIGHDEKD-S 
NIEKALGEGKLLDMVSVVRETLETASSVPVSIAVTGDSGNGMSTFINALR-KIGHNEED-S 
ALRTAFESGDIPQAASRLRELLANSETTRLEVGVTGESGAGKSSLINALR-GLGAEDPG-A 
ALRTAFESGDLPQAASHLQELLASTESIRLEVGVTGESGAGKSSLINALR-GLEAEDPG-A 
ALRSAFESGDIPQAASRLRELLASSQSIRLEVGVTGESGAGKSSLINALR-GVGAEDPG-A 
TIRDVFAGESPETIPHRLISLLEVFDRFKIDIAVTGDSGAGKSSLINAIL-GLKPDDKG-A 
KTRKLK-------------DKLTELENVTLNMAITGMTGAGKSSFVNALR-GLRDDDEG-A 
KTTKLK-------------DKLTELENVTLNMAITGMTGVGKSSFVNALR-GLRDDDKD-A 
ATAKAK-------------ESFDQFMNVSLNIAVTGKTGSGKSSFINALR-GLKDDDEG-A 
AAVKAK-------------EELDRLDSVTLNIAVTGEAGAGKSSFINALR-DLSDEDEN-S 
PDVHLNSSAEYINEMECVIEQNKQLGNVTLHVAVTGSTGAGKSSFINAIR-GLTSDDEN-A 
--------------MECVIEQNKQLGNVTLHVAVTGSTGAGKSSFINAVR-GLTSDDEN-A 
AVNTIK-------------EYLKQQDLVELNIGVTGESGSGKSTFVNAFR-GLGDEDEG-S 
AVSRIR-------------EYLRKQDLVELNVGVTGESGSGKSTFVNAFR-GLGDEDEG-S 
AFGTIS-------------NYFKETSLV-LNIGVTGESGSGKSTFVNAFR-GLGDEDEG-S 
AINTIK-------------ECLRKQDLVELNIGVTGESGSGKSTFVNAFR-GLGNEEKG-S 
NLLETLKESIEKNNISDIRDALEDMLISRINIAIAGERNAEKATFINSLR-GLSQEDEG-A 
ITKLQNMYKSTGFGAAKVSAVLEALSHFQLDVAVLGETGSGVSTLVNALV-GLENEESS-G 
QISKLSQTRDFTDNPSKLQAILGALDHFRLDVGVLGETGCGSSSLINALL-GLKNSNET-A 
AAAKIK-------------ELLDNPSNATLNIGITGESGSGKSSFVNAFR-GVDHKDEKEA 
AAAKIK-------------ELLDNTSNTTLNIGITGEAGSGKSSFVNAFR-GVDDRDEK-A 
AVDKIK-------------KLLERAANTPLNIGITGESGSGKSSFVNAFR-GVDHQDNQ-A 
AVDKIK-------------KLLEKRANTPLNIGITGESGSGKSSFVNAFR-GVDHRDNQ-A 
AVREAFETGGLEAALSWVRAGLERLGSARLDLAVAGTTNVGLVLDMLLGLDPGDPGAAPAS 
AVREAFETGGLEAALSWVRSGLERLGSARLDLAVAGKADVGLVVDMLLGLDPGDPGAAPAS    
--------------------------MTEYKLVVVGAGGVGKSALTIQLIQNHFVDE---- 
N/TXXD
G4
SAK 
G5 
H2B H1 S2 S3αA 310 αB αC H2H2AS1 S4 
S5 H4 αE S6 αF αd H3 H5
GXXXXGK/MS
    G1 
SWI
G2 
DXXG/SWII
G3 
N 
1 -------------------MGQLFSSPKSD-ENNDLPSSFTGYFKKFNTGRKIISQEILN
1 ---------------------------------MAWASSFDAFFKNFKRESKIISEYDIT 
1 ---------------MDQFISAFLKGASENSFQQLAKEFLPQYSALISKAGGMLSPETLT 
1 -------------------MGQSS-STPSHKTGGDLASSFGKFFKDFKLESKILSQEAIT 
1 -------------------MGQSPPSTPSNRNGGDLASSFDKFFKEFKLDSKIISQETIS 
1 ---------------MDKFMCDFLVGKN---FQQLAINFIPHYTTLVNKAGGIIASENLD 
1 --------MKPSHSSCEAAPLLPNMAETHY---APLSSAFPFVTSYQTGSSRLPEVSRS- 
1 --------------------------------------------------------MEAM 
1 ---------LHCFFPLLQVTPLLSDVTQPTHSLHTPLLTSSNYDMPYNMGWSSLSKETAI 
1 -------------------------MTQPNHSLHIPLSTSFTSIVPYNMGWTVLPKATAT 
1 -------------------------MAQPTQSLHTPSPTSFTSTVPYHKGGSILSESGAM 
1 -----------------------------------MATSRLPAVP--EETTILMAKEELE 
1 -----------------------------------MATSKLPVVPGEEENTILMAKERLE 
1 -----------------------------------MATSKLRAVPGEEETTILMAKEELE 
1 ------------------------------------------MFFSRLCMPAKVQEDHLG 
1 -------------MPEKEEDKNENLYIISSEFLDIMSNATDDPDSISEDMKEVIDAKPKE 
1 ---------------KEEEDENENLYIVSSEFINIMSNATDDPDSISVDMKEVIDAKPNE 
1 -------------------------------------METQDP-AIAEAVQASGESTLEK 
1 ----------------------------------MTDDSSADM-NFSGALQRLGESDPNA 
1 ---------------MKIQKQKQELSNSSKPDTHSHSTAKENV-SLKSANTVQVEHIYEM 
1 ------------------------------------------------------------ 
1 -------------------------------MATFEDYCVITQEDLDDIKDSISTQDLPS 
1 -------------------------------MDILEDYDIITQNDLEEIKESISTEDLPT 
1 ------------------------------VDALEHLYEIKVEDKLKEIKEILYTQDLPT 
1 ----------------------------MSNISQKVVLLFAEQEELVDLRKAISTQDLPT 
1 ----------------------------------------------------MADVIKGL 
1 ----------------------------------MLHGGWLKARYATQHVQQTEKLETED 
1 ----------------------MAIQCTHRICSYLTNSLFFRFVVSTALRSMKINQDDLD 
1 ---------------------------------------MADSSDIVEIKEALRNNNQAL 
1 ---------------------------------------MADSSDFAEIKEALQNNNQAL 
1 -MVNVCVCYITVGLSVGMISRLSDFYIVTVGFALCVQVIMADSLDTTEIKEALQNNNQAL 
1 -MVNVCVCYITVGLSVGMISRLSDFYIVTVGFALCVQVIMADSLDTTEIKEALQNNNQAL 
1 -----------------------------------------RLLPPAQDGFEVLGAAELE 
1 -----------------------------------------RLLPPAQDGFEVLGAAELE 
1 ------------------------------------------------------------ 
Irga6 
Irgb6 
Irgd 
IRGB12(dog) 
IRGB11(dog) 
IRGD  (dog) 
Irgm1 
IRGM(a)(human) 
IRGM6(dog) 
IRGM5(dog) 
IRGM4(dog) 
Irgc  
IRGC (human) 
IRGC (dog) 
irgg1(zebrafish) 
irge1(zebrafish) 
irge5(zebrafish) 
irge3(zebrafish) 
irge4(zebrafish) 
irge2(zebrafish) 
irge6(zebrafish) 
irgf1(zebrafish) 
irgf3(zebrafish) 
irgf2(zebrafish) 
irgf4(zebrafish) 
irgq2(zebrafish) 
irgq1(zebrafish) 
irgq3(zebrafish) 
irgf7(Tetraodon) 
irgf8(Tetraodon) 
irgf6(Fugu) 
irgf5(Fugu) 
Irgq1 
IRGQ1(human) 
H-Ras-1(human) 
Irga6 
Irgb6 
Irgd 
IRGB12(dog) 
IRGB11(dog) 
IRGD  (dog) 
Irgm1 
IRGM(a)(human) 
IRGM6(dog) 
IRGM5(dog) 
IRGM4(dog) 
Irgc  
IRGC (human) 
IRGC (dog) 
irgg1(zebrafish) 
irge1(zebrafish) 
irge5(zebrafish) 
irge3(zebrafish) 
irge4(zebrafish) 
irge2(zebrafish) 
irge6(zebrafish) 
irgf1(zebrafish) 
irgf3(zebrafish) 
irgf2(zebrafish) 
irgf4(zebrafish) 
irgq2(zebrafish) 
irgq1(zebrafish) 
irgq3(zebrafish) 
irgf7(Tetraodon) 
irgf8(Tetraodon) 
irgf6(Fugu) 
irgf5(Fugu) 
Irgq1 
IRGQ1(human) 
H-Ras-1(human) 
αG 
FLLDSDLETLKKSMKFYRTV 
MISD-ILENLDETFNLYRSY  
FFKGFDLPEQEQCLKDYRSY 
LINDNEVEKLEETLHLYRSY 
YISDNDVETLKDTLTLYRSY 
CFNGFDFPQQEKCLNLYQSH 
SLGVRDDDNMGECLKVYRLI 
-------------------- 
TLGIWNADDLGECLIAYHLF 
ILGIQDEDDLGQCLIAYHLF 
ILGIQNANDLGEFLNAYHRL 
LAAAYDDALLIRSLRGYHRS  
LAAAYDDALLIHSLRGYHRS  
LAAAYDDALLIRSLRGYHRS  
-------------------- 
VSLAVDYGIMKKFFKQVFMA  
VSLAVEYVIMKKFFKQVFMA 
LSAACDTGMVALFLTRCYFA 
ISLITDKAILIVYLIGCHYA  
LSMACDAAILLGFFTKCYYA 
LSMACDAAILLGFFIKCYYA 
LSISADIAIIAEELRKYYSA  
LSVAVDLVIVKREIEIYYST 
LSISVNVDIIAEELTKYYSE 
LSVAVDVMIIKEETEKYFRG 
VSSMVDATVGVRILVKAQIS 
-------------------- 
-------------------- 
LSVAVDLSLIVGLVQQYKTS 
LSVAVDLSLIAGLVQQYKTG 
LSVAVDGALIAGVVQQYKTG 
LSAAVDADLIAGVVQQYKTG  
LGWACDVALLRGQLAEWRRA 
LGWACDVALLRGQLAEWRRG 
-------------------- 
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Figure 17. Extended alignment of the vertebrate IRG proteins.  
Individual sequences are given in full and are labeled as in Figure 18. Unusual residues in the G1 motif are highlighted (M of the GMS proteins in green and two deviant residues in 
the zebrafish irgq sequences in pink). The essential structural relationship between IRG genes and quasi-IRG genes is apparent in the alignment despite the modified G-domains. For 
mouse and human IRGQ the long carboxylterminal coding exons that contain the p47 homology were used for the alignment. In human IRGQ the sequence 
NPKGESLKNAGGGGLENALSKGREKCSAGSQKAGSGEGP was removed from the alignment between positions 210 and 211 (highlighted in turquoise) to prevent extensive gap 
formation. The position of the intron present in pufferfish and zebrafish irgf genes is indicated by two adjacent residues highlighted in blue. Canonical GTPase motifs are indicated by 
red boxes. The nucleotide and amino acid sequences themselves can be obtained in the p47 (IRG) GTPase database from our laboratory website (http://www.genetik.uni-
koeln.de/groups/Howard/index.htm). 
 
αΙ αJ αK 
Irga6        319
Irgb6        305 
Irgd        324 
IRGB12(dog)      319 
IRGB11(dog)      320 
IRGD (dog)       321 
Irgm1        310 
IRGM(a)(human) 
IRGM6(dog)      278 
IRGM5(dog)       298 
IRGM4(dog)       298 
Irgc        302 
IRGC(human)      304 
IRGC(dog)        304 
irgg1(zebrafish) 
irge1(zebrafish) 309 
irge5(zebrafish) 307 
irge3(zebrafish) 284 
irge4(zebrafish) 285 
irge2(zebrafish) 319 
irge6(zebrafish) 318 
irgf1(zebrafish) 293 
irgf3(zebrafish) 293 
irgf2(zebrafish) 293 
irgf4(zebrafish) 290 
irgq2(zebrafish) 276 
irgq1(zebrafish) 
irgq3(zebrafish) 
irgf7(Tetraodon) 308 
irgf8(Tetraodon) 285 
irgf6(Fugu)      351 
irgf5(Fugu)      351 
Irgq1        303 
IRGQ1(human)  343  
H-Ras-1(human) 
TIQERLSRYIQEFCLANGYLLP-----------------KNSFLKEIFYLKYYFL 
SLEDKLFKYIKHISSVTGGPV-----------------AAVTYYRMAYYLQNLFL 
SIIAQATSAAEAFCAVKGGPE-----------------SSAFQALKVYYRRTQFL 
SLGEKLLRYVEKFCSVSGGLI-----------------ATGVYFRKIFYLQNYFL 
PLGEKLLKYVEKFCSVSGGPI-----------------AAGIYFRKIYYLKNYFL 
SIAEKAMKCVECYCSVNGGLP-----------------STIFQFFKIYFLHLKFI 
KLRLMTCAIVNAFFRLLRFLP-------------------CVCCCLRRLRHKRML 
------------------------------------------------------- 
AVSCMNCNTSSCLYTILRYIPL---------------LGDFIINFLRKWKHRRLL 
ALSCMNCKTASYLYSILSYIPF---------------LGDTVINYLRVWKHRHFL 
ALSWMNCNAASYLYSVLSYIPI---------------LGTTGIHYLKWWSQGHLL 
VLRLYSQSSDGAMRVARAFERG--------IPVFGTLVAGGISFGTVYTMLQGCL 
VLRLYSQSSDGAMRVARAFERG--------IPVFGTLVAGGISFGAVYTMLQGCL  
VLRLYSQSSDGAMRVARAFEKG--------IPVFGTLVAGGISFGTVYTMLQGCL 
------------------------------------------------------- 
LIDMMSNPVIAITKTLGTIMAL-------LPG--GALPAGGAAVASVHYLLNVGL 
LMDMISNPVIAIAVTLGTIMAL-------LPG--GALPAGGTAVATVHYLLNVGL 
ALTRLQVSGTLVVLFSAEYVAS-------LVPGVGSVAAAGLSFGTTYYLLRSGL 
RISPMAKPVKSLEDLLDSKNLAVN------------VQNTADAFRNSHTNLTRAL 
KLTNKELSALTSKEAAVKFAWS-------MVPVVGSIKTAQMSYSTTLNLLRTGV 
KLTNKELSALTSKEAAVKFAWS-------MVPVVGSKKTAQMSYSTTLKLLRTGV 
ILTLLGAASVLISEDAVELLVS-------FIPIIGSVVAGGLSYLTVSGMLKKAL 
LLSLVGAVSVVGAESTVEYILS-------LVPILGTVVAGGLSYLTVSTMLRRAL 
IINLLEAEVPKIEN---EYFLS-------FMPFIGTEIKKIKSSVAVSSMLKTAL 
ILALLSSATLVLGGMSVLAAESALEYFLSTIPLIGSVAAAAMSYKTITLMLKKTL 
VKRRLAEAEKDTST--ATTRLV-------ELAIPRQARSVSRSFTVMLQALNNAI  
------------------------------------------------------- 
------------------------------------------------------- 
ITQTLNQTASVAGLMAAEEGLR-------FFPIFGTMIAGSLSCAVIYKALSDFL 
IVKALSELASVAGLMAAEEGLR-------FIPIFGTMIAGTLSYAATYNALSDFL 
ILKLLLQSAAVAGLMLAEEGLK-------FIPLFGTLVASTLSYKVTEKALLDFL 
VLNLMSQSSAISSLTETRESYS-------FIPLFGIPVARKLSYEITERALHNFL 
RLGSWAGEGTAGGAALSALSFL--------WPTGGAAATGGLGYRAAHGVLLQAL 
RLGAWAGEGTAGGAALGALSFL--------WPAGGAAATGGLGYRAAHGVLLQAL 
------------------------------------------------------- 
DMVTEDAKTLLKEICLRN---------------------------------------------------------- 
DTAANDAIALLNSKALFEKKVG---PYISEPP--EYWEA------------------------------------- 
NIVVDDAKHLLRKI-ETVNVA------------------------------------------------------- 
EAVVSDAKVLLNKEEIFKETVGSGQAYLLQDVGIENRKSDATSS-------------------------------- 
DTVVSDAKVLLKKEEIFKDPVDSEQTYLHTNVGNENGKSDTSSS-------------------------------- 
NTVADDAKILLHKTLEILSHRR------------------------------------------------------ 
FLVAQDTKNILEKILRDSIFPPQI---------------------------------------------------- 
---------------------------------------------------------------------------- 
EIVAEDTRTILKKILKDSII-------------------------------------------------------- 
EIVAKDTRSIVKKILTDSII-------------------------------------------------------- 
EIVAEDTKTILKKILEDAII-------------------------------------------------------- 
NEMAEDAQRVRIKALEEDEPQGGEVSLEAAGDNLVEKRSTGEGTSEEAPLSTRRKLGLLLKYILDSWKRRDLSEDK 
NEMAEDAQRVRIKALEDDEPQP-EVSLEVASDNGVEKGGSGEGGGEEAPLSTCRKLGLLLKYILDSWKKHD-SEEK 
NEMAEDAQRVRIKALEEDEPQS-EVSLEAAGDNGVEKRGSGEGGCEEAPLSARRKLGLLLKYILDSWKKRDLSEEK 
---------------------------------------------------------------------------- 
KEMADDTRKVLVVSQLA----------------------------------------------------------- 
REMADDTRKVLAISQLA----------------------------------------------------------- 
KELANVAREIRKEVLDSVR--------------------------------------------------------- 
NEMIKDMRQVLQVAGLDE---------------------------------------------------------- 
QDLAETAS-------------------------------------------------------------------- 
QDLAETAREVLKAAGVTGVY-------------------------------------------------------- 
NEIAEDARNVLMASLETEV--------------------------------------------------------- 
NDIAEDARNVLNASLETEV---------------------------------------------------------
NVIAEDIRNVI----------------------------------------------------------------- 
NDLAKDAETVFKALLETEV--------------------------------------------------------- 
DDMGADAEKVVAMVTGERQ--------------------------------------------------------- 
---------------------------------------------------------------------------- 
---------------------------------------------------------------------------- 
EMLTDDAQYVFEKALRCMNSSV------------------------------------------------------ 
KMLTEDAQNVFEKALRCMNSSV------------------------------------------------------ 
HMLAEDAQNVFKRALCCMNSSV------------------------------------------------------ 
DMLTEDAQDVYNRVINHINS-------------------------------------------------------- 
DEMLADAEAVLGPPEPNQ---------------------------------------------------------- 
DEMRADAEAVLAPPEPAQ---------------------------------------------------------- 
---------------------------------------------------------------------------- 
FGVDETSLQRLARDWEIEVDQVEAMIKSPAVF-KPTDEE
FGLDDASLENIAQDLNMSVDDFKVHLRFPHLF-AEHNDE
FGLDDQSIKEIAEKLGAPLADIKGELKCLDFWSLVKDN-
FGLDDASLETIAKDLNVSVEKLKANLTSPHLLSVEKEDE
FGLDDISLKTIAKDLNVSVEKLKANLMFPHLLSVEKYDE
FGLDEKSVKGIAEKLDMSVEEIKSFTKSLDFWLLVKDD-
FGVDDESVQQVAQSMGTVVMEYKDNMKSQNFYTLRREDW
---------------------------------------
FGVDDESLQQIAQSMGKPMEEYRAIMKSRDLHTIIRGDW
FGVDDKSLQQMAQSMGKPMEEYRAIMKSQDVHTVLTGDW
FGVDDDSLQEVAQSMGKPKEEYKAIMKSQDLHTALAWDW
FGLDDDSLAKLAEQVGKQAGDLRSVIRSPLAN-EVSPET
FGLDDDSLAKLAEQVGKQAGDLRSVIRSPLAN-EVSPET
FGLDDDSLAKLAEQVGKQAGDLRSVIRSPLAN-EVSPET
---------------------------------------
FGLSNQALQVLSERVNKPVEVLNAAKTSRFKD-GVTDRI
FGLSNQALEVLSGRVNKPVKVLKAAKTSRFKD-GITEHI 
FGLDDGSLARLSEKINK--PLVGHLAKSKIAS-AIQEK-
LGLNEKSLKQLSERTNKPVSLLKLAIKSPVSL-AVLDRM
FGLDEKSIDKLSVRVNN--LSLKAIRRSPLVV-AIGQK-
FGLDEKSIDKLSVRVNN--PSLKAIRRSPLVV-AIGQK- 
FGLDDPSLQKLCERSGKTVEELKSLMKSPLHH-GINPSS
FGLDDPSLQMLCERSGKTIEEFKSLMKSPLRG-GINPAS
FGLDDQSLQKLCERSGKTIEELKSLMKSPLCY-GINTSL
FNLDDESLQRLCDVSGKSLEEIKSLMKSPLKA-GIGSYS 
LCLDDESLQRLARQRGL-DPAKLKALRTCALSVEVSKSE 
--------------------------------------- 
---------------------------------------
FGLDTPSLQRLADTTGVQLTDLTSVIRSPLSLDNINAQL 
FGLGRPSLQRLADTTGVQLTDLTSVIRSPLGLNIIDAEL 
FGLDGPSLQRLADSTGVPLEDLTSVVRSPLSLNTIDKAF
FGLGRPSLQRLVAITGVPLVDLT-IISSPLTLDNINTDL
LGLEPAAVARRERALGLAPGVLATRTRFPGPVTRAEVEA 
LGLEPTALARRERALGLASGELAARAHFPGPVTRAEVEA 
--------------------------------------- 
αΗ CαL 
413 
415 
420 
440 
441 
419 
409 
181 
377 
397 
397 
463 
463 
433 
250 
410 
408 
386 
384 
410 
422 
398 
398 
387 
402 
379 
247 
161 
417 
394 
460 
456 
407 
447
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Figure 18. Extended phylogeny of the G domains of IRG and related proteins.  
The phylogeny relates all of the IRG sequences described in this report and reveals the distinct clades on which the 
nomenclatural fine structure is based. All except the mouse sequences are labeled with the species of origin. Dog 
IRG sequences are found in the B, C, D and M clades, and human sequences only in clades C and M. The mouse 
and human quasi-IRG proteins, IRGQ (FKSG27), could not be included in the phylogeny because they are so 
deviant in the G-domain 
                                                                                                                                                                           Results I 
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III.I.12.Positive selection in the family of the p47 GTPases 
 
The p47 GTPase family is a resistance mechanism to fight against  intracellular pathogens. It is 
expected that genes involved in immunity will evolve faster to coadapt under the selective 
pressure generated by the pathogens which usually have fast evolving capacity. If the pairwise 
alignment of given sequences, which are closely related to each other, has more non-
synonymous substitutions per site than synonymous substitutions (Ka/Ks>1), these genes are 
considered as fast evolving genes. It was a crucial question to answer whether the p47 GTPases 
are fast evolving genes or not?  Therefore, the codon based selection test was employed for the 
estimation of synonymous (Ks) and non-synonymous (Ka) substitutions per site in the protein 
coding region of the p47 GTPases (Fig 19).  The p47 GTPases within mouse or between mouse 
and rat were aligned in pairwise manner. The aligned sequences were edited to obtain correct 
ORFs, whenever possible. The protein coding sequences, which have correct pairwise 
alignments, were used for the estimation of synonymous (Ks) and non-synonymous (Ka) 
substitutions based on the methods established by (Comeron, 1999). All of the estimated Ka/Ks 
values are shown in figure 19. The selection test within the mouse was performed using the 
genes Irga4, Irga7, Irga3, Irga8, Irga2, Irga6, Irgb1, Irgb4, Irgb2, Irgb5. For the selection test 
between mouse and rat, the p47 genes Irgm1 Irgm2, Irgm3, Irgd, Irgc, Irgb1, Irgb4, Irgb13, 
Irgb14, Irga4, Irga6, Irga15, Irga13 were used. Because these genes were only the genes have 
an intact full length pairwise alignment.  Four (Irga4, Irga7, Irga8 and Irga3) of the p47 GTPases 
within the mouse were detected to be positively selected especially in the C-terminal region. 
Further analyzes were performed using the pairwise alignments between rat and mouse (Fig. 
19b), Two (Irga4 (Irg15 in rat) and Irgm2) of the p47 GTPases were detected to be positively 
selected. It is worth noting that Irgc was detected to be evolving under purifying selection which 
is unique among the members of the p47 GTPase family (Fig. 19b). Micro-evolutionary analysis 
at the population level is necessary to reveal whether p47 GTPases are indeed fast evolving 
genes. If so, it will be of particular interest to know, which region of the individual protein 
preferentially positively selected and to which extant positive selection maintained the members 
of the p47 GTPases. 
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Figure 19. Codon based selection test for p47 GTPases 
(a) Codon based selection test was performed using the ORF (Full length), N-terminal (1-275 a.a) and C- terminal 
(275-end of the respective sequence) region of close family members of p47 GTPases within the mouse. Deletions 
and insertions were removed to align sequences properly. (b) Codon based selection test was performed using the 
ORF (Full length), N-terminal (1-275 a.a) and C- terminal (275-end of the respective sequence) region of mouse and 
rat p47 GTPases. Deletions and insertions were removed to align sequences properly. Analysis was performed using 
the program K-Estimator 6.0 (Comeron, 1999) with multiple hits correction method Kimura-2 parameter. 
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III.II.RESULTS II 
 
III.II.1.The human GMS fragment (IRGM).    
 
IRGM  is transcribed in unstimulated human tissue culture lines, Hela and GS293 cells with no 
increase after interferon induction (Fig. 20a). Polyadenylated transcripts of IRGM occur with 
five 3’ splicing isoforms extending more than 30 kb 3’ of the long coding exon. By a 
combination of Est and genomic database analysis, and 5‘-3‘ RACE PCR from the coding region 
of the human GMS fragment, it was possible to clone different transcripts containing the human 
GMS fragment (Fig. 20b). The identity of amplified fragments with the human GMS fragment 
was confirmed by sequencing. Three Ests can be found in the public databases (BC038360, 
BC038359 and BI764111), and comparison of these Ests with amplified splice variants revealed 
that all of the Ests for IRGM in the databases are identical to the 3’splice variant, IRGMc. The 
IRGM coding ORF is located in long transcripts downsteam of a long putatively untranslated 
exon from the adjacent 5‘ genomic region, and upstream of a 3‘ region containing one or more 
exons derived from regions far 3‘ of the GMS fragment. As it is typical for the p47 GTPases (see 
above), the entire GMS ORF is encoded on a single exon. The shortest form of transcript, 
IRGM(a), reads through the splice-site immediately downstream of the ORF and terminates 
behind a polyadenylation signal sequence at the 5‘ end of the intron. The longer transcripts splice 
out of this region to one or more exons more than 30 kb downstream. In all cases, the transcripts 
are polyadenylated.  
 The transcript of the human GMS fragment thus has a highly unusual structure with its 
extended 5‘ untranslated region of more than 1000 nucleotides, and especially the presence of 
one or more exon-intron boundaries downstream of the putative termination codon in three of its 
five splice forms which are expected to lead to rapid RNA degradation via nonsense-mediated 
decay (Ohnishi et al., 2003; Singh and Lykke-Andersen, 2003; Wilkinson, 2005). 
The 5‘ untranslated region of the GMS fragment transcripts is similar to the U5 region of 
an endogenous retroviral element (ERV9) repetitive element. The promoter region corresponds 
to the ERV9 U3 long terminal repeats (LTR) without interferon response elements. The 
difference in the expression level in different cell lines was consistent with the expectation of 
classical transcription profile of ERV9 promoters (Ling et al., 2002) (Fig. 20a) As noted above, 
transcripts (IRGM (b) and (c)) are easily detectable in unstimulated tissue culture cells and total 
RNA obtained from human tissues (Liver, Brain, Testis) (Fig. 20a). However, RT-PCR 
experiments using several different human cell lines (HepG2, Thp1, SW480, Primary fibroblasts 
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HS-27) failed to detect an induction of IRGM by IFN-γ (data not shown). The human 
lymphoblastoid cell line, T2, showed a 2-3 fold induction of IRGM after interferon treatment. 
 At the protein level the shortest isoform of IRGM, IRGM(a), is shorter than a canonical 
G-domain, due to truncation in the middle of β-strand six just before the G5 sequence motif 
which interacts with the guanine base of the bound nucleotide (Fig. 17 and Fig. 20b). The longer 
isoforms are terminated by short sequence extensions unrelated to any known GTPase domains. 
 
 
 
Figure 20. Structure and expression of the human IRGM gene.  
(a) (left panels) RT-PCR analysis of the expression of IRGM in HeLa and GS293 cells. IRGM(b) and (c) splice 
variants were amplified simultaneously by the same primer pair (IRGMs1-rGMS). A different downstream primer 
(IRGMs1-r1), internal to all the 3’ splice forms was used to show differences in the overall expression level of 
IRGM in the two cell lines. No RT a cDNA preparation without reverse transcriptase. The band immediately below 
the IRGMc band in GS293 cell material, indicated with an asterisk, is a nonspecific band amplified only in this cell 
line. The band was sequenced and is unrelated to IRGM. (right panel) Analysis of IRGM expression in human brain, 
liver and testis. GAPDH was used as a control. (b) Five splice forms of the IRGM gene have been identified, as 
indicated: IRGM(a)-IRGM(e). The promoter and 5’-untranslated regions of the gene are associated with an ERV9 
retroviral LTR. Scale-bar is given in base pairs. 
 
III.II.2.Purification and analysis of recombinant IRGM(a) protein 
 
To characterize IRGM(a) protein biochemically, recombinant IRGM(a) protein N-terminally 
fused to MBP (Maltose binding protein) was expressed and purified from E. coli. Due to the in 
efficient digestion of the fused protein with enterokinase, thrombin digestion site was introduced 
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immediately after the enterokinase digestion site, integrated protease digestion site to pMALp2E 
vector, just before the putative start codon of IRGM(a) protein (Fig. 21a). MBP-IRGM(a) fusion 
protein was recovered in a soluble form (Fig. 21b) and subjected to further purification using  gel 
filtration and anion exchange chromatography. Gel filtration experiments showed that the protein 
of interest eluted in the void volume of the column suggesting a high molecular complex or 
aggregation of the protein. Further analysis was performed using the dynamic light scattering to 
detect exact molecular mass of the complex. Dynamic light scattering analysis showed that 
IRGM(a) protein forms a complex of about 14000 kD (Fig. 22). Due to the consistent impurity 
problem faced during the purification experiments, a GTPase deficient IRGM(a) protein was 
generated by mutational exchange of serine (S) to asparagine (N) at position 47  corresponding 
to  G1 motif, which is known to be essential for GTPase activity (GxxxxGMS to GxxxxGMN) 
(Taylor et al., 1996). This mutant MBP-IRGM(a) protein was expressed under the same 
conditions as wild type protein.  
 
Figure 21. Purification and analysis of recombinant IRGM(a) protein. 
(a) Schematic representation of expression construct of IRGM(a) protein. IRGM(a) protein was fused to C-terminus 
of MBP (Maltose binding protein) in open reading frame using commercially available  prokaryotic expression 
vector pMALp2E . Arrow indicates the position of introduced thrombin digestion site by PCR (black box) after the 
enterokinase digestion site (white box). (b) Purified recombinant MBP-IRGM(a) protein using amylase resin. 
Supernatant obtained after centrifugation of 50000g for 30min at 4°C of lysate obtained from E. coli (NB42) which 
is induced with 100 μM IPTG (SI ) for 15 hours at 18 °C or not induced (SU). The supernatant (SI) was loaded on 
1G amylase resin column. Flow thorough (FT) was collected and washed (w) 10 column volumes. Proteins 
specifically bound to the coloumn  was eluted with 10 μM Maltose containing elution buffer (elution steps 1-7). 
Purified protein used to raise an antiserum(c) GTPase hydrolysis assay of recombinant MBP+IRGM(a) protein. 
80μM of MBP+IRGM(a) wild type (IRGMwt) and mutated (IRGMnm)  incubated in the same condition for 2 hours 
at 37 °C in B1 buffer. IIGP1 (80μM) was used as positive control. BSA (80μM) and Buffer alone were included as 
negative controls.  
 
Thin layer chromatography (PLC) experiments based on radioactively labeled GTPase assay 
showed that both mutated and wild type fusion proteins exhibit indistinguishable GTPase 
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activity (Fig. 21c). It can therefore be concluded that GTPase activity is the result of non-specific 
protein contamination. Recently, same biochemical properties were observed with the mouse 
GMS type Irg protein Irgm2, (GTPI) which is expressed in E. coli N-terminally fused to GST, 
(Robert Finking, personal communication). Therefore, it is probable that expression of GMS 
type p47 GTPases in a prokaryotic system is problematic and other expression systems have to 
be tested. 
 
Figure 22. Dynamic light scattering (DLS) of MBP-IRGM fusion protein complex 
(a) Dynamic light scattering (DLS) analysis of mutated MBP-IRGM(a) fusion protein in the presence of GTP 
average number of R (hydrodynamic radius) is 31nm which is approximately equal to 14000kD protein mass (b) 
DLS analysis of wt MBP-IRGM(a) fusion protein in the presence of GTP average number of R is 36nm which is 
approximately equal to 14100kD protein mass (c) DLS analysis of IIGP1 in the absence of GTP average number of 
R is 3.1nm which is approximately equal to 47kD protein mass (Uthaiah, 2002). (c) DLS analysis of MBP-IRGM(a) 
fusion protein in the presence of GTP average number of R 36nm which is approximately equal to 14500kD protein 
mass. 80 µM from each protein in the presence or absence of GTP in B1 buffer (50mM Tris/HCl, 5mM MgCl2, 
2mM DTT, PH: 7.4) in final volume 70 µl was kept on ice. 10 µl of 100mM GTP was added and mixed very 
quickly by pipetting. The mixture immediately was transferred to spectrophotometer cuvette and placed into the 
Dynamic Light Spectrophotometer (Dynapro, protein solutions) at 37°C. 
 
 
 
                                                                                                                                                                          Results II 
 68
III.II.3.Immunofluorescence analysis of IRGM(a)-ctag1 and IRGM(b) 
 
Immunofluorescence analysis was carried out to examine the intracellular distribution of 
IRGM(a) in human cell lines. IRGM(a) tagged with ctag1 (see Material and Methods) was 
transiently expressed in HeLa and GS293 cells. Under these conditions IRGM(a) exhibited two 
types of formation; aggregated and soluble (Fig. 23a). The ratio between aggregated and soluble 
form was varied between experiments. 90% of the aggregated form of IRGM(a) protein tagged 
with ctag1 has unexplained nuclei disruption (data not shown). Other spliced form of IRGM 
protein, IRGM(b) was cloned in mammalian expression vector pGW1H  and was transiently 
expressed to confirm that aggregate formation of IRGM protein is not specific to differential 
splicing form. IRGM(b) was detected  using the rabbit antiserum, raised against recombinant 
human IRGM produced in E. coli, (see material methods and  below) (Fig 23b). Our analysis 
was consistent with previous observation that there were two types of formation and of those 
formed aggregate, 90% has disrupted nucleus formation. This is probably due to an experimental 
artifact, which could be linked to the general problems of overexpression of proteins however 
other p47 GTPases (IIGP1, LRG47, IGTP) expressed under identical conditions did not cause 
nuclei disruption. Finally, endogenous expression of IRGM protein was analyzed by 
immunofluorescence. Analysis using the human cell lines HeLa, GS293 and T2 cells revealed 
that there are no specific signals to antibody used (α4181) in detectable level. There is only 
background Golgi staining which is also observed with preimmune antiserum (indicated with 
white arrows in Fig. 23c). Our immunofluorescence analysis is consistent with the results 
obtained by immunoblotting (see below). Thus, it is evident that specific signal for endogenous 
IRGM protein can not be detected under these experimental conditions.     
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Figure 23. Immunoflourescence analysis of IRGM protein 
(a) IRGM(a) protein c-terminally tagged with ctag1 is transiently expressed in HeLa cells using the antibody 
(αctag1) of a dilution 1:5000 ratio showing aggregated (left) and soluble expression (right). Dapi is used to label 
nuclei and indicated with N. Images were taken using the 63X objective (630) (b) IRGM(b) protein is transiently 
expressed in Hela cells using the antibody (α4181) in 1-500 ratio showing aggregated (left) and soluble expression 
(right). Dapi is used to label nuclei and indicated with N. Images were taken using the 63X objective (630) (c)  
Screening of endogeneous IRGM protein in Hela cells (left). The results were crosschecked using 4181-prebleed 
serum (right). Background Golgi staining is indicated with white arrows. Dapi is used to label nuclei and indicated 
with N. Images were taken using the 100X objective (1000). For handling all images, Zeiss Axioplan II microscope 
equipped with cooled CCD camera and metamorph software (4.5) are used.   
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III.II.4.Westernblot analysis of IRGM protein 
 
A rabbit antiserum (α4181), raised against recombinant human IRGM(a) produced in E. coli  
(see material and methods) could not detect specific signal for endogenous IRGM protein from 
extracts prepared using human Hela, GS293, T2, Thp1, HepG2 cell lines (Fig. 24a-b). 
Additionally, no IRGM protein could be detected after induction by interferon (Fig. 24c) 
suggesting that IRGM protein is not translated in vivo and is not induced by interferon in 
cultured cell lines under these experimental conditions.   
 
 
Figure 24.  Endogeneous expression of  IRGM protein in human cell lines 
(a) Eukaryotic expression vector pGW1H containing of IRGM(b) transfected (+) or not transfected (-) to Hela and 
GS293 cells, respectively. 24 hours post transfection, cells were harvested and lysed in 1X SDS protein loading 
buffer. IRGM protein was detected by immunoblotting with antibody (α4181) at 1:500 dilution. (b)  Endogeneous 
expression of IRGM protein in Hela, T2 and Thp1 cells. (+) and (-) indicate transfected or untransfected cells, 
respectively. Cells were harvested and lysed in 1X SDS protein loading buffer. IRGM protein was detected by 
immunoblotting with  antibody (α4181) in 1-500 dilution. (c) Interferon induction experiments of IRGM protein in 
human cell lines (Hela, HepG2 and T2 cells). Cells were induced (+) or uninduced (-) for 48 hours with 200 u/ml 
IFN-γ and protein extracts were prepared by cell lysis (2% TritonX 100 in PBS with protease inhibitor) for 2 hours 
on ice. IRGM(b) transfected GS293 cells were used as positive control (GS293-T). hGBP1 was used as positive 
control for interferon induction and gel loading was assessed by immunoblotting with ER60 specific antibodies. 
Detection of IRGM protein on nitracellulase membrane was performed using the antibody (α4181) in 1-500 
dilution.  
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IV.DISCUSSION 
 
 Adaptation of an organism to different environments is the main cause of organismal diversity 
but there are many types of adaptation mechanisms. Host-pathogen interaction is possibly the 
strongest adaptation mechanism that leads different species to coevolve (Haldane, 1949), 
(Summers et al., 2003). Coevolution of the species is maintained by two-way biochemical 
interactions leading to responses in both pathogen and host cell (Galan and Bliska, 1996). 
Responses against pathogens by the host cell use complex signaling pathways and require 
involvement of different types of regulation and induction of specific regulators such as 
cytokines. One of the cytokines involved in resistance against pathogens is interferon γ, which is 
known to be one of the most important regulators of immunity. Interferon γ is responsible for 
induction of more than 800 genes (Boehm et al., 1997). It has been suggested that in mouse, the 
interferon γ-induced resistance activity against protozoa and pathogenic bacteria is mainly 
mediated via the p47 GTPase family in a cell autonomous manner (Taylor, 2004).   
The p47 GTPase family may be one of the most important resistance factors in the mouse 
(Taylor, 2004). The evolutionary analysis of p47 GTPases led us to the following unexpected 
conclusions; Firstly,  the family of p47 GTPases has 23 members in the mouse. It is also shown 
that a minimum estimate of the number of potentially functional p47 GTPases in mouse is not 
just six, as previously described (Boehm et al., 1998), but rather 20.  Strikingly, the resistance 
mechanism of p47 GTPases appears to be completely absent from the human lineage. Secondly, 
this mechanism might make use of hetero-dimer, trimer or even higher oligomer formation. 
Thirdly, members of the p47 GTPase family appear to be fast evolving genes. However, only 5 
(4 in C-terminus) genes of the mouse family members could be shown to have been under 
positive selection. Finally, different numbers 23, 15, 7, 18, 2, and 2 of relatively differentiated 
members of p47 GTPases are present in mouse, rat, dog, Zebrafish, Fugu and Tetraodon, 
respectively. Variable numbers of p47 GTPases in different species may reflect a co-adaptation 
process in order to generate diversity in the resistance mechanisms acting on pathogens which 
are usually known to be fast evolving.  
All the above conclusions and implications of the results obtained in this study will be 
discussed in detail in the following sections.  
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IV.1.p47 GTPases are completely absent from the human lineage 
 
Including with the previously published six inducible p47 GTPases, I have reported here that the 
family of p47 GTPases in the mouse is encoded by 23 genes sharing many common properties at 
their N-terminus (first three α-helices), C-terminus (last seven α-helices), and G-domain (near to 
the N-terminus with six β sheets and five α-helices) (Fig. 7, 9 and 11). Out of the 23 identified 
genes, two are likely to be pseudogenes. Of the remaining 21 genes, 14 were shown to be 
interferon-γ-inducible and database analysis indicates that the 6 of the remainig 7 p47 GTPase 
gene are also functional with respect to the promoter and transcript structure. One gene, Irgc, 
was shown to be not containing any interferon response element in its promoter region and this 
study provides evidence that it is not involved in immunity (see below). As the interferon-γ-
inducibility is generally indicative of an immune function of the respective gene, the presence of 
14 interferon-γ-inducible members of the p47 GTPase family argues for a remarkable 
significance of these genes for immunity.Indeed several members this family have been shown 
to be essential for the resistance of mice against diverse pathogens, including T. gondii, L. 
monocytogenes, M. tuberclosis (Taylor, 2004). On the other hand, the human genome encodes 
only one representative p47 GTPase-like gene, which seems not to be involved in immunity and 
one expressed fragment, which encodes only the G-domain of a GMS-like GTPase with the 
promoter region containing an endogeneous retroviral element (ERV9) (see below). It is very 
well known that pathogens that are able to infect mice have at least one close relative, which is 
infectious for human. The number of pathogens, against which p47 GTPases are involved in 
resistance are listed in Table 1. It is therefore necessary to ask, “Why do humans lack such a 
strong resistance mechanism?”  
It is expected and known that there are differences between the human and the murine 
immune system, some of which are listed in table 5. It is known from previous reports (Mestas 
and Hughes, 2004) that none of the known immune mechanisms drastically differs between 
mouse and man. At least one representative of each resistance mechanism which is present in 
mouse is also present in man. This can be explained in the context of coadaptation of host with 
their specific pathogens. However, to link the absence of the entire resistance mechanism 
mediated by p47 GTPases in humans to a classical coadaptation of host and pathogen is not a 
satisfactory explanation. It can be suggested that the mechanism disappeared from the human 
lineage because of the integration of a retroviral element into the promoter region of the GMS-
like GTPase, IRGM. As discussed below, the loss of one central member of the p47 GTPase 
family may have implications for the proper function of the whole resistance mechanism 
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mediated by this family. Thus, changing the expression profile of the putative IRGM gene may 
have resulted in a non-functional system. In the human lineage, another strategy must have been 
present to eliminate intracellular pathogens. Therefore, the disappearance of p47 GTPase family 
from the human genome might be either because of an accident or classical host-pathogen 
coadaptation. 
 Mouse  Human Notes Reference 
TLR2 expression 
on PBL 
Low (induced on 
many cells 
including T cells) 
Constitutive (but not 
on T cells) 
Binds lipopeptides (Rehli, 2002) 
TLR3 Expressed on DC, 
Mac. Induced by 
LPS. 
Expressed by DC. 
No LPS induction 
Binds dsRNA (Rehli, 2002) 
TLR9 Expressed on all 
myeloid cells, 
plasmocytoid DC 
and B cells 
Expressed only on 
B cells, 
plasmocytoid DC 
and NK cells 
Binds CpG (Lund et al., 
2003) 
TLR10 Absent Present  (Roach et al., 
2005) 
Sialic acid 
Neu5GC 
expression 
Widespread Absent Binds pathogens (Varki, 2001) 
Leukocytes 
defensins 
Absent Present  (Risso, 2000) 
Paneth cell 
defensins 
At least 20 Two  (Ouellette and 
Selsted, 1996) 
Macrophage NO Induced by IFN-γ Induced by 
IFN-α/β, IL-4+ anti 
CD23 
 (Weinberg, 
1998) 
CD4 on 
Macrophages 
Absent Present  (Crocker et al., 
1987) 
NK inhibitory 
receptor for MHC1 
Ly49 (family 
except Ly49D and 
H) 
KIR  (Lanier, 1998) 
FcαRI Absent Present  (Monteiro and 
Van De Winkel, 
2003) 
*TLR11, TLR12 
and TLR13  
Present Absent Recognize profilin like 
molecules from the 
protozoan parasite T. 
gondii and 
uropathogenic E. Coli 
(Roach et al., 
2005) 
(Yarovinsky et 
al., 2005) 
* The family of 
p47 GTPases  
20 functional 
genes 
Absent A mechanism required 
for resistance against 
vacuolar pathogens 
(Table 1) 
(Bekpen et al., 
2005) 
 
Table 5. Summary of known differences between mouse and human innate immunity.  
Some of the different genes or gene family involve in innate immunity were summarized. Original table containing 
all the differences known in adaptive and innate immunity were prepared by (Mestas and Hughes, 2004) and * 
updated by using recent reports.  
  
As mentioned above, it is concluded that humans have only one full-length p47 GTPase, IRGC, 
which is homologous to mouse IRG proteins. Irgc is the single p47 GTPase located on mouse 
chromosome 7, hence, showing a different chromosomal location from the other chromosome 11 
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and 18 groups. Human IRGC, which is located on chromosome 19 is syntenic to mouse Irgc. 
This protein displays a high degree of homology (more than 90%) and is orthologous between 
mouse, dog and human. Codon based selection analysis revealed that the Irgc gene is evolving 
under purifying selection (Fig. 19), thereby following the characteristic evolutionary behavior of 
housekeeping genes rather than immunity related genes. Notably, it is expressed only in testis. 
Furthermore, inducibility experiments were carried out with interferon γ and β. There was no 
detectable level of interferon-induced transcription of Irgc in both human or mouse cells. In 
addition, analysis of different tissues derived from mice infected with the pathogen Listeria 
monocytogenesis, which is known to cause massive interferon-dependent induction of classical 
p47 GTPases (Boehm et al., 1998), showed no up-regulation of Irgc (Christophe Rohde personal 
communication). Considering the evolutionary behavior, gene structure and functional analysis, 
the IRGC gene is very unlikely to be a representative of the p47 GTPase family in the context of 
human cell autonomous immunity. 
The other p47 GTPase like protein IRGM is not considered to be a functional gene because it 
does not encode a full-length p47 GTPase and because no protein product could be detected by 
immunoblotting and immunofluorescence analysis under all experimental conditions tested. 
Currently, there is no explanation why the IRGM gene is not translated. ERV9 involved 
regulation of transcription is very well known and reviewed by Lower et al., 1996. The promoter 
and transcriptional structure of the IRGM gene is very similar to ZNF80 gene which encodes a 
putative zinc finger protein (Di Cristofano et al., 1995) and it is reported that ERV9 LTR 
regulates the transcription of β-globin gene via locus control region (LCRs) (Routledge and 
Proudfoot, 2002). Furthermore, ERV9 LTR is located, in the antisense orientation, in the second 
intron of  the axin gene,  which contains eleven exons and spans 58kb on chromosome 16. It has 
been shown that ERV9 LTR also has an effect on the transcription of the axin gene  (Ling et al., 
2002).  
ERV9 LTR driven expression is highly effective especially in embryonic, hemotapoietic 
cells. The various kind and different number of transcripts expression driven by LTR was 
detected in adrenal gland and testis (Ling et al., 2002; Svensson et al., 2001). The difference in 
the level of IRGM gene expression in HeLa and GS293 cells was also observed. Approximately, 
100-fold higher expression was detected in the embryonic kidney cell line, GS293 than in HeLa 
cells. RT-PCR analysis using cDNA, synthesized from human brain, liver and testis total RNA 
showed that IRGM has highest expression in testis (Fig. 20). It was of interest to elucidate 
whether the IRGM promoter region also possesses the capability of interferon inducibility or not. 
Bioinformatic screening analysis for an interferon response element, using 10kB upstream of the  
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transcription start site, in the promoter region of IRGM, revealed no potential ISRE or GAS site. 
To confirm that this gene is not regulated by interferons, interferon-inducibility experiments 
were carried out using different cell types (see above) and resulted in a failure to up-regulate the 
IRGM gene or protein by interferon γ  and β after 24 hour. Thus, an alternative interferon-
inducible promoter comprising ISRE or GAS elements out side the analyzed 10kB promoter 
region, is unlikely to be present. Immunoblotting and immunofluorescence analysis using an 
antiserum raised against recombinant IRGM protein failed to show its presence in human cells 
despite the presence of transcript. It is therefore concluded that IRGM is an expressed 
pseudogene. However, there is no doubt that the IRGM protein sequence is closely homologous 
to the mouse Irgm genes. Irgm1 (LRG47) is up to now the most effective resistance gene among 
all mouse Irg genes (Table 1) (MacMicking et al., 2003). The IRGM gene in Chimp (Pan 
troglodytes) a close relative of human, has promoter and genomic structure similar to that of the 
human gene. This clearly indicates that the structure of IRGM is a common feature in primates at 
least for Hominini tribe. Therefore, it can be suggested that humans had the mechanism of p47 
GTPases and probably lost the entire mechanism during the course of primate evolution leading 
to the human lineage (see Fig. 25) while the mechanism was retained by the other vertebrates 
(Fig. 17) as dogs rodents and fish.  
 
Figure 25. ERV9 element in primates and evolutionary history. 
(a)ERV9 LTRs are present both in the higher and lower primates (Ling et al., 2002).Copy numbers of ERV9 LTRs 
in primates and non-primates relative to the haplaoid copy numbers in human detected by northern blot. (b)Inferred 
evolutionary history of ERV9 elements superimposed on a phylogenetic tree of primate evolution (Costas and 
Naveira, 2000).Estimations of ERV9 transpositional ages are based on average divergences of members of each 
subfamily from their respective consensus sequences. 
 
Maybe the explanation for the loss of the p47 GTPase family in the human lineage, is the 
disruption of the promoter region of the IRGM gene by the ERV9 LTR. Such an event would be 
predicted to lead to a complete change in the expression profile. The interferon inducible 
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promoter would become converted to a constitutive promoter which is unresponsive to 
interferons. The promoter region of IRGM like other ERV9 derived promoters contains GATA 
(Shivdasani and Orkin, 1996), CCAAT (Tenen et al., 1997) (Yamanaka et al., 1997), and 
CCACC (Miller and Bieker, 1993) motifs and is potentially capable of binding to cognate 
transcription factors expressed in embryonic and hematopoietic cells. ERV9 is an endogenous 
retroviral element belonging to a family containing at least 14 different subfamilies and is 
specific to primates. Probable appearance of ERV9 was calculated to be as early as 40 million 
years ago and the main expansion in primates was observed 15 million years ago (Costas and 
Naveira, 2000) (Ling et al., 2002). Therefore, it can be assumed that the disruption of the 
promoter region of human IRGM in the ancestor of primate lineage took place during the 
expansion period of the retroviral element within the primate lineages (see Fig. 25b). 
However, the question remains why the the whole p47 GTPase family should disappear 
when only one gene is damaged by a retroviral integration. Recent studies indicate that the 
family of p47 GTPases is functionally interdependent. This is supported by the observation that 
the GMS proteins (Irgm1, Irgm2 and Irgm3) are required for the function of the murine GKS 
type Irg proteins (Irga6, Irgb6 and Irgd). Namely, the transfected individual GKS proteins form 
unexplained aggregate structures whose behaviour differs drastically from the intracellular 
behavior of the interferon-induced endogenous GKS type p47 GTPases. In culture cell lines 
using a transient eukaryotic expression system, co-transfection of GMS proteins together with 
GKS proteins results in re-localization of the transfected GKS proteins similar to that of 
endogenous GKS proteins. Similarly and more importantly, the GMS type Irg proteins are 
required for the transfer of GKS proteins to the toxoplasma containing vacuole in cultures cells 
(Julia Hunn and Nina Schroeder unpublished results). Additionally, some Irg proteins appear to 
be transcribed as unusual tandem genes (Irgb2-1, Irgb5-b4) or as a triplex, which contains two 
GMS proteins (rat irgm2, rat Irgm3) and one GKS protein (rat Irgb10) (see below). Furthermore, 
recent functional genetic analyses by targeted gene knock out experiments suggest a unique 
importance of Irgm1 protein among other p47 GTPases. The Irgm1 (LRG47) appears to be 
required for all the p47-dependent resistances yet tested, while the other p47s appear to be 
required only individual resistances. Therefore, it can be suggested that the GMS genes are the 
key players for p47 GTPases in mouse, meaning that the system itself probably is working in a 
layer like structure or combinations (see below). This interdependent mosaic behavior of p47 
GTPases is also observed in the intracellular localization of the family members. Irgm2, Irgm3, 
Irga6, Irgb6 and Irgd localize to the taxoplasma containing vacuole, (Martens S, 2005). Irgm1 is 
localized to the Mycobacterium containing vacuole (MacMicking et al., 2003). However, It can 
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be suggested that the other Irg genes probably also require GMS genes to be fully functional. 
Therefore, altering the expression profile of one of the most important family member by ERV9 
is the possible reason why human lost the entire family of p47 GTPases.  After the disruption of 
the promoter region of human IRGM by the retroviral element, the p47 GTPase family may have 
lost much of its advantage and may indeed have caused enough costs to be eliminated. In this 
context, it is worth reiterating that loss of normal gene function driven by endogenous retroviral 
element integration associated with several type of disease and cancer formation is well known 
and reviewed in detail by Lower et al., 1996. On the other hand, fitness costs of resistance genes 
is a very well described phenomenon in immunity (Tian et al., 2003), (Rigby et al., 2002), 
(Burdon and Thrall, 2003). As mentioned before, one resistance gene in Arabidopsis, RPM1, has 
a significant cost of fitness. Both resistance and susceptibility alleles frequently occur together 
within natural populations. The evolution of the interferon-inducible resistance gene, Mx1, which 
is required for resistance against influenza virus A and B, Mx1, is maintained by balancing 
selection in the nature (Jin et al., 1998b; Staeheli et al., 1988). However, cost of fitness for the 
Mx1 gene, have not been reported. Resistance genes in the mouse are generally regulated by 
cytokines such as interferon γ and β. Fitness cost related with resistance genes is probably the 
reason why the transcription of inducible large GTPases is controlled by interferons. Higher 
fitness cost of p47 GTPases might be also responsible for the loss of the mechanism from human 
lineage. It is hard to prove whether the ERV9 or fitness cost of p47 GTPases was primarily 
responsible for the disappearance of the family from human lineages. Perhaps, the best 
explanation will be that the combination of both was the reason why humans do not have the 
mechanism of p47 GTPases. However, as pointed out in results, the family of p47 GTPases has 
also appearently disappeared from other groups like birds and Xenopus suggesting that these 
genes evolved with the mechanism of immune response, under different selection pressures 
(coevolution) leading to their disappearance from some of the main branches of the eukaryotes. 
It is an important and un-answered question what replaces p47 GTPases function in man? 
All the innate immune mechanisms such as nitric oxide and oxygen radicals (Fang, 2004; Nathan 
and Shiloh, 2000), purinergic receptors (Lammas et al., 1997), tryptophan depletion (Pfefferkorn, 
1984; Robinson et al., 2003), cation depletion (Schaible and Kaufmann, 2004), authophagy 
(Gutierrez et al., 2004) and TLRs (Roach et al., 2005), are present in the mouse. It is possible 
that one or more of the mechanisms listed above filled the gap left by loss of the p47 GTPases in 
man. This is consistent with the observation that a mouse oviduct cell line expresses interferon 
inducible iNOS (inducible nitric oxide synthase) however does not express IDO (2’3’ 
indolamine deoxygenase) upon treatment by interferon whereas in Hela cells IDO expression can 
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be induced by interferon treatment and is responsible for a remarkable level of resistance against 
Chlamydia species causing disease in humans (Nelson et al., 2005).  
It is of course possible that an unrelated and so far unidentified molecular machine in the 
primates performs the resistance mechanism of p47 GTPases. In fact, preliminary screening 
revealed that a primate specific gene family called Morpheus, which has similar evolutionary 
behavior like p47 GTPases, exists with unknown function. It has been shown by Johnson M. E. 
et al., (Johnson et al., 2001) that fifteen distinct copies of duplicated segments were present on 
chromosome 16 of human and transcripts were identified for six of the 15 genomic copies. 
Similar to p47 GTPases, the number of the duplication segments is variable within the primate 
lineages as 9, 17, 15, 25-30 which is specific to primate species in orangutans, gorillas, human, 
and chimpanzee respectively. Codon based selection analysis revealed that they are relatively 
fast evolving genes, therefore, their function are expected to be related either with immunity or 
reproduction. It will be of interest to see whether this family or undiscovered families specific to 
the human genome are responsible for the mechanism of p47 GTPases in man.  
  The mouse is a model organism used as an experimental model for human diseases for 
many decades, however in this study, a clear distinction between the mouse and the human 
immune system in the sense of cell autonomous immunity is discovered. In the light of the data 
presented here, scientists should consider the  differences in cell autonomous immunity between 
man and mouse when they carry out experiments to analyze the immune response against 
intracellular pathogens. 
 
IV.2.Evolution of p47 GTPases  
 
Evolution of p47 GTPases can be explained in two ways. Firstly, the family of p47 
GTPases is evolving by increasing or decreasing the number of the genes probably because of 
the negative selection pressure by the pathogens. This leads to a increased or decreased diversity 
within p47 GTPases among different species. Secondly, the members of p47 GTPases itself are 
relatively fast evolving genes (see below and Fig. 19). 
All the vertebrates analyzed so far fugu, danio, mouse, dog, cow, pig, amphibian have at 
least one copy of a p47 GTPase-like gene or a set of p47 GTPases whereas in plants, so far no 
p47 GTPaselike gene was detected. It is clear from  fig. 18 and 26 that variations in the number 
of the p47 GTPases among different species are generated via gene duplications, which can arise 
through polyploidization, non-homologous recombination, or retrotransposition. The plausible 
duplication scenario for p47 GTPases in mouse is depicted in fig. 27. Gene duplications are 
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considered to be a mechanism to increase the diversity in immunity-related genes or gene 
families,  (Wagner, 2002) (Kondrashov et al., 2002) (Leister, 2004). This has e.g. been shown for 
the 2’-5’ Oas family that is crucial in the interferon induced antiviral response (Kumar et al., 
2000) (Mashimo et al., 2003).  
 
Figure 26. Schematic representation of diversity of IRG proteins in vertebrates 
(a) Observed diversity of p47 GTPases within vertebrates specific to species that is correlated with the diversity of 
parasites of which p47 GTPases used for. When the diversity of the pathogen increase, the diversity of p47GTPases 
increase (Intensity of the black color and number of the IRG proteins). Pseudogenes were not included. GMS or 
Quasi type GTPases depicted in green color.  Please note that over all diversity for rat and dog summarized here 
based on the search performed on available public databases which were not completed yet. By the accumulation of 
data the picture can be changed. (b) The plausible combinations of p47 GTPases acting as resistance factor against 
pathogens were summarized. The question mark indicates the expected GKS or GMS type p47 GTPases waiting to 
be functionally analyzed on specified pathogen. For more information, please see (Table 1) 
 
When the gene duplication occurs, the duplicated gene becomes redundant and free of 
selection (Kondrashov et al., 2002). Therefore most of the duplicated genes are predicted to 
become lost due to accumulation of deleterious mutations or subjected to directional positive 
selection because they are now free from the obligation of purifying selection (Wagner, 1998) 
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(Wagner, 2002). Only two of the 23 p47 GTPases in mice were classified as pseudogenes in 
C57BL/6 mice by a criterion not being able to encode a full-length protein because of the 
accumulation of null mutations resulting in generation of stop codons in the primary ORF. 
However, it appears that in the family of p47 GTPases, many genes stay intact after duplication. 
 
Figure 27. Duplication scenario for mouse Irg proteins 
Possible duplication scenario of 23 mouse Irg proteins were illustrated by using phylogenetic analysis and 
chromosomal distribution of p47 GTPases as reference. Arrows indicates the predicted duplication events giving 
rise to new gene formation. Irga proteins, which are located on mouse chromosome 18, were illustrated in purple 
color.  Irgb, Irgm and Irgd proteins which are located on mouse chromosome 11 were illustrated in dark blue, green 
and light blue color respectively. Irgc, which is located on chromosome 7, was illustrated in orange color. 
Pseudogenes are colored in red.   
 
Diversity of p47 GTPases acting on pathogens was probably generated by increasing the 
number of p47 GTPases in different species. This will result in different numbers of p47 
GTPases among different organisms which may reflect evolutionary coadaptation by direct host-
pathogen interactions. So far, dog, mouse, rat, fugu, tetraodon, and zebrafish show very different 
distribution of p47 GTPases (Fig 26). Furthermore, two of the reported pseudogenes Irgb5 and 
truncated p47 GTPase Irgb10 in mouse encode full length functional p47 GTPases in rat whereas 
two of the highly degraded pseuodogenes in rat Irga14 and Irga16, are functional genes in 
mouse. Even in the Czech II mouse (M. musculus musculus), which is a very close relative of 
C57BL/6 (M. musculus domesticus), different subsets of p47 GTPases can be detected. For 
instance, in C57BL/6 mice Irga8 is a pseudogene since there is an insertion of adenine base at 
the position 614 corresponding to 204th amino acid while Czech II mouse has a full length gene 
closely homologue to Irga8 (Fig 7).  
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Generation of diversity by somatic recombination and gene conversion are very well 
known mechanism in adaptation to fight against pathogens (Martinsohn et al., 1999),(Flajnik, 
2004), (Summers et al., 2003). Pancer et al., (Pancer et al., 2004) showed that LRRs (leucine 
reach repeats), which are a characteristic feature of innate immune recognition receptors, could 
be used for generation of diversity. This suggests that genes involved in innate immunity can 
indeed be used in generation of diversity. Therefore, it could be suggested that host pathogen 
coadaptation is the primary defining force for the fate of the duplicated p47 GTPase gene or 
genes to determine whether they will decay to pseudogenes or evolve into new functional genes 
and act as another tool for diversity to fight against pathogens. 
Apart from generating diversity by genomic duplication, the individual p47 GTPases are 
subjected to positive selection. Five of the p47 GTPases were detected to be under positive 
selection especially in their C-terminus, suggesting recent coadaptation (Fig. 19). It is known 
that the so called αK helix in the C-terminal region of Irgm1 and Irgm2 is important for the 
proper intracellular localization of the respective protein (Martens et al., 2004). Recently, Kaiser 
et al., (Kaiser et al., 2004) identified for the first time interaction of the IIGP1 protein with 
Hook3, which is a microtubule motor binding protein and involved in cellular trafficking. The 
interaction occurs via the last α helix (αL) of C- terminus of IIGP1, which has some homology 
to other p47 GTPases within the family. Two fugu p47 GTPases, Irgf6 and Irgf5, highly 
differentiated in their C-terminus, however, preserve the classical properties of the C-terminal 
region of the p47 GTPases family whereas both genes are almost completely identical in N-
terminus and G-domain. Therefore, it is possible that the C-terminus of p47 GTPases is generally 
important for localization as well as interaction with other proteins, perhaps even direct 
interaction with the proteins or molecules from pathogens.  
 
IV.3.Oligomeric structures in p47 GTPases family 
 
It is reported here that four of the mouse p47 GTPases were found to be transcribed as 
tandem genes, Irgb5 together with Irgb4 and Irgb2 together with Irgb1. The Irgb2-b1 tandem can 
be amplified by RT-PCR on cDNA synthesized by using mRNA extracted from L929 cell line 
and was shown to be inducible by interferon γ. In rat, there is a transcript encoding a triple p47 
GTPase, comprising sequences equivalent to rat Irgb10-Irgm3-Irgm2. Rat Irgb13-Irgb14 has a 
genomic structure and splicing pattern similar to that of mouse Irgb2-b1 suggesting that rat 
Irgb13-Irgb14 can be transcribed as a tandem gene (Fig. 9 and 10a). Moreover, Zebrafish has 
one tandem pair containing irgg with quasi GTPase irgq.  
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Dynamin, dynamin like GTPases, Mx, and GBP are GTPases, which can form GTP 
dependent oligomers and this oligomerization is required for the function. Since the family of 
p47 GTPases shares biochemical properties with the dynamin like GTPases, it was expected that 
p47 GTPases are functional by formation of higher molecular structure in vivo, however 
formation of tandems at the transcriptional level was unexpected. Similar to classical dynamin 
like GTPases, Irga6 can form oligomers in vitro and formation of oligomers is stimulated by 
GTP binding (Uthaiah et al., 2003). Furthermore, Irga6 (IIGP1) forms dimers as determined by 
crystal structure and site-directed mutational analysis of the dimer-interface showed that N-
terminal interaction is essential for dimerization (Ghosh et al., 2004). However, the dimer 
observed in the crystal structure shows N-terminus to N-terminus interaction of Irga6. The 
tandems and trimer are encoding head to tail genes and especially, the crystal structure of the rat 
trimer is completely unpredictable.    
Why does a mouse need 20 functional genes of which transcription is tightly regulated by 
interferon γ and use this repertoire in a non-redundant way? The p47 GTPase family is massively 
induced by IFN-γ after 24 hours and the calculated induction ratio ranges from no or very low 
level up to 215 fold for IIGP1 and 50 for LRG47 at transcriptional level. The calculated number 
of protein molecules of IIGP1 per cell in L929 cells induced with 200 U/ml interferon γ after 24 
hour is approximately 2x106 (Jia Zeng unpublished results). If we make a rough calculation and 
assume that all the p47 GTPases are inducible (130 fold in approximate average) and are 
translated and active, the number of p47 GTPases in the cell within first 6 hours will increase 
from almost zero to 14 which is in total 14X130 = 1820 fold more p47 GTPases in the cell. 
However, the existence of transcription of tandem and triple Irgs, suggests that the functional 
unit of p47 GTPases might be dimmers, trimers or even higher oligomers. This view is also 
supported by yeast two hybrid assay (analysis of protein-protein interaction in S. cerevisiae) 
(Kaiser, 2005).  
If we imagine that p47 GTPases would function as dimers and the position of the invidual 
p47 GTPases within the dimer is omitted (for example A-B=B-A, A-C=C-A), then the total 
number of the different dimers would be 91 possible combinations by using 14 individual p47 
GTPase. If the functional unit is a trimer, then the total number will be 364 different 
combinations. Such diversity could be a big advantage for an organism to fight against pathogens 
(Fig. 26). In reality, combinations of p47 GTPases might be different. However, each pathogen 
has its way of infection and requires different niche to survive within the cell. The functional unit 
(combination) of p47 GTPases is probably required for resistance against specific pathogens. In 
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fact, it is known that TLRs can form homo and hetero-dimers in different combinations and so 
they can recognize different PAMPs. For example, TLR2 can form heterodimers with TLR1 or 
TLR6. A consequence of this cooperation is an increased repertoire of ligand specificities 
(Beutler, 2004) (Janeway and Medzhitov, 2002). It can be suggested from genetic evidence in 
mouse, fish, and rat that formation of higher molecular structures in p47 GTPases might 
naturally occur in a way that hetero-dimers, trimers, tetramers or even higher oligomers may 
form. Perhaps, it is an advantage for an organism to transcribe two or three genes in one unit 
rather than transcribing them separately and arranging them to interact post translationally. In 
fact, it is known that functionally related genes, at least in immune system are often genetically 
linked. For example, The TAP1 and LMP2 genes are transcribed from a shared bidirectional 
promoter containing an IFN response factor element that confers IFN-γ inducibility (Wright et 
al., 1995), (Dovhey et al., 2000). 
Classical p47 GTPases TGTP (Irgb6), IIGP1(Irga6), IRG47 (Irgd), and IGTP (Irgm3) 
localize at the parasitophorous vacuole upon infection by Toxoplasma gondii (Martens et al., 
2005 and Sascha Martens unpublished results). The pathogen containing vacuole is probably the 
place where functional oligomers form and one can easily imagine how many combinations of 
p47 GTPases are available at the same time on the phagosome.  
 
IV.4.Origin of p47 GTPases 
 
The p47 GTPase family might have been originated from cyanobacteria by horizontal gene 
transfer, and evidence for this assumption is that firstly all ORFs of classical p47 GTPases are 
encoded on a single exon which is characteristic for a gene of prokaryotic origin, though 
certainly not diagnostic. Secondly, there are GTPases present in bacteria (especially in 
cyanobacteria) with significant homology to the G-domain of p47 GTPases. Secondary structure 
prediction analysis reveals that they are related with p47 GTPases (Jonathan C. Howard personal 
communication). It will be of interest to elucidate whether cyanobacterial p47 GTPase-like genes 
possess a crystal structure similar to IIGP1.  
   
 
 
 
 
 
                                                                                                                                                                                                                                                                               Appendix 
 84
 
V.APPENDIX  
 
V.1.Appendix Table 1. List of all IRG gene family members and related genes  
(Please note that detailed descriptions of the most of the genes presented in the table was prepared by Julia Hunn) 
  
Gene name Genesymbol/ID Synonyms Genomic sequences /Accession 
no. 
cDNA or EST sequence Accession numbers Notes 
Mouse      
Irga1 Irga1 
MGI:1795294 
MGI:1653512 
New gene 
 AC132320 
AC102225 
BI658674 (NMRI, 5’EST, nearly 100%)  
BG915086 (NMRI, 5’EST; not 100% ) 
 
Irga2 Irga2 
MGI:915200 
MGI:1257137 
MGI:1257136  
New gene 
 AC132320 
AC102225  
XM_140378 
AA968296 (C57BL/6, 5’EST, 100%, not full length) 
AA968378 (C57BL/6, 3’EST, 100%, not full length) 
 
Inducible by IFN-γ. 
Irga3 Irga3 
New gene 
 
 AC132320  
XM_140379 (C57BL/6J) 
BY751179 (NOD, EST, not 100%, 610bp) 
 
Inducible by IFN-γ. 
Irga4 Irga4 
New gene 
 AC132320) 
XM_140380 (Irgb4/Irgb5 tandem)
BY750970 (NOD, EST, nearly 100%, 700 bp) 
BU696309 (C57BL/6, EST, nearly 100%, 530 bp) 
Inducible by IFN-γ. 
Irga5Ψ Irga5 
New gene 
 AC132320 None A transcript is inducible by IFN-γ but the coding 
sequence of the gene is disrupted repeatedly. 
Irga6 Irga6 
MGI:1926259 
MGI:2147195 
MGI:2147350 
IIGP, IIGP1, 
Iigp1 
 
AC135638 
 
AJ007971  (C57BL/6, 100% correct) 
AF194871 (C57BL/6, also NM_021792, 100%) 
BC004649 (C57BL/6, cDNA 100%, 2330bp) 
 (Boehm et al., 1998) (MGI:1889878); (Zerrahn et 
al., 2002) 
Inducible by IFN-γ. 
Irga7 Irga7 
New gene 
 NT_039674 (C57BL/6J, Chr.18 
genomic contig, 73.9 Mb)  
XM_487533 (C57BL/6, 100%) 
None known  
Irga8 Irga8 
MGI:953940 
(C57BL/6) 
MGI:2384767 
MGI:1489193 
(CZECHII) 
MGC:28198  
BC023105 
AC135638 BC023105 (CZECHII cDNA, = NM_145357, not 
100%, full length) 
BB637466 (C57BL/6J, 5’EST, not 100%, not full 
length)  
BF163606 (CZECHII, not 100%, not full length) 
BE198503 (C57BL/6, 3’EST, 100%, not full length) 
In C57BL/6 a non-canonical guanine after bp 849 
in BC023105 (= aa 204) puts the sequence out of 
frame just before Helix H4; the reading frame is 
complete in BC023105 (CZECHII, Mus musculus 
musculus).  
Inducible by IFN-γ. 
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New gene 
 
BE198089 (C57BL/6, 3’EST, 100%, not full length) 
BX520309 (C57BL/6, 3’EST, 100%, not full length 
Irgb1 Irgb1 
MGI:1519766 
New gene 
 
 AL645849 BC022776 tandem Irgb2/ Irgb1 (CZECHII, not 
100%, protein: Q8R5D8) 
BF144722  (CZECHII, EST, not 100%, starts with 3’ 
end of Irgb2) 
The Irgb2/Irgb1 gene pair is almost certainly 
transcribed in tandem. The protein has not yet been 
described.  
Inducible by IFN-γ. 
Irgb2 Irgb2 
MGI:1518599 
New gene 
 
 AL645849 BC022776 tandem Irgb2/ Irgb1 (CZECHII, not 
100%, protein: Q8R5D8) 
BF144934 (CZECHII, 5’ Irgb2 cDNA, not 100%) 
BY735436 (from cell line RCB-0527 Jyg-MC(B), 
strain unknown, 5’ Irgb2, not 100%) 
See note above, Irgb1. 
Irgb3 Irgb3 
MGI:1553791 
(FVB/N) 
New gene 
 
 
 
AL627237 
AL669850 (unordered)  
AF060196 (129/SvJ, genomic, 1 
bp difference, ATG(Irgb3)= bp 
1353; Stop = bp 2659)  
BF539106 (FVB/N, 3'EST, not 100%)  
 
The genomic sequence of Irgb3 is followed after 
950 bp by a retroposon corresponding to the 
proteasome regulator PA28b (MGI:1331589). The 
presence or absence of this retroposon 
unambiguously distinguishes Irgb3 from Irgb4. 
Irgb4 Irgb4 
MGI:1795392  
MGI:3041173 
New gene 
9930111J21Rik 
 
AL627237 
AL669850 (unordered) 
BC066104 (C57BL/6, Irgb5/Irgb4 tandem, 100%)  
BI655221 (NMRI, EST, not 100%) 
See note above for Irgb3. 
Irgb4 is probably normally expressed as a distinct 
3’ exon in a tandem transcript downstream of 
Irgb5. 
Irgb5 Irgb5 
MGI:3041173  
MGI:2401562 
New gene 
 
9930111J21Rik AL627237 
AL645688 
AL669850 (unordered) 
BC066104 (C57BL/6, Irgb5/Irgb4 tandem; not 100% 
at 5’ end)  
AK037088 (C57BL/6, cDNA, = NM_173434, 100%, 
unknown 5’ end) (protein = BAC29698= Q8CB10) 
Irgb5 is probably normally expressed as a separate 
5’ exon in a tandem transcript upstream of Irgb4. 
However AK037088 does not splice into Irgb4. 
Thus Irgb5 can exist as a single p47 unit or as a 
tandem with Irgb4. 
The reference number MGI:2401562 refers to 
several ESTs belonging to Irgb5 and Irgb9. 
Inducible by IFN-γ. 
Irgb6 Irgb6 
MGI:98734  
MGD-MRK-
15077 
TGTP,  
Mg21, Gtp2 
 
 
AL627237 
AL645688 
AL669850 (unordered) 
L38444 (C57BL/6, 100%) 
NM_011579 (NOD, 2 aa difference) 
U15636 (C.D2-Idh-1/Pep-3, 2 aa difference) 
BC085259 (NMRI, cDNA, 100%) 
BC034256 (CECHII, cDNA, not 100%) 
(Carlow et al., 1998; Lafuse et al., 1995) Inducible 
by IFN-γ. 
Irgb7Ψ Irgb7 
New gene 
 AL645688 
AL669850 (unordered) 
None known Pseudogene: STOP codon before G-domain. Not 
inducible by IFN-γ, no known transcript. 
Irgb8 Irgb8 
MGI:1672892 
New gene 
 AL645849 BG974191 (NMRI, 3’ EST, not full length, not 
100%,) 
So similar to Irgb1, b3 and b4 that non-identical 
EST sequences are hard to disentangle. 
Irgb9 Irgb9 
MGI:2401562 
 AL645849  
XM_204704 (C57BL/6, full 
BB630182 (EST, short) The reference number MGI:2401562 refers to 
several ESTs belonging to Irgb5 and Irgb9. 
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New gene length, 100%) 
Irgb10 Irgb10 
MGI:1282384  
 AL928857 AI122314 (C57BL/6, short EST, not 100%) Short, terminates before end of G domain in S6. 
Inducible by IFN-γ. 
Irgc Irgc 
New gene 
CINEMA 
 
AC073810 (RP23-57J6) 
GENSCAN00000140134 
BB615720 (C57BL/6 cDNA, 99%, 606 bp) 
36 ESTs, none full length (e.g. CA464745  5’mRNA, 
874bp, 100% except of first two bp) 
 
An Irgc-related sequence has recently been named 
HGTP-47(MacMicking, 2004). This sequence 
(NP_950178=NM_199013= AK089224, NOD) 
contains 4 frameshifts relative to the C57BL/6 
genomic sequence leading to a largely incorrect 
protein sequence. The reference numbers  
MGI:2685948 and MGI:2685320 both relate to this 
error sequence. 
Irgd Irgd 
MGI:99448 
MGD-MRK-
16217 
IRG-47, IRG47, 
Ifi47, 47kDa, 
Iigp4 
AL645688 
AL669850 (unordered) 
M63630 (B6D2F1, =NM_008330, 100% correct) 
 
(Gilly and Wall, 1992). This is the first report of a 
p47 GTPase and has given its name (IRG-47) to the 
whole family.  
Inducible by IFN-γ. 
Irgm1 Irgm1 
MGI:107567  
MGD-MRK-
36139 
LRG-47, 
LRG47, Ifi1, 
Iigp3 
AL645849 U19119 (BALB/c, =NM_008326, 100% correct) (Sorace et al., 1995); Two 5’ splice variants exist. 
See notes human IRGM below.  
Inducible by IFN-γ. 
Irgm2 Irgm2 
MGI:1926262 
MGI:2144195 
GTPI 
Iigp2 
AL928857 AJ007972 (C57BL/6; 100%) 
NM_019440 (CZECHII, = BC005419, not 100%) 
(Boehm et al., 1998), MGI:1889878. 
Two 5’ splice variants exist.  
Inducible by IFN-γ. 
Irgm3 Irgm3 
MGI:107729 
MGD-MRK-
36305 
MGI:2144580 
IGTP 
Igtp 
AL928857 U53219 (C57BL/6, cDNA, 100%) 
NM_018738 (NOD, cDNA, not 100%) 
(Taylor et al., 1996), MGI:82341 
Inducible by IFN-γ. 
 
Irgq Irgq 
MGI:2667176 
New gene 
FKSG27 
 
AC073810 AF322649 (C57BL/6, mRNA, = NM_153134)  
Human      
IRGC UniGene 
Hs.515444 
R30953_1 
GeneID: 56269 
New gene 
CINEMA 
human IIGP5, 
cinema1 
 
AC005622 
HChr.19 cosmid 
BC066939 (cDNA, 100%) 
NM_019612 (cDNA, 100%) 
 
 
IRGM UniGene 
Hs.519680  
New gene 
human LRG-
47-like protein 
(LRG47, LRG-
AC010441 
Chr.5  
XM_293893 (splice variant a, 
BC038360 (splice variant c, 3’EST) 
BC038539 (short EST) 
BI764111 (short EST) 
5 different 3’ splice variants (a-e) (see main paper 
Bekpen et al, Fig. 8b). 
The orthology of Irgm1 with human IRGM implied 
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GeneID: 345611 
MIM: 608212 
 
47), IFI1 100%) Sequences have been confirmed by RT-PCR 
(unpublished) 
 
by use of the name LRG47 or IFI1 for the human 
gene is incorrect. The use of LRG47 as a synonym 
or alias for human IRGM is therefore not 
recommended. 
IRGQ UniGene 
Hs.546476 
GeneID: 126298  
Homo sapiens 
FKSG27, Irgq1 
AC006276 
 
AF322648 (=NM_001007561 mRNA, 100%)  
Dog      
IRGB11 New gene  AACN010148430  
AAEX1030324 
AAEX1030325 
  
IRGB12 New gene  AACN01030937 
AAEX1030324 
AAEX1030325 
 Confirmed by RT-PCR but not sequenced. 
Inducible by IFN-γ. 
IRGC New gene CINEMA AACN010031536 
AAEX01054272 
  
IRGD New gene  AAEX01030325   
IRGM4 New gene  AAEX01059458  Confirmed by RT-PCR but not sequenced. 
Inducible by IFN-γ. 
IRGM5 New gene  AACN010384735  
AAEX01030325 
 Confirmed by RT-PCR but not sequenced. 
Inducible by IFN-γ. 
IRGM6 New gene  AACN010300899 
AAEX1030325 
 Confirmed by RT-PCR but not sequenced. 
Inducible by IFN-γ. 
Fugu      
irgf5 New gene 
 
 Fugu_Sc2554 (Ensembl v3)  irgf genes of zebrafish, Fugu and Tetraodon have 
the long coding exon broken by an intron. 
irgf6 New gene 
 
 Fugu_Sc2554 (Ensembl v3) CA589084 (GI:25133662: 606 bp mRNA linear EST; 
hab53f04.y1 Fugu UT7 adult skin Takifugu rubripes 
cDNA clone) 
AL837863 (GI:21879801; 491 bp mRNA linear; 
F000A Takifugu rubripes cDNA clone F000A03aF7, 
mRNA sequence, skin)  
See note above, irgf5 
Tetraodon      
irgf7 
 
New gene 
 
 SCAF112 (Ensembl v32, Jul 05) GSTENT00000024001 irgf genes of zebrafish, Fugu and Tetraodon have 
the long coding exon broken by an intron. 
irgf8 
 
New gene 
 
 SCAF112 (Ensembl v32, Jul 05) 
 
GSTENT00000023001 See note above, irgf7. 
Zebrafish      
irge1 XP_693404  AL935330 (CH211-230C14) BM316215 (3' EST)  Zebrafish irge genes have the long coding exon 
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New gene 
 
CR391937 (CH211-175G6)  unbroken by an intron, like the mammalian p47 
genes 
XP_693404 (GI:68383735, 502 aa linear VRT 30-
JUN-2005 predicted: similar to immunity-related 
GTPase family, cinema 1 [Danio rerio]. 
DBSOURCE REFSEQ: accession XM_688312.1  
(Short N-terminus) 
irge2 XP_693474 
New gene 
 
 AL935330 (CH211-230C14) 
CR391937 (CH211-175G6) 
None See note above, Irge1.  
XP_693474 (GI:68383738, 352 aa linear VRT 30-
JUN-2005 predicted: similar to immunity-related 
GTPase family, cinema 1 [Danio rerio]. 
DBSOURCE REFSEQ: accession XM_688382.1 
(Short N-terminus) 
irge3 New gene 
 
 AL935330 (CH211-230C14) 
CR391937 (CH211-175G6) 
AW233145 (5' cDNA ) 
 
See note above, Irge1.. 
irge4 XP_693622 
New gene 
 
 AL935330 (CH211-230C14) 
CR391937 (CH211-175G6) 
CN501017 (5' EST) 
CK142408 (5' EST) 
See note above, Irge1.. 
XP_693622 (GI:68383741, 385 aa linear VRT 30-
JUN-2005 predicted: similar to immunity-related 
GTPase family, cinema 1 [Danio rerio].  
DBSOURCE REFSEQ: accession XM_688530.1 
Irge5 XM_681093 
New gene 
 
 NW_635044 (GI:67045019; chr. 9 
contig; bp 307225 308757) 
 See note above, Irge1. 
XM_681093 (GI:68365895, 1533 bp mRNA linear 
VRT 30-JUN-2005 predicted: Danio rerio similar 
to immunity-related GTPase family,  cinema 1 
(LOC557936), mRNA.  
Irge6 XM_695163 
New gene 
 
 NW_633868 (gi:67045754; chr. 
18 contig; bp 5057602-5058696) 
 See note above, Irge1. 
XM_695163 (GI:68390584, 1095 bp mRNA linear 
VRT 30-JUN-2005 predicted: Danio rerio similar 
to immunity-related GTPase family, cinema 1 
(LOC571560), mRNA.  
irgf1 XP_700498 
New gene 
 
 CR384077 
DKEY-79I2 
CN503005 (5' EST) irgf genes of zebrafish, Fugu and Tetraodon have 
the long coding exon broken by an intron. 
XP_700498 (397 aa linear VRT 30-JUN-2005 
predicted: similar to immunity-related GTPase 
family, cinema 1, partial [Danio rerio]. 
irgf2 New gene 
 
 CR384077 
DKEY-79I2 
None 
 
See note above, irgf1. 
 
irgf3 
 
New gene 
 
 WGS traces 
zDH64-1061h13.q1k 
ZDH88-124d21.p1k 
AL924569 See note above, irgf1. 
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zfish35935-195b06.p1c 
irgf4 New gene 
 
 ENSDARG00000010545 None See note above, irgf1. 
irgg New gene 
 
 AL935330 (CH211-230C14) 
CR391937 (CH211-175G6) 
CA473205 (5' EST) No intron in long coding exon. Short, terminates in 
Helix F. 
Probably the 5’ end of a tandem with irgq1. 
irgq1 
 
New gene 
 
 AL935330 (CH211-230C14) 
CR391937 (CH211-175G6) 
BQ481364 (5’ EST) and BQ481122 (3’ EST) from 
cDNA clone IMAGE:5899497. The 5’ end of this 
clone is in the 3’ end of irgg and reads into the 5’ end 
of irgq1. 
Short, terminates in helix F. Probably the 3’ end of 
a tandem with irgg. 
irgq2 
 
XP_684591 
New gene 
 
 BX072550 
DKEY-245P1 
BF938149 5’ EST and BI880124 3’EST from  
cDNA clone IMAGE:4200886 
XP_684591 (GI:68381188, 379 aa linear VRT 30-
JUN-2005 predicted: similar to 
RGD1311107_predicted protein [Danio rerio]. 
DBSOURCE REFSEQ: accession XM_679499.1 
irgq3 
 
New gene 
 
 BX127973; 
SP6 end of BAC DKEY-279M7 
Zv4_scaffold1709.9 
None  
C. elegans      
C46E1.3 WP:CE34758 
GI:3300129;  
CAE17750 
 AL008867.1  (GI:3217208, 
cosmid C46E1) 
None Predicted protein, tandem G domains. 
W09C5.2 CAB63329.1 
GI:6580259 
 Z82077 (GI:3873420, Cosmid 
W09C5) 
None Predicted protein. 
Bacteria      
BAA10832 GI:1001345  BA000022.2 (GI:47118304, 
Synechocystis sp. PCC 6803) 
 Synechocystis sp . PCC 6803 
Predicted protein. 
BAA18140 GI:1653224 
 
 BA000022.2 (GI:47118304, 
Synechocystis sp. PCC 6803) 
 Synechocystis sp . PCC 6803 
Predicted protein. 
BAA18642 GI:1653731  BA000022.2 (GI:47118304, 
Synechocystis sp. PCC 6803) 
 Synechocystis sp . PCC 6803 
Predicted protein. 
BAC08557 GI:22294728  BA000039.2 (GI:47118315, T. 
elongatus BP-1) 
 Thermosynechococcus elongatus BP-1 
Predicted protein. 
BAC08842  GI:22295014  BA000039.2 (GI:47118315, T. 
elongatus BP-1) 
 Thermosynechococcus elongatus BP-1 
Predicted protein. 
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V.2.Appendix Table 2. Splicing acceptors and donors for IRG proteins in mouse 
Splicing junctions are indicated with blue. Genes alternatively spliced are indicated as (a) and (b). (2) indicates the splice variant specific to 
alternative promoter of respective gene.second promoter.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
                 
First Splicing   
                
Second Splicing   
 
Name of 
the Gene Splicing Donor Splicing Acceptor Splicing Donor Splicing Acceptor  
 Irgb1 GAGCAGGTGAGCTCA  TCTATTCAGCATCCT    
 Irgb2 TGTGAGGTAAGGGT CTCCCTTAGGTACCA    
 Irgb5(a) GGAACAGGTACCTGAA TTTCTTTAGTACCATC    
 Irgb5(b) AGGACAAGGCAGGTAA TTCTCTCCAGAGCACC GGAACAGGTACCTGAA CTTTCTTTAGTACCATC  
 Irgb6 CTGCTGAGGTAAGTGA CTCCATTCAGCTTCTA    
 Irgb7 CTGCTGAGGTAAGTGA CCTCCCTTAGGTACCATT    
 Irgd(a) TCTTCACTGTGAGTACC TCTCTGCTAGGGCTCAT TGGATCTGGTGAGTGCG CTTCTCACAGAGCTTCC  
 Irgd(b) TGGATCTGGTGAGTGCG AATTTTGCAGTAGTCTT GAGGCCAGGTAGGCTG CTTCTCACAGAGCTTCC  
 Irgd(c) TGGATCTGGTGAGTGCG CTTCTCACAGAGCTTCC    
 Irgm1(a) TGGATCAGGTAAGTAA TATCTAATAGGGTTTGA CCTGCGAGGTGGGGTAG ACTCTTACAGGCTGCTC  
 Irgm1(b) GGATCAGGTAAGTAAA ACTCTTACAGGCTGCTC    
 Irgb9 GGAACAGGTACCTGAG CTCCCTTTAGTATCATC    
 Irgm2(a) TGAGCAGGTAGGTGAG GTAATTTCAGGTTGCCC    
 Irgm2(b) TGAGCAGGTAGGTGAG TTTAAGCCAGTTCTGGA ATCCAGGGTGAGTCTT GTAATTTCAGGTTGCCC  
 Irgm3 TGAGCAGGTAGGTGAG TTTCTAACAGGTTCTGA CTGGAAGGTGAGTTAG TCTTCTGCAGACTTTTA  
 Irgb10 GGAGCTGGTGAGTGAG TTCCCTCCAGTGTCCTG    
 Irga1 GATTTCTGGTAACTCA CTCCACACAGTGCAGCA ATTTGTTGGTTTGTTT TTTCTTCCAGTGGCTTT  
 Irga2 GATTTCTGGTAACTCA TTTCTTCCAGTGCCTTT    
 Irga3 AGTTTCTGGTAAGTGT CTTCTTTCAGTGCCTTT    
 Irga4(a) AGTTTCTGGTAAGTGG CTTCTTTCAGTAACCTT    
 Irga6(a) AGTTTCTGGTAAGTGG TTTCTTCCAGTGCCTTT    
 Irga6(b) AGTTTCTGGTAAGTGG TCAAAACAGGATTTCT ATTAAAGGTAGGCTAT TTTCTTCCAGTGCCTTT  
 Irga6 (2) ATTTTCTGGTAACTCA TTTCTTCCAGTGCCTTT    
 Irga8(a) AGTTTCTGGTAAGTGG CTTCTTTCAGGGCCTTT    
 Irga8(b) AGCAGGGGTGGGTTCT TCTGTTAAGATTTAAT AGTTGAGGTATACCTA CTTCTTTCAGGGCCTTT  
 Irgc CATCTGAGGTAGGTTAG TTCTCCTGCAGCCACT    
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V.3.Appendix Table 3. Detailed analysis of Triple formation in Rat 
AY321344 (mRNA amplified from rat liver). Blue highlighted seq. indicates the position of the splicing, yellow 
highlights show the charecteristics conserved a.a sequence for p47 GTPase.  
 
1 
1 
61 
21 
121 
41 
181 
61 
241 
81 
301 
101 
361 
121 
421 
141 
481 
161 
541 
181 
601 
201 
661 
221 
721 
241 
781 
261 
841 
281 
901 
301 
961 
321 
1021 
341 
1081 
361 
1141 
381 
1201 
401 
1261 
421 
1321 
441 
1381 
461 
1441 
481 
1501 
501 
1561 
521 
1621 
541 
1681 
561 
1741 
581 
1801 
601 
1861 
621 
1921 
641 
1981 
661 
2041 
681 
2101 
701 
  AGCTAGAAATGGGGAGAAAGAGAAAACAAACTTCTCGGCAATGAACAAGATCCTGTGT 
 X  A  R  N  G  E  K  E  K  T  N  F  S  A  M  N  K  I  L  C  
ACAGCAAGGTTTGTGTGGGAACAAACACAGGACTGTCAAGAAGCACGCATGTTGACTGTG 
 T  A  R  F  V  W  E  Q  T  Q  D  C  Q  E  A  R  M  L  T  V  
TTTAATTTAGTGCTGAAGAAACGGCCATGCCTGCGGCCCCCGTGGCTGCTGCCACCACTG 
 F  N  L  V  L  K  K  R  P  C  L  R  P  P  W  L  L  P  P  L  
CTGCTCCTGCAGCTGCTTGCTGCTGCCCCAGCCAAGGCCGAAGCAAAGGAAGAGTCGGAG 
 L  L  L  Q  L  L  A  A  A  P  A  K  A  E  A  K  E  E  S  E  
GAATCAGATGAGGACCAACCCACACTGCCTTACAACTTTGTAGTAAGCTGCGACTGTTGT 
 E  S  D  E  D  Q  P  T  L  P  Y  N  F  V  V  S  C  D  C  C  
GTCTATGTGGCCGTGGGGATTGAACCTTGGACCCAGGGCAAGCTAGTGTCCTGTGCACTT 
 V  Y  V  A  V  G  I  E  P  W  T  Q  G  K  L  V  S  C  A  L  
ACAGCCATGGGTCAGTCTTCTTCTAAACCTGATGCAAAGGCCCATAATATGGCCTCCAGC 
 T  A  M  G  Q  S  S  S  K  P  D  A  K  A  H  N  M  A  S  S  
TTTAATGAGTTCTTCAAGAGTTTCAAAATGGAAAGTAAAATCCTTTCTGAGGAGACCATC 
 F  N  E  F  F  K  S  F  K  M  E  S  K  I  L  S  E  E  T  I  
AATTCAATTCAGTCGTGTGTGCAAGAAGGAGACATACAGAAGGGAATTTCTATAATCAAT 
 N  S  I  Q  S  C  V  Q  E  G  D  I  Q  K  G  I  S  I  I  N  
GCTGCCTTGGCAGACATTGAGAAGGCCCCCCTGAACATCGCAGTGACAGGGGAGACGGGG 
 A  A  L  A  D  I  E  K  A  P  L  N  I  A  V  T  G  E  T  G  
GCAGGAAAGTCCACTTTCATTAATGCCCTGAGGGGAGTAGGGCATGAAGAGAGTGAGTCA 
 A  G  K  S  T  F  I  N  A  L  R  G  V  G  H  E  E  S  E  S  
GCTAAGATTGGAGCAGTGGAGACAACCATGGATAAGTTCCCTAAGTTCCCTAACGTGACC 
 A  K  I  G  A  V  E  T  T  M  D  K  F  P  K  F  P  N  V  T  
ATCTGGGACCTCCCTGGGGTCGGGACATGTAACTTCAAACCAGAAGAATATCTGAAGAAG 
 I  W  D  L  P  G  V  G  T  C  N  F  K  P  E  E  Y  L  K  K  
CTGCGGTTCCAGGAGTATGACTTCTTCCTTATCATCTCAGCTACTCGCTTTAGAGAGAAT 
 L  R  F  Q  E  Y  D  F  F  L  I  I  S  A  T  R  F  R  E  N  
GATGCCCAGCTGGCCAAAGCAATCAAAAAAATGAAAAAGAACTTCTATTTTGTTCGAACA 
 D  A  Q  L  A  K  A  I  K  K  M  K  K  N  F  Y  F  V  R  T  
AAAATTGACAGTGATTTGTGGAATCAGAAGAAGTGTAAACCCAAGTCCTACAATAAGGAA 
 K  I  D  S  D  L  W  N  Q  K  K  C  K  P  K  S  Y  N  K  E  
AAAATCCTGGAGGAAATTCGCAAAGACTGTGTGGAGAAGCTGCAGAACGCTCGGGTGGCC 
 K  I  L  E  E  I  R  K  D  C  V  E  K  L  Q  N  A  R  V  A  
TCTGCTCGCGTCTTCTTAGTCTCCAGCGTTGAGGTAGCACAGTTTGACTTTCCTGAGCTG 
 S  A  R  V  F  L  V  S  S  V  E  V  A  Q  F  D  F  P  E  L  
GAGTCCACCCTTTTGGAAGAGCTGCCAGCGCACAAGCGTCATGTCTTCATGCAGTGCCTC 
 E  S  T  L  L  E  E  L  P  A  H  K  R  H  V  F  M  Q  C  L  
CCTAGCATTACCGAGAGGGCTATTGACCGCAGGAGAGATGCCCTGAGACAGAAGATCTGG 
 P  S  I  T  E  R  A  I  D  R  R  R  D  A  L  R  Q  K  I  W  
TTGGAGGCTCTGAAGTATGGCGCGTCGGCCACCATCCCCATGATGTGTTTCTTCAATGAT 
 L  E  A  L  K  Y  G  A  S  A  T  I  P  M  M  C  F  F  N  D  
GACATCGAGGAGCTTGAGAAGATCCTGACCCACTACAGGGGTAGCTTTGGGCTGGATGAC 
 D  I  E  E  L  E  K  I  L  T  H  Y  R  G  S  F  G  L  D  D  
GAGTCGCTGAAAAACATGGCCAGTGAGTGGTCCATGTCTGTGGAGGAGCTGAAGTCCTTC 
 E  S  L  K  N  M  A  S  E  W  S  M  S  V  E  E  L  K  S  F  
ATTAACTCACCCCATTTGCTGTCATGTGAGATGAATGAATCTGTGTCAGACAAGATGGTG 
 I  N  S  P  H  L  L  S  C  E  M  N  E  S  V  S  D  K  M  V  
AAACCCTACCGGGCAGAGCTCTACCGGGTCACTATCCCCCAGCATAGAGCTGCCATCCAG 
 K  P  Y  R  A  E  L  Y  R  V  T  I  P  Q  H  R  A  A  I  Q  
GATAGGACCTGGACAGGAGTGCAGAGAGTCACCTTTGTCCCAGGACAGCAGGAGACCAAG 
 D  R  T  W  T  G  V  Q  R  V  T  F  V  P  G  Q  Q  E  T  K  
GAGGCAATTCCCTCAGAGCCACAGAAAGTCTCCATGTCACAGGGAGACAACTGGGGTGTT 
 E  A  I  P  S  E  P  Q  K  V  S  M  S  Q  G  D  N  W  G  V  
TTTACCCCTTTCATAAACATGGCGAAACCTCTCAAGCCGCCATTGTTTAAATCCATCACT 
 F  T  P  F  I  N  M  A  K  P  L  K  P  P  L  F  K  S  I  T  
GCTGGTGAGTCATCCTATAGCAGCCAGAACTCTTCTTCTCCAGAAGTCATTGAGAAGGTC 
 A  G  E  S  S  Y  S  S  Q  N  S  S  S  P  E  V  I  E  K  V  
GGTAAGGCTGTGGCAGAGGGGGATTTACAGAAAGTGATATACACAGTCAAAGAGGAAATG 
 G  K  A  V  A  E  G  D  L  Q  K  V  I  Y  T  V  K  E  E  M  
CAGAGTAAGTCTAGATACACGGTAAAAATCGCCGTGACTGGGGACTCTGGCAATGGCATG 
 Q  S  K  S  R  Y  T  V  K  I  A  V  T  G  D  S  G  N  G  M  
TCATCTTTCGTCAACGCCCTTAGGCTCATTGGACATGAGGAGGAGGATTCAGCTCCCACT 
 S  S  F  V  N  A  L  R  L  I  G  H  E  E  E  D  S  A  P  T  
GGGGTGGTGAGGACCACCCAGAAACCAGCCTGTTACTCCTCTTTCCACTTTCCCTATGTG 
 G  V  V  R  T  T  Q  K  P  A  C  Y  S  S  F  H  F  P  Y  V  
GAGCTGTGGGACCTGCCTGGCACCGGGGTCACAGCCCAGAGCATGGAGAGCTACCTGGAT 
 E  L  W  D  L  P  G  T  G  V  T  A  Q  S  M  E  S  Y  L  D  
GAGATGCAGTTCAGCGCATATGACCTTATCATCATCATTGCTTCTGAGCAGTTCAGCTCG 
 E  M  Q  F  S  A  Y  D  L  I  I  I  I  A  S  E  Q  F  S  S  
AATCATGTGAAGCTGGCCGAAGCCATGCAGAGGATGAGAAAGAGGTTCTATGTCGTCTGG 
 N  H  V  K  L  A  E  A  M  Q  R  M  R  K  R  F  Y  V  V  W  
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2161 
721 
2221 
741 
2281 
761 
2341 
781 
2401 
801 
2461 
821 
2521 
841 
2581 
861 
2641 
881 
2701 
901 
2761 
921 
2821 
941 
2881 
961 
2941 
981 
3001 
1001 
3061 
1021 
3121 
1041 
3181 
1061 
3241 
1081 
3301 
1101 
3361 
1121 
3421 
1141 
3481 
1161 
3541 
1181 
3601 
1201 
3661 
1221 
3721 
1241 
3781 
1261 
3841 
1281 
3901 
1301 
3961 
1321 
4021 
1341 
4081 
1361 
4141 
1381 
4201 
1401 
4261 
1421 
4321 
1441 
ACCAAGCTGGACAGGGACATCAGCACAAGTACCTTCCCTGAACCCCAGCTCCTGCAGAGT 
 T  K  L  D  R  D  I  S  T  S  T  F  P  E  P  Q  L  L  Q  S  
ATCCAAAAGAATATCAGGGAGAATCTCCAGAAGGCTCAGGTGAGGGACCCCCCCATATTT 
 I  Q  K  N  I  R  E  N  L  Q  K  A  Q  V  R  D  P  P  I  F  
CTGGTCTCCTGCTTTAGTCCATCTTTTCACGACTTCCTAGACCTTAGAGAGACACTGCGA 
 L  V  S  C  F  S  P  S  F  H  D  F  L  D  L  R  E  T  L  R  
AAAGACATCCACAACATCAGGTACAGAGATCCCTTAGAGACCCTTTCTCAAGTCTGCGAC 
 K  D  I  H  N  I  R  Y  R  D  P  L  E  T  L  S  Q  V  C  D  
AAGTGCATCAACAATAAGGCGCTCTCTCTGAAGGAGGACCTGATGTTCACGAAACACCTG 
 K  C  I  N  N  K  A  L  S  L  K  E  D  L  M  F  T  K  H  L  
GAGGCAGCTGTCAGCCCCCCGTATGATATTGCTGACCTGGAGAGGAGTCTGGACACCTAC 
 E  A  A  V  S  P  P  Y  D  I  A  D  L  E  R  S  L  D  T  Y  
CAGAAGCTCTTTGGTGTGGATAATGAGTCACTTAGGAGGGTAGCTCAGAGTACAGGGAGA 
 Q  K  L  F  G  V  D  N  E  S  L  R  R  V  A  Q  S  T  G  R  
CCAGAGATGAGCACCAGGGCCTTGCAGTTCCAGGACTTGATCAAGATGGACAGGAGACTG 
 P  E  M  S  T  R  A  L  Q  F  Q  D  L  I  K  M  D  R  R  L  
AGGTTGATGATGTGTTTTGTCGTGAACATACTCCTCAGGGTTCTTGGAAGTCCATGGTGG 
 R  L  M  M  C  F  V  V  N  I  L  L  R  V  L  G  S  P  W  W  
TTCGGCTTGTGGGATGTCGTTACCCGATACTTCAGACACCAGAGACAGAAGCGCATCATT 
 F  G  L  W  D  V  V  T  R  Y  F  R  H  Q  R  Q  K  R  I  I  
GAAATAGTTGCTAAGAACACCAAGACCTCCTTGAGGAGAGCTCTAGAGGACTATACACTT 
 E  I  V  A  K  N  T  K  T  S  L  R  R  A  L  E  D  Y  T  L  
CCTCCTGAAATCCTTTGTGAAGGCTGCCTGGAAGACAGCAGTTTTCTCCCGTTCACCTTT 
 P  P  E  I  L  C  E  G  C  L  E  D  S  S  F  L  P  F  T  F  
GGAACACAGAGCCATGCCTACCTGGATGCTGCCATGCTTCTGGCCTTGCCTGAACCTCTG 
 G  T  Q  S  H  A  Y  L  D  A  A  M  L  L  A  L  P  E  P  L  
AACCTGGGCCAAGAGGTGGGTGGCTTCCGGCAATTTCGTGCTGATAGCAGCAGGGGATTA 
 N  L  G  Q  E  V  G  G  F  R  Q  F  R  A  D  S  S  R  G  L  
GAAAAAGAAACCCAGTTACTTGGGCTCTTTCTCTCACTGCCTGATAGAATTGGGTTAACT 
 E  K  E  T  Q  L  L  G  L  F  L  S  L  P  D  R  I  G  L  T  
CTTTGTGAGCCAGTGAGAAAGGAGAAAAAAGGAAGCACACTGGGCTCCTGGGAGGAAGCC 
 L  C  E  P  V  R  K  E  K  K  G  S  T  L  G  S  W  E  E  A  
ACTGACAATAAGCCTTCATCAGTGCTGGCCCCCGACTTGGGGAGGTTCTGGACCCCAGCC 
 T  D  N  K  P  S  S  V  L  A  P  D  L  G  R  F  W  T  P  A  
GGCAAGACGGTGAAGTCTACATCCAGGGTTGCTCCATTGCTCACCAGCATGGAAGAAGCA 
 G  K  T  V  K  S  T  S  R  V  A  P  L  L  T  S  M  E  E  A  
GTCGGGTTGCCCGAGGATAAACAGTTTGCATGCTTATCCGACGCTGTATTCATTTCCAAA 
 V  G  L  P  E  D  K  Q  F  A  C  L  S  D  A  V  F  I  S  K  
GACAACAGTATTTTATCTGTAGAAGTCATCAAGAGTATTCAGGCTGCTGTGGCGGGAGGG 
 D  N  S  I  L  S  V  E  V  I  K  S  I  Q  A  A  V  A  G  G  
AACGGGGTGGAAGTGGTCTCTATAGTTAAAGAGATTGTGCAGAAAGTATCCAGAACCACA 
 N  G  V  E  V  V  S  I  V  K  E  I  V  Q  K  V  S  R  T  T  
ATGAAAATCGCTGTGACTGGGGACTCTGGCAATGGCATGTCATCTTTCGTCAACGCCCTT 
 M  K  I  A  V  T  G  D  S  G  N  G  M  S  S  F  V  N  A  L  
AGGCTCATTGGACATGAGGAGGAGGATTCAGCTCCCACTGGGGTGGTGAGGACCACCCAG 
 R  L  I  G  H  E  E  E  D  S  A  P  T  G  V  V  R  T  T  Q  
AAACCAGCCTGTTACTCCTCTTCCCACTTTCCCTATGTGGAGCTGTGGGACCTGCCTGGC 
 K  P  A  C  Y  S  S  S  H  F  P  Y  V  E  L  W  D  L  P  G  
ATAGGGACCACAGCCCAGAGCATGGAGAGCTACCTGGATGAGATGCAGTTCAGCGCATAT 
 I  G  T  T  A  Q  S  M  E  S  Y  L  D  E  M  Q  F  S  A  Y  
GACCTTATCATCATCATTGCTTCTGAGCAGTTCAGCTCGAATCATGTGAAGCTGGCCGAA 
 D  L  I  I  I  I  A  S  E  Q  F  S  S  N  H  V  K  L  A  E  
GCCATGCAGAGGATGAGAAAGAAGTTCTATGTCGTCTGGACCAAGCTGGACAGGGACATC 
 A  M  Q  R  M  R  K  K  F  Y  V  V  W  T  K  L  D  R  D  I  
AGCACAAGTACCTTCCCTGAACCCCAGCTCCTGCAGAGTATCCAAAAGAATATTAGGGAG 
 S  T  S  T  F  P  E  P  Q  L  L  Q  S  I  Q  K  N  I  R  E  
AATCTCCAGAAGGGGAAAGTGAAGGAGCCCCCCATATTCCTGGTATCTATCATGAAGCCT 
 N  L  Q  K  G  K  V  K  E  P  P  I  F  L  V  S  I  M  K  P  
TTATTACATGACTTCGAAAGGCTTAGGGAGACCCTACGGAAAGACCTCTCTGACATCAAG 
 L  L  H  D  F  E  R  L  R  E  T  L  R  K  D  L  S  D  I  K  
TACCATGGTCTCTTAGAAACCCTTTACCAAATTTGTGAGAATACTATTAATGAGAGAGTA 
 Y  H  G  L  L  E  T  L  Y  Q  I  C  E  N  T  I  N  E  R  V  
GAGTCCATTAAAAAGATCATAGATGAAAATAACCTACAAAGAGAGTTTGGAATCTTGACT 
 E  S  I  K  K  I  I  D  E  N  N  L  Q  R  E  F  G  I  L  T  
CCAGACAACCTGACAGAGACTCGGAAAGTCTTCCAAGAAATCTTTGGTGTGGATGACCAA 
 P  D  N  L  T  E  T  R  K  V  F  Q  E  I  F  G  V  D  D  Q  
TCTCTCAGCCAGGTGTCTCGGAGTATGGAAAAGCCAGATACACATTACAAGGCTAGCATA 
 S  L  S  Q  V  S  R  S  M  E  K  P  D  T  H  Y  K  A  S  I  
GAGTCCCAGGAGATACAGGGGACCTCTGCTCCAGATCCTGGGAAGCGCACCCTCTTGGCT 
 E  S  Q  E  I  Q  G  T  S  A  P  D  P  G  K  R  T  L  L  A  
TTCTCTGTGTTTACCCTTACGACACCAAACCCAGACACTATTGCGAATGCCAAGAAGTGC 
 F  S  V  F  T  L  T  T  P  N  P  D  T  I  A  N  A  K  K  C  
ATGCTGACAGGAGCCTGAAATAAA 
 M  L  T  G  A  *  N  K  
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V.4.Appendix Table 4. Accession numbers of p47 GTPases or p47 GTPases like sequences 
in vertebrates 
 
Bos taurus 
NCBI 
gi|76641788|ref|XM_584684.2| 
gi|76641786|ref|XM_868819.1| 
gi|73586534|gb|BC102181.1| 
gi|77736036|ref|NM_001034545.1| 
gi|76641800|ref|XM_868949.1| 
 
Gallus gallus 
NCBI 
gi|50749529|ref|XM_426495.1| 
gi|46428515|emb|CR389870.1| 
gi|46428036|emb|CR389391.1| 
 
Ensemble  
Contig2.1127  
Contig2.1130  
Contig40667.1  
Contig2737.5 
Contig2.1063  
Contig2.1060 
Contig42.364 
Contig2.1057  
 
Sus scrofa 
AW435928 
BI346828 
 
Xenopus tropicalis 
Scaffold_496 
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V.5.Appendix Figure 1. Multiple alignment of individual rat proteins (Irgb10,Irgm2, 
Irgm3) with rat tandem AY321344. Alignment was performed using BCM search launcher 
with default options and highlighted using Boxshade server version 3.21.  
 
Irgb10      1 ------------------------------------------------------------ 
Irgm3       1 ------------------------------------------------------------ 
Irgm2       1 ------------------------------------------------------------ 
AY321344    1 MNKILCTARFVWEQTQDCQEARMLTVFNLVLKKRPCLRPPWLLPPLLLLQLLAAAPAKAE 
 
Irgb10      1 ------------------------------------------------MGQSSSKPDAKA 
Irgm3       1 ------------------------------------------------------------ 
Irgm2       1 ------------------------------------------------------------ 
AY321344   61 AKEESEESDEDQPTLPYNFVVSCDCCVYVAVGIEPWTQGKLVSCALTAMGQSSSKPDAKA 
 
Irgb10     13 HNMASSFNEFFKSFKMESKILSEETINSIQSCVQEGDIQKGISIINAALADIEKAPLNIA 
Irgm3       1 ------------------------------------------------------------ 
Irgm2       1 ------------------------------------------------------------ 
AY321344  121 HNMASSFNEFFKSFKMESKILSEETINSIQSCVQEGDIQKGISIINAALADIEKAPLNIA 
 
Irgb10     73 VTGETGAGKSTFINALRGVGHEESESAKIGAVETTMDKFPKFPNVTIWDLPGVGTCNFKP 
Irgm3       1 ------------------------------------------------------------ 
Irgm2       1 ------------------------------------------------------------ 
AY321344  181 VTGETGAGKSTFINALRGVGHEESESAKIGAVETTMDKFPKFPNVTIWDLPGVGTCNFKP 
 
Irgb10    133 EEYLKKLRFQEYDFFLIISATRFRENDAQLAKAIKKMKKNFYFVRTKIDSDLWNQKKCKP 
Irgm3       1 ------------------------------------------------------------ 
Irgm2       1 ------------------------------------------------------------ 
AY321344  241 EEYLKKLRFQEYDFFLIISATRFRENDAQLAKAIKKMKKNFYFVRTKIDSDLWNQKKCKP 
 
Irgb10    193 KSYNKEKILEEIRKDCVEKLQNARVASARVFLVSSVEVAQFDFPELESTLLEELPAHKRH 
Irgm3       1 ------------------------------------------------------------ 
Irgm2       1 ------------------------------------------------------------ 
AY321344  301 KSYNKEKILEEIRKDCVEKLQNARVASARVFLVSSVEVAQFDFPELESTLLEELPAHKRH 
 
Irgb10    253 VFMQCLPSITERAIDRRRDALRQKIWLEALKYGASATIPMMCFFNDDIEELEKILTHYRG 
Irgm3       1 ------------------------------------------------------------ 
Irgm2       1 ------------------------------------------------------------ 
AY321344  361 VFMQCLPSITERAIDRRRDALRQKIWLEALKYGASATIPMMCFFNDDIEELEKILTHYRG 
 
Irgb10    313 SFGLDDESLKNMASEWSMSVEELKSFINSPHLLSCEMNESVSDKMVK------------- 
Irgm3       1 ------------------------------------------------------------ 
Irgm2       1 ------------------------------------------------------------ 
AY321344  421 SFGLDDESLKNMASEWSMSVEELKSFINSPHLLSCEMNESVSDKMVKPYRAELYRVTIPQ 
 
Irgb10    360 ------------IMEKIFAVTGG---------LIATGLYFRKSYYMQNYFLDTVSEDAKI 
Irgm3       1 ----------------------------------------------------MAKPLKPP 
Irgm2       1 ------------------------------------------------------------ 
AY321344  481 HRAAIQDRTWTGVQRVTFVPGQQETKEAIPSEPQKVSMSQGDNWGVFTPFINMAKPLKPP 
 
Irgb10    399 LLKKKVFLQGSEDSE--------------------------------------------- 
Irgm3       9 LFKSITAGESSYSSQNSSSPEVIEKVGKAVAEGDLQKVIYTVKEEMQSKSRYTVKIAVTG 
Irgm2       1 ------------------------------------------------------------ 
AY321344  541 LFKSITAGESSYSSQNSSSPEVIEKVGKAVAEGDLQKVIYTVKEEMQSKSRYTVKIAVTG 
 
Irgb10        ------------------------------------------------------------ 
Irgm3      69 DSGNGMSSFVNALRLIGHEEEDSAPTGVVRTTQKPACYSSFHFPYVELWDLPGTGVTAQS 
Irgm2       1 ------------------------------------------------------------ 
AY321344  601 DSGNGMSSFVNALRLIGHEEEDSAPTGVVRTTQKPACYSSFHFPYVELWDLPGTGVTAQS 
 
Irgb10        ------------------------------------------------------------ 
Irgm3     129 MESYLDEMQFSAYDLIIIIASEQFSSNHVKLAEAMQRMRKRFYVVWTKLDRDISTSTFPE 
Irgm2       1 ------------------------------------------------------------ 
AY321344  661 MESYLDEMQFSAYDLIIIIASEQFSSNHVKLAEAMQRMRKRFYVVWTKLDRDISTSTFPE 
 
Irgb10        ------------------------------------------------------------ 
Irgm3     189 PQLLQSIQKNIRENLQKAQVRDPPIFLVSCFSPSFHDFLDLRETLRKDIHNIRYRDPLET 
Irgm2       1 ------------------------------------------------------------ 
AY321344  721 PQLLQSIQKNIRENLQKAQVRDPPIFLVSCFSPSFHDFLDLRETLRKDIHNIRYRDPLET 
 
Irgb10        ------------------------------------------------------------ 
Irgm3     249 LSQVCDKCINNKALSLKEDLMFTKHLEAAVSPPYDIADLERSLDTYQKLFGVDNESLRRV 
Irgm2       1 ------------------------------------------------------------ 
AY321344  781 LSQVCDKCINNKALSLKEDLMFTKHLEAAVSPPYDIADLERSLDTYQKLFGVDNESLRRV 
 
Irgb10        ------------------------------------------------------------ 
Irgm3     309 AQSTGRPEMSTRALQFQDLIKMDRRLRLMMCFVVNILLRVLGSPWWFGLWDVVTRYFRHQ 
Irgm2       1 ------------------------------------------------------------ 
AY321344  841 AQSTGRPEMSTRALQFQDLIKMDRRLRLMMCFVVNILLRVLGSPWWFGLWDVVTRYFRHQ 
 
Irgb10        ------------------------------------------------------------ 
Irgm3     369 RQKRIIEIVAKNTKTSLRRALEDYTLPPEILCEGSGVPSSGIQAASGSFCIEP------- 
Irgm2       1 ------------------------------------------------------------ 
AY321344  901 RQKRIIEIVAKNTKTSLRRALEDYTLPPEILCEGCLEDSSFLPFTFGTQSHAYLDAAMLL 
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Irgb10        ------------------------------------------------------------ 
Irgm3         ------------------------------------------------------------ 
Irgm2       1 ------------------------------------------------------------ 
AY321344  961 ALPEPLNLGQEVGGFRQFRADSSRGLEKETQLLGLFLSLPDRIGLTLCEPVRKEKKGSTL 
 
Irgb10        ------------------------------------------------------------ 
Irgm3         ------------------------------------------------------------ 
Irgm2       1 ------------------------------------------MEEAVGLPEDKQFACLSD 
AY321344 1021 GSWEEATDNKPSSVLAPDLGRFWTPAGKTVKSTSRVAPLLTSMEEAVGLPEDKQFACLSD 
 
Irgb10        ------------------------------------------------------------ 
Irgm3         ------------------------------------------------------------ 
Irgm2      19 AVFISKDNSILSVEVIKSIQAAVAGGNGVEVVSIVKEIVQKVSRTTMKIAVTGDSGNGMS 
AY321344 1081 AVFISKDNSILSVEVIKSIQAAVAGGNGVEVVSIVKEIVQKVSRTTMKIAVTGDSGNGMS 
 
Irgb10        ------------------------------------------------------------ 
Irgm3         ------------------------------------------------------------ 
Irgm2      79 SFVNALRLIGHEEEDSAPTGVVRTTQKPACYSSSHFPYVELWDLPGIGTTAQSMESYLDE 
AY321344 1141 SFVNALRLIGHEEEDSAPTGVVRTTQKPACYSSSHFPYVELWDLPGIGTTAQSMESYLDE 
 
Irgb10        ------------------------------------------------------------ 
Irgm3         ------------------------------------------------------------ 
Irgm2     139 MQFSAYDLIIIIASEQFSSNHVKLAEAMQRMRKKFYVVWTKLDRDISTSTFPEPQLLQSI 
AY321344 1201 MQFSAYDLIIIIASEQFSSNHVKLAEAMQRMRKKFYVVWTKLDRDISTSTFPEPQLLQSI 
 
Irgb10        ------------------------------------------------------------ 
Irgm3         ------------------------------------------------------------ 
Irgm2     199 QKNIRENLQKGKVKEPPIFLVSIMKPLLHDFERLRETLRKDLSDIKYHGLLETLYQICEN 
AY321344 1261 QKNIRENLQKGKVKEPPIFLVSIMKPLLHDFERLRETLRKDLSDIKYHGLLETLYQICEN 
 
Irgb10        ------------------------------------------------------------ 
Irgm3         ------------------------------------------------------------ 
Irgm2     259 TINERVESIKKIIDENNLQREFGILTPDNLTETRKVFQEIFGVDDQSLSQVSRSMEKPDT 
AY321344 1321 TINERVESIKKIIDENNLQREFGILTPDNLTETRKVFQEIFGVDDQSLSQVSRSMEKPDT 
 
Irgb10        ------------------------------------------------------------          
Irgm3         ------------------------------------------------------------          
Irgm2     319 HYKASIESQEIQGYQQDGWPLVWLHRPVIQFFSTGLDRVPCCFYSPHHRYTQQKGVLDET 
AY321344 1381 HYKASIESQEIQGTSAPDPGKRTLLAFSVFTLTTPNPDTIANAKKCMLTGA---------      
 
       Irgb10        ----------           
       Irgm3         ----------           
       Irgm2     379 AGKTKNFLWK 
       AY321344      ----------           
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V.6.Appendix Figure 2. Multiple alignment of Czech II mouse p47 GTPases.  
Alignment was performed using BCM search launcher with default options and highlighted 
using Boxshade server version 3.21. Irgm1 is excluded from alignment because it is partial 
sequence. 
 
Irgb6     1 ----------------------------MAWASSFDAFFKNFKRESKIISEYDITLIMTYIEENKLQKAVSVIEKVLRDIEDAPLNIAVT 
Irgb1     1 -------HPPLNTATCQTSTGRTSQITAQLLGFNFKNFFKSFKKESKILSEETITLIESHLENKNLQGALTVISHALRNIDKAPLNIAVT 
Irgb2     1 -----------------------MGQTSSSTSPPKEDPPLKFQVKTKVLSQELIASIESSLENGNLQETVSAISSALGDIEKAPLNIAVM 
Irga9     1 --------------MGQLFS--SPQSEHQDLASSFTEYFKKFKTGNKIISQDIITLVELSLAKGNIQEANSAIRNALKEIDSTPLNVAVT 
Irga10    1 --------------MGQLFS--SPQSEHQDLASSFTEYFKKFKMGNKIISQDIISLVELSMAKGNIQGANSAIKNALKEIDSTPLNVAVT 
Irga8     1 --------------MGQLFSNMPKDEDKGNLESSFTEYFRNYKQETKIISEETTRSIELCLKKGDIQRANSIISDALKNIDNAPINIAVT 
Irgm2     1 --------------------MEEAVESPEVKEFEYFSDAVFIPKDGNTLSVGVIKRIETAVKEGEIVKVVSIVKEIIQNVSRNKIKIAVT 
Irgm3     1 MDLVTKLPQNIWKTFTLFINMANYLKRLISPWSKSMTAGESLYSSQNSSSPEVIEDIGKAVTEGNLQKVIGIVKDEIQSKSRYRVKIAVT 
Irgd      1 ----------MDQFISAFLKSASENNFQQLAKEFLPQYSALISKAGGMLSPETLTGIHKALQEGNLSDVMSQIQKAISAAENAILEVAVI 
 
 
Irgb6    63 GETGTGKSTFINALRGVGH-EEKDAAPTGAIETTMKRTPYPH-PKLPNVTIWDLPGIGSTTFTPQNYLTEMKFGEYDFFIIISATRFKEN 
Irgb1    84 GETGTGKSSFINALRGISS-EEKDAAPTGVIETTMKRTPYPH-PKLPNVTIWDLPGIGSTNFPPQNYLTEMKFGEYDFFIIISATRFKEI 
Irgb2    68 GETGTGKSSLINALQGVGDDEEGAAASTGIIHTTTERTPYTY-TKFPSVTLWDLPGIGSTAFQPHDYLKKIEFEEYDFFIIVSAIRIRQS 
Irga9    75 GESGSGKSSFINTLRGIGH-EEKGAAKTGVVEETMERHPYKH-PNMPNVVFWDLPGIGTQTFPPKTYLEKMKFYEYDFFIIISATRFKKN 
Irga10   75 GESGSGKSSFINTLRGIGH-EEKGAAKTGVMEETMERHPYKH-PNMPNVVFWDLPGIGTTKFPPKTYLEKMKFYEYDFFIIISATRFKKN 
Irga8    77 GESGAGKSSLINALREIKA-EEESAAEVGVTETTMKVYSYKH-PKVKNLTLWDLPGIGTKKFPPKTYLETVEFKKYDFFIIVSAIRFTNH 
Irgm2    71 GDSGNGMSSFINALRLVGH-EEKDSAPTGVVRTTQKPTCYFS-SHFPYVELWDLPGLGATAQSVESYLEEMQISTYDLIIIVASEQFSSN 
Irgm3    91 GDSGNGMSSFINALRFIGH-EEEDSAPTGVVRTTKKPACYSSDSHFPYVELWDLPGLGATAQSVESYLEEMQISTFDLIIIVASEQFSSN 
Irgd     81 GQSGTGKSSFINALRGLGH-EADESADVGTVETTMCKTPYQH-PKYPKVIFWDLPGTGTPNFHTDTYLDQVGFANYDFFIIISSSRFSLN 
 
 
Irgb6   151 DAQLAKAIAQMGMNFYLVRTKIDSDLDNEQKFKPKSFNKEKLLKKIKDYCSNHLQESLYSEPLVFLVSNVDISKYDFPKLETKLLQDLPA 
Irgb1   172 DAHLAKAIAKMNTKFYFVRTKIDQDVSNEQRSKPRSFNRDSVLKKIKDECLDLLQKVLSSQPPIFLVSNFDVSDFDFPKLETTLLKELPA 
Irgb2   157 DIELAKAIVQMNRGLYFVKTKTDSDLENEKRVNPMRFNRENTLKRLRICISSNLKEWIQQEPPVFLVSNFDVSDFDFPKLESTLLSQLPA 
Irga9   163 DIDLAKAISMMKKEFYFVRTKVDSDLNNEEDFKPQNFDREKVLQNIRLNCVNTFKENGIAEPQIFLVSNKNVCHYDFPVLIDRLISDLPL 
Irga10  163 DIDLAKAISMMKKEFYFVRTKVDSDLNNEEDFKPQNFDREKVLQNIRLNCVNNFKENGIAEPPIFLVSNKNVCHYDFPVLMDKLISDLPV 
Irga8   165 EIELAKAIRIMKKNYYFVRSKVDFDLYNEEKSKPRNFNRENTLNQVRNYYLDTFRESKIDEPQVFLISNHDLSDYDFPVLMDTLLKDLPA 
Irgm2   159 HVKLAITMQRMRKRFYVVWTKLDRDLSTS------TFPEPQLLQSIQKNIRDSLQKEKVKEHPMFLVSVFKPESHDFPKLRETLQKDLPV 
Irgm3   180 HVKLAITMQRMRKRFYVVWTKLDRDLSTS------TFPEPQLLQSIQRNIRENLQQAQVRDPPLFLISCFSPSFHDFPELRNTLQKDIFS 
Irgd    169 DALLAQKIKDAGKKFYFVRTKVDSDLYNEQKAKPIAFKKEKVLQQIRDYCVTNLIKTGVTEPRIFLISNLDLGTFDFPELEETLLKELPG 
 
 
Irgb6   241 HKRHVFSLSLQSLTEATINCKRDSLKQKVFLEAVKAGVLATIPLGGMIS-DILENLDETFNLYRSYFGLDDASLENVAKDLNMSVDDFKV 
Irgb1   262 HKRHLFMMSLHSVTETTIARKRDFLRQKIWLEALKAGVWATIPLGGLVR-DKMQKLEETLTLYRSYFGLDEASLENIAKDFNVSVNEIKA 
Irgb2   247 YKHQIFMSTLQVVINAIVDRKRDMLKQKIWKESIMPRAWATIPSRELTQ-KDMEMLQQTLNDYRSSFGLDEASLENIAEDLNVTLEELKA 
Irga9   253 YKRQNFMLSLPNITESAIEKKQQFLKQSIWLEGFAPDLLSIKPSLAFLN-SDLETLEKSMKFYRSVFGVDEASLKSLATAWKIPVDQVEA 
Irga10  253 YKRHNFMLSLPNITESAIEKKRQFLKQRIWLEGFAADLMSIIPTLTFLLDSDLETLKKSMKFYRTVFGVDEASLKSLATAWKIPVDQVEA 
Irga8   255 EKRHNFLLSLPNITEAAIQKKYNSPKQYIWLQAMEDGLLATVPAVGILKDLDKERLKRSLDYYRDLFGVDDESLMFMAKDAQVPFELLKI 
Irgm2   243 IKYHGLVETLYQVCEKTVNERVEFIKKS----------IDEDNLHTDFGISDPGNAIEIRKAFQKTFGLDDISLHLVSLEMKNKHFNTSM 
Irgm3   264 IRYRDPLEIISQVCDKCISNKAFSLKEDQ------M--LMKDLEAAVSSEDDTANLERGLQTYQKLFGVDDGSLQQVARSTG--QTGDGL 
Irgd    259 HKRHMFALLLPNISDASIELKKHFLREKIWLEALKSAAVSFIPFMTFFKGFDLPEQEQCLKDYRSYFGLDDQSIKEIAEKLGAPLADIKG 
 
 
Irgb6   330 HLRFPHLFSEHNDESLEDKLFKYIKHISSVTGGPVAAVTYYRMAYYLQNLFLDTAANDAIALLNSKALFEKKVGPYISEPPEYWEA---- 
Irgb1   351 HLRSLQLLTKNNDMSFKEKLLKYIEYISCVTGGPLASGLYFRKTYYWQSLFIDTVASDAKSLLNKEEFLSEKPGSCLSDLPEYWETGMEL 
Irgb2   336 NIKSPHLFSDEPDTSLTEKLLKYIG-------NP-----YFSKVFHLQNYFIDTVASDVKIILSKEELFTEQ------------------ 
Irga9   342 MMKSPAVFKPTDEETIQERLSRYVLEICFANRYLFRKNLFLRNVFYLKYYFLDMVTEDAKTLLKEIYLRNKLPSN--------------- 
Irga10  343 MMKSPAVFKPTDEETIQERLSRYVREFCLANGFLVTKNHYLREIFYLKYYFLDMVTEDAKTLLKEICLRNKLLSN--------------- 
Irga8   345 KLKSPYLLELEEETLGGLILN-CVEKFASANGGLLATGLYFRKTYYLQFHFLDTVAEDAKVLLKEAY----------------------- 
Irgm2   323 ESQETQRYQQDDWVLARLYRTGTRVGSIGFDYMKCCFSSHHSRCKQQKDILDETAAKAKEVLLKNPETLHSSSLGRFRQLESSPQPCTPC 
Irgm3   344 QGSAVPGLDQD-------------GQETGADDVFCREQVPQGSRKLMVVWLVETLSPATSDTRGTSSSLK-------------------- 
Irgd    349 ELKCLDFWSLVKDNSIIAQATSAAEAFCAVKGGPESSAFQALKVYYRRTQFLNIVVDDAKHLLRKIETVNVA------------------ 
 
 
Irgb6       ----------------------- 
Irgb1   441 ----------------------- 
Irgb2       ----------------------- 
Irga9       ----------------------- 
Irga10      ----------------------- 
Irga8       ----------------------- 
Irgm2   413 VPPVEITPLSPTPWGPSSLRLLG 
Irgm3       ----------------------- 
Irgd        ----------------------- 
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V.7.Appendix Figure 3. Multiple alignment of rat and mouse p47 GTPases.  
Alignment was performed using BCM search launcher with default options and highlighted 
using Boxshade server version 3.21. rat Irga14 is excluded from alignment because it is highly 
degraded and was diffucult to align. 
 
 
Irgb2            1 ----------------------MGQTSSSTSPPKEDPPLTFQVKT-KVLSQELIASIESSLEDGNLQETVSAISSALGDIEKVPLNIAVM 
Irgb7            1 ------PFWFVPPLGTIDICQDWVKLPLLHPLQRRILLLTFQMKT-KILSQELITFIELYLEDGNLXETVSAISSALGDIEKVPLNIAVM 
Irgb5            1 -------------MGQTSSSTPPPKEDPDLTSSFGTNLQNFKMKT-KILSQELIAFIESSLEDGNLQETVSAISSALGGIEKAPLNIAVM 
Irgb9            1 -------------MGQTSSSTLPPKDDPDFIASFGTNLQNFKMKT-KILSQELIAFIESSLEDGNLRETVSAISSALGGIEKAPLNIAVM 
Irgb14(rat)      1 -------------MGQTSSSTTPPKEDPDLTSSFGTNLQNFEMKT-KILSQELITFIESSLEGGNLRETVSAISDALSDIEKAPLNIAVI 
Irgb3            1 -------------------------MAQLLVFSFENFFKNFKKES-KILSEETITLIESHLEDKNLQGALSEISHALSNIDKAPLNIAVT 
Irgb4            1 -----QHPPLHTATCQPSSSRPSRLTLQLLVFSFENFFKNFKKES-KILSEETITLIESHLEDKNLQGALTEISHALSNIDKAPLNIAVT 
Irgb8            1 -------------------------MAQLLVISFENFFKNFKKES-KILSEETITLIESHLEDKNLQGALSEISHALSNIDKAPLNIAVT 
Irgb1            1 -----QHPPLNTATCQTSTGRTSQITAQLLEFNFKNFFKNFKKES-KILSEETITLIESHLENKNLKEALTVISHALRNIDKAPLNIAVT 
Irgb13(rat)      1 -----QHPPGHTATCKSSSSRSSPLTAQLLSLGLKIFFKSFKKES-KILSEETVTLIESHLEDKNLQGALSTISHALRNIDKAPLNIAVT 
Irgb6            1 ---------------------------MAWASSFDAFFKNFKRES-KIISEYDITLIMTYIEENKLQKAVSVIEKVLRDIESAPLHIAVT 
Irgb10(rat)      1 ---------------MGQSSSKPDAKAHNMASSFNEFFKSFKMES-KILSEETINSIQSCVQEGDIQKGISIINAALADIEKAPLNIAVT 
Irgb10           1 ---------------MGQSSSKPDAKAHNMASSLTEFFKNFKMES-KIISKETIDSIQSCIQEGDIQKVISIINAALTDIEKAPLNIAVT 
Irga3            1 ------------MGQLFSHIPKDEDKG-NLESSFTEYFRNYKQET-KIISEETTRSIELCLKRGDFQRANSVISDALKNIDNTPINIAVT 
Irga8            1 ------------MGQLFSNMPKDEDKG-NLESSFTEYFRNYKQET-KIISEETTRSIELCLKKGDIQRANSIISDALKNIDNAPINIAVT 
Irga16(rat)      1 -------------------MKTGNLES-SLQICFTAYFRKYKPET-KIISEEITRLTELCLKRGDLQGANSVISDALKNIDIAPINIAVT 
Irga4            1 ------------MGQLLSDTSKTEDNE-DLVSSFNEYFKNIKTE--KIISQETIDLIKLYLNKGNIHGANSLISDALRNIDNAPINIAVT 
Irga7            1 ------------MDQLLSDTSKNEDND-DLVSSFNAYFKNIKTEN-KIISQETIDLIELHLNKGNIHGANSLIREALKNIDNAPINIAVT 
Irga15(rat)      1 ------------MGQLFSDTSKSEDNGGDLVSSSNAYFKKINTKT-KIISPETIRLIELHLSKGNILGASDLISDALKNIESIPINIAVT 
Irga12(rat)      1 ---------------MGQWFSSKNEQHQDLASSFKEYFKKFKTGH-KIISEEIITSVELSMTKGNIQMANSTISEALRDIDGTPLNVAVT 
Irga11(rat)      1 --------------MGQLFSLTTNEQGEDLPSSFAKYFKKFKTGH-KIISEEIITSVELSMTKGNIQMANSAISEAFREIDSTPLNVAVT 
Irga13(rat)      1 ---------------MGQWFSSKNEKHQDLASSFKEYFKKFKTGH-KIISEEIITSVELSMTKGNIQMANSAISEALREIDGTPLNVAVT 
Irga2            1 --------------MGQLFSSRRS-EDQDLSSSFIEYLKECEKGI-NIIPHEIITSIEINMKKGNIQEVNSTVRDMLREIDNTPLNVALT 
Irga6            1 --------------MGQLFSSPKSDENNDLPSSFTGYFKKFNTGR-KIISQEILNLIELRMRKGNIQLTNSAISDALKEIDSSVLNVAVT 
Irga1            1 --------------MGQLFSLLKN-KCQFLVSSVAEYFKKFKKIV-IIILQEVTTSIELDMKKENFQEANSAICDALKEIDSSLVNVAVT 
Irga5(rat)       1 --------------MGQLFSGTAK--SEALYSSFSEYFKKFKAEN-KIISQETITLIELYLILEDLPQANNEITSALRKLANTPLNVAVI 
Irga5(Edited)    1 --------------MGQLFSGTSK--SEALCSSFTEYFQKFKVEN-KIISQEISTLIELYLTLGDVQQANNAITYALRXLARTPQNVALI 
Irgd(rat)        1 ----------MDQFITAFLKGASEKNFQQLAMEFLPQYSALISKSGGMLSPETLSAIHYALQEGRLSDVMNQIQEAISAAENAVLEVAVI 
Irgd             1 ----------MDQFISAFLKGASENSFQQLAKEFLPQYSALISKAGGMLSPETLTGIHKALQEGNLSDVMIQIQKAISAAENAILEVAVI 
Irgc(rat)        1 -------------------------------MATSRLPAVPEEETTILMAKEELEALRTAFESGDIPQAASRLRELLATTETTRLEVGVT 
Irgc             1 -------------------------------MATSRLPAVP-EETTILMAKEELEALRTAFESGDIPQAASRLRELLANSETTRLEVGVT 
Irgm3(rat)       1 -----------------------MAKPLKPPLFKSITAGESSYSSQNSSSPEVIEKVGKAVAEGDLQKVIYTVKEEMQSKSRYTVKIAVT 
Irgm3            1 MDLVTKLPQNIWKTFTLFINMANYLKRLISPWSKSMTAGESLYSSQNSSSPEVIEDIGKAVTEGNLQKVIGIVKDEIQSKSRYRVKIAVT 
Irgm2(rat)       1 --------------------MEEAVGLPEDKQFACLSDAVFISKDNSILSVEVIKSIQAAVAGGNGVEVVSIVKEIVQKVSRTTMKIAVT 
Irgm2            1 --------MPTSRVAPLLDNMEEAVESPEVKEFEYFSDAVFIPKDGNTLSVGVIKRIETAVKEGEVVKVVSIVKEIIQNVSRNKIKIAVT 
Irgm1(rat)       1 ----------------------MPETSTHNAPLNLSFPSVPSYQIGCSSLPEISRSTERALKEGKLPELVYGVKETVATLSQIPVSIFVT 
Irgm1            1 --------MKPSHSSCEAAPLLPNMAETHYAPLSSAFPFVTSYQTGSSRLPEVSRSTERALREGKLLELVYGIKETVATLSQIPVSIFVT 
 
 
Irgb2           68 GETGAGKSSLINALQGVGDDEEGAAASTGVVHTTTERTPYTY-TKFPSVTLWDLPSIGSTAFQPHDYLKKIEF-EEYDFFIIVSAIRIKQ 
Irgb7           84 GETGAGKSSLINALQGTGADEDGVTAPVGVVYTTIEKKSYPY-AKFPSAILWELPAIGFHHFQPHDYLKKIKF-EEYDFIIVS-AGRIKH 
Irgb5           77 GETGAGKSSLINALQGVGDDEEGAAASTGVVHTTTERTPYTY-TKFPSVTLWDLPGIGSTAFQPHDYLKKIEF-EEYDFFIIVSSGRFKH 
Irgb9           77 GETGAGKSSLINALQGVGDDEEGAAASTGVVHTTTERTPYTY-TKFPSVTLWDLPGIGSTAFQPHDYLKKIEF-EEYDFFIIVSSGRFKH 
Irgb14(rat)     77 GETGAGKSSLINALQGVGADKEGTAAPTGVVHTTSERTPYTY-TKFPCVTLWDLPGIGSPAFQPHDYLKKIKF-EEYDFFIIVSSGRFKH 
Irgb3           65 GETGTGKSSFINALRGVRDEEE-GAAPTGVVETTMKRTPYPH-PKLPNVTIWDLPGIGSTTFPPQNYLTEMKF-GEYDFFIIISATRFKE 
Irgb4           85 GETGTGKSSFINALRGVRDEEE-GAAPTGVVETTMKRTPYPH-PKLPNVTIWDLPGIGSTTFPPQNYLTEMKF-GEYDFFIIISATRFKE 
Irgb8           65 GETGTGKSSFINALRGVRGEEE-GAAPTGVVETTMKRTPYPH-PKLPNVTIWDLPGIGSTNFQPQNYLTEMKF-GEYDFFIIISATRFKE 
Irgb1           85 GETGTGKSSFINALRGISSEEK-DAAPTGVIETTMKRTPYPH-PKLPNVTIWDLPGIGSTNFPPQNYLTEMKF-GEYDFFIIISATRFKE 
Irgb13(rat)     85 GETGAGKSSFINALRGVRDDEE-CAAPTGVVEKTKERTPYPH-PKLANVTIWDLPGIGSTTFPPQNYLAEMKF-GEYDFFVIISATRFKE 
Irgb6           63 GETGAGKSTFINTLRGVGHEEK-GAAPTGAIETTMKRTPYPH-PKLPNVTIWDLPGIGTTNFTPQNYLTEMKF-GEYDFFIIISATRFKE 
Irgb10(rat)     75 GETGAGKSTFINALRGVGHEES-ESAKIGAVETTMDK----F-PKFPNVTIWDLPGVGTCNFKPEEYLKKLRF-QEYDFFLIISATRFRE 
Irgb10          75 GETGAGKSTFINALRGIGHEES-ESAESGAVETTKDRKKYTH-PKFPNVTIWDLPGVGTTNFKPEEYLKKMKF-QEYDFFLIISSARFRD 
Irga3           77 GESGAGKSSLINALREVKAEEE-SAAEVGVTETTMKVSSYKH-PKVKNLTLWDLPGIGTMKFQPKDYLEKVEF-KKYDFFIIVSSSRFTK 
Irga8           77 GESGAGKSSLINALREIKAEEE-SAAEVGVTETTMKVYSYKH-PKVKNLTLWDLPGIGTKKFPPKTYLETVEF-KKYDFFIIVSAIRFTN 
Irga16(rat)     70 GVSGAGKSSLINALREVKDEGE-GAAEVGVAESTMKTDSYEQ-PQNK-FDIMGLAWYNSEISTKKNYLEKVEF-KKYDFFIIVSSIQIAK 
Irga4           76 GESGAGKSSLINALIGIGPEEE-GAAEVGVIETTMKRTSYKH-PKIETLTLWDLPGIGTQKFPPKTYLEEVKF-KEYDFFIIVSATRFTK 
Irga7           77 GESGVGKSSFINALIGTGPEEE-GAAEVGVIETTMKRNFYKH-PKIETLTLWDLPGIGTQKFPPKTYLEEVKF-KEYDFFIIVSSTRFTK 
Irga15(rat)     78 GESGAGKSSFINALRGIRPEEE-GAAEVGVVETTMERTPYQH-PKIKTLTLWDLPGIGTQKFPPKTYLEKVKF-EEYDFFIIASATRFTK 
Irga12(rat)     75 GESGAGKSSFINALRGIGHEEE-GAAEIGVVETTAERWPYKH-PSMPNVVIWDLPGIGTTNFPPKTYLEKMKF-YEYDFFIIISATRFKK 
Irga11(rat)     76 GESGAGKSSFINALRGIGHEEE-GAAEIGVVETTMWRHKYQH-PSMPNVVIWDLPGIGTTNFPPKTYLEKMKF-YEYDFFIIISATRFKK 
Irga13(rat)     75 GESGAGKSSFINALRGIGHEEE-GAAKIGVVETTAERWPYKH-PSMPNVVIWDLPGIGTTTFPTKTYLEKMKF-YEYDFFIIISATRFKK 
Irga2           75 GETGSGKSSFINTLRGIGHEEG-GAAHTGVTDKTKERHPYEH-PKMPNVVFWDLPGTGSEDFQPKTYLEKMKF-YEYDFFIIISATRFKK 
Irga6           76 GETGSGKSSFINTLRGIGNEEE-GAAKTGVVEVTMERHPYKH-PNIPNVVFWDLPGIGSTNFPPNTYLEKMKF-YEYDFFIIISATRFKK 
Irga1           75 GETGSGKSSFINTLRGIGHEEE-GAAKTGVVEATMERHPYKH-PNMPNVVFWDLPGIGSTKFPPKTYLEKMKF-YEYDFFIIISATCFKK 
Irga5(rat)      74 GESGTGKSSFINVFRGVGHEDE-TAAPIGVVETTMRRTPYRH-PNIPNVVIWDLPGIGTTNFPPKDYLEKMKF-CEYDFFIIISATRFRK 
Irga5(Edited)   74 GESGRGKYSFINVFRGLDMKRK-MAT-VGVVETTMNRTPYRN-PNIPNVIIWDLPGIGTTNFPPKHYLKKMQFYVMYDFFIIVSATCFRK 
Irgd(rat)       81 GESGTGKSSFINALRGLGHEEA-ESADVGTVETTMYKTPYQH-PKYPNVIFWDLPGTGTPNFHTDTYLDRVGF-ANYDFFIIISSSRFSV 
Irgd            81 GQSGTGKSSFINALRGLGHEAD-ESADVGTVETTMCKTPYQH-PKYPKVIFWDLPGTGTPNFHADAYLDQVGF-ANYDFFIIISSSRFSL 
Irgc(rat)       60 GESGAGKSSLINALRGVGAEDP-GAALTGVVETTMQPSPYPH-PQFPDVTLWDLPGAGSPGCSADKYLKEVDF-GRYDFFLLVSPRRCGA 
Irgc            59 GESGAGKSSLINALRGLGAEDP-GAALTGVVETTMQPSPYPH-PQFPDVTLWDLPGAGSPGCSADKYLKQVDF-GRYDFFLLVSPRRCGA 
Irgm3(rat)      68 GDSGNGMSSFVNALRLIGHEEE-DSAPTGVVRTTQKPACYSS-FHFPYVELWDLPGTGVTAQSMESYLDEMQF-SAYDLIIIIASEQFSS 
Irgm3           91 GDSGNGMSSFINALRFIGHEEE-DSAPTGVVRTTKKPACYSSDSHFPYVELWDLPGLGATAQSVESYLEEMQI-STFDLIIIVASEQFSS 
Irgm2(rat)      71 GDSGNGMSSFVNALRLIGHEEE-DSAPTGVVRTTQKPACYSS-SHFPYVELWDLPGIGTTAQSMESYLDEMQF-SAYDLIIIIASEQFSS 
Irgm2           83 GDSGNGMSSFINALRLIGHEEK-DSAPTGVVRTTQKPTCYFS-SHFPYVELWDLPGLGATAQSVESYLEEMQI-SIYDLIIIVASEQFSL 
Irgm1(rat)      69 GDSGNGMSSFINALRIIGHEED-ASAPTGVVRTTQTRAEYSS-SHFPNVVLWDLPGLGATAQTVENYIEEMKF-STCDLFIIVASEQFSS 
Irgm1           83 GDSGNGMSSFINALRVIGHDED-ASAPTGVVRTTKTRTEYSS-SHFPNVVLWDLPGLGATAQTVEDYVEEMKF-STCDLFIIIASEQFSS 
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Irgb2          156 SDIELAKAIVQMNRGLYFVRTKTDSDLENEKLCNPMRFNRENILKSIRICLSSNLKERFQQEPPVFLVSNFDVSDFDFPKLESTLLSQLP 
Irgb7          171 SDVELAKAIVQMNRGLYFNRTKTDIDLKNEKLYNPMRFNRENTLKSLQICISSNLKECFHQEPPVFLVSNFDVSDFDFPKLESTLLSQLP 
Irgb5          165 NDAELAKAIVQMNRSFYFVRTHTDLDLMVVKRSNPRRFNRENTLKQIRHTISSMLKEVTHQEPPVFLVSNFDVSDFDFPKLESTLLSQLP 
Irgb9          165 NDAELAKAIVQMNRSFYFVRTHTDLDLMVVKLSDPRKFNKENILEQIRNSISNILKEVTHQEPPVFLVSNFDVSDFDFPNLESTLLSQLP 
Irgb14(rat)    165 NDAELAKAIVQMNRSFYFVRTHIDLDLMVVKLSAPKRFDKENILEEILNSISSILKEVTYQEPPVFLVSNFNVSDFDFRKLETTLLEELP 
Irgb3          152 IDAHLAKTIEKMNTKFYFVRTKIDQDVSNEQRSKPRSFNRDSVLKKIRDDCSGHLQKALSSQPPVFLVSNFDVSDFDFPKLETTLLRELP 
Irgb4          172 IDAHLAKTIEKMNTKFYFVRTKIDQDVSNEQRSKPRSFNRDSVLKKIRDDCSGHLQKALSSQPPVFLVSNFDVSDFDFPKLETTLLRELP 
Irgb8          152 IDAHLAKAIAKMNTKFYFVRTKIDQDVSNEQRSKPKSFNRDSVLKKIRDDCSGHLQKVLSSQPPVFLVSNFDVSDFDFPKLENTLLRELP 
Irgb1          172 IDAHLAKAIAKMNIKFYFVRTKIDQDISNEQRSKPKSFNRDSVLKKIKDECLGLLQKVLSSQPPIFLVSNFDVSDFDFPKLETTLLKELP 
Irgb13(rat)    172 TDAHLAKAIAKMNTKFYFVRTKIDQDLRNEEKSKPKVFNRDGVLKKIRDDCSQHLQKDLSSEPPIFLVSNFDVSDFDFPKLETTLLSELP 
Irgb6          150 NDAQLAKAIAQMGMNFYFVRTKIDSDLDNEQKFKPKSFNKEEVLKNIKDYCSNHLQESLDSEPPVFLVSNVDISKYDFPKLETKLLQDLP 
Irgb10(rat)    158 NDAQLAKAIKKMKKNFYFVRTKIDSDLWNQKKCKPKSYNKEKILEEIRKDCVEKLQNARVASARVFLVSSVEVAQFDFPELESTLLEELP 
Irgb10         162 NEAQLAEAIKKMKKKFYFVRTKIDSDLWNEKKAKPSSYNREKILEVIRSDCVKNLQNANAASTRGFLSLKL------------------- 
Irga3          164 LELDLAKATRIMKKNYYFVRSKVDCDLDNEKKSKPRNFNRENTLNQVRNSYLDTFRESKIDEPQVFLISNHDLSDYDFPVLMDTLLKDLP 
Irga8          164 HEIELAKAIRIMKKNYYFVRSKVDFDLYNEEKSKPRNFNRENTLNQVRNYYLDTFRESKIDEPQVFLISNHDLSDYDFPVLMDTLLKDLP 
Irga16(rat)    156 HEVDLAKAIGIMKKNYYVVRTKVDSDLERGEIHRPHSFNRENTLNQIG-DCLDTSRDNEIDEPQLFLISDHNLSDYDFPVLMDTLIKDLP 
Irga4          163 LELDLAKAITNMKKNYYFVRTKVDIDVENERKSKPRTFEREKALKQIQSYSVKIFNDNNMAVPPIFLISNYDLSDYDFPFLVDTLIKELH 
Irga7          164 HELDLAKAIGIMKKNYYFVRTKVDIDLENERKSKPRTFDREKTLKQIQSYAMNTFSDNNMAIPPIFMVSNYDLSKYDFPVMMDTLIKDLH 
Irga15(rat)    165 LELDLAKAIRIMKKNYYFVRTKVDFDLENEKRSKPRTFDREKTLKKIRGCTMKTFRENNMDVPQIFLISSYNLSDYDFPVLMDTLIKDIP 
Irga12(rat)    162 TDTDLAKAISMMKKDFYFVRTKVDSDLRNEENTKPRSFDREKVLQNIRLNCVKHFKENGMDEPPIFLISNIDLSDYDFPILMDKLISDLP 
Irga11(rat)    163 NDIDLAKAISMMKKDFYFVRTKVDSDLRNEENTKPRSFDREKVLQNIRLNCVKHFKENGMDEPPIFLISNIDLSDYDFPILMDKLISDLP 
Irga13(rat)    162 NDIDLAKAISMMKKDFYFVRTKIDSDLRNEEEFKPRSFDREKVLQNIRFNCVKHFKENGIDEPPIFLISNRNLSDYDFPILMDKLISDLP 
Irga2          162 NDIDLAKAIGIMKKEFYFVRTQVDSDLRNEEDFKPQTFDREKVLQDIRLNCVNTFRENGIAEPPIFLISNKNVCHYDFPVLMDKLISDLP 
Irga6          163 NDIDIAKAISMMKKEFYFVRTKVDSDITNEADGKPQTFDKEKVLQDIRLNCVNTFRENGIAEPPIFLLSNKNVCHYDFPVLMDKLISDLP 
Irga1          162 NDIDLAKAISMMKKEFYFVRTKVDTDLRNEEDFKPQTFDKEKVLQDIRLNCVNTFKENGIAEPPIFLISNENVCHYDFPVLMDKLISDLP 
Irga5(rat)     161 NDIDLAKAVSMMKKDFYFVRTKMDIDLENEMECK-DTFSRETFLKHIRSHCVTMFKKNNLHVPPIFLISNRNVSDYDFPILKAMLQNKLS 
Irga5(Edited)  161 NDIDLSKAVVMIKKKDFLLRTKEDIDIENEN----------------------------------------------------------- 
Irgd(rat)      168 NDALLAQKIKDAGKKFYFVRTKVDSDLYSEERTRPRTFRKEQVLQRIRDYCLSNLTDIGVSEPRIFLISNFDLDAFDFPKLEETLLKELP 
Irgd           168 NDALLAQKIKDAGKKFYFVRTKVDSDLYNEQKAKPIAFKKEKVLQQIRDYCVTNLIKTGVTEPCIFLISNLDLGAFDFPKLEETLLKELP 
Irgc(rat)      147 VETRLASEILRQGKKFYFVRTKVDEDLAATRNQRPSGFSEAAVLQEIRDHCAERLRAAGLSDPRIFLVSNLSPNRYDFPMLVTTWEHDLP 
Irgc           146 VESRLASEILRQGKKFYFVRTKVDEDLAATRSQRPSGFSEAAVLQEIRDHCTERLRVAGVNDPRIFLVSNLSPTRYDFPMLVTTWEHDLP 
Irgm3(rat)     155 NHVKLAEAMQRMRKRFYVVWTKLDRDISTSTFPE------PQLLQSIQKNIRENLQKAQVRDPPIFLVSCFSPSFHDFLDLRETLRKDIH 
Irgm3          179 NHVKLAITMQRMRKRFYVVWTKLDRDLSTSTFPE------PQLLQSIQRNIRENLQQAQVRDPPLFLISCFSPSFHDFPELRNTLQKDIF 
Irgm2(rat)     158 NHVKLAEAMQRMRKKFYVVWTKLDRDISTSTFPE------PQLLQSIQKNIRENLQKGKVKEPPIFLVSIMKPLLHDFERLRETLRKDLS 
Irgm2          170 NHVKLAITMQRMRKRFYVVWTKLDRDLSTSTFPE------PQLLQSIQRNIRDSLQKEKVKEHPMFLVSVFKPESHDFPKLRETLQKDLP 
Irgm1(rat)     156 NHVKLAKIIQSMGKRFYVIWTKLDRDLSTSVLSE------VRLIQNIQENIRENLQKEGVKEVPIFLVSNLDPLLHDFPELRNTLQTDLS 
Irgm1          170 NHVKLSKIIQSMGKRFYIVWTKLDRDLSTSVLSE------VRLLQNIQENIRENLQKEKVKYPPVFLVSSLDPLLYDFPKLRDTLHKDLS 
 
Irgb2          246 AYKHQIFMSTLQVVINAIVD-RKRDMLKQKIWKESIMPRAWATIPSRGLTQK-DMEMLQQTLNDYRSSFGLNEASLENIAEDLNVT-LEE 
Irgb7          261 AYKHQIFMRTLQVVINAIVD-WKRDMLKQKVWKESTTPRAWATIPSLGLTQK-DMEMLQQTLNDYRSSFGLDEASLKNIAEDLNVT-LEE 
Irgb5          255 AYKHHMFMLTLPIVTDSTID-RKRDMLKQKVWKESTMPRAWATIPSLGLTQK-DMEMLQQTLNDYRSSFGLDEASLENIAEDLNVT-LEE 
Irgb9          255 AYKHHMFMLTLPIVTDSTID-RKRDMLKQKIWKESIMPRAWATIPSRGLTQK-DMEMLQQTLNDYRSSFGLDEASLENIAEDLNVT-LEE 
Irgb14(rat)    255 AYKRHIFMLTLPTVTESTID-RKRDMLKQKIWKESIMPRAWASIPFRGLTQN-DIEMLEQTLNDYRSSFGLDEASLENIAGDLNVT-LEE 
Irgb3          242 SHKRHLFMMSLHSVTETAIA-RKRDFLRQKIWLEALKAGLWATIPLGGLVRN-KMQKLEETLTLYRSYFGLDEASLENIAKDFNVS-VNE 
Irgb4          262 SHKRHLFMMSLHSVTETAIA-RKRDFLRQKIWLEALKAGLWATIPLGGLVRN-KMQKLEETLTLYRSYFGLDEASLENIAKDFNVS-VNE 
Irgb8          242 AHKRHLFMMSLHSVTETAID-RKRDFLRQRIWLEALKAGVWTTIPLGGLVRD-KMQKLEETLTLYRSYFGLDEASLENIAKDFNVS-VNE 
Irgb1          262 AHKRHLFMMSLHSVTETTIA-RKRDFLRQKIWLEALKAGLWATIPLGGLVRD-KMQKLEETLTLYRSYFGLDEASLENIAKDFNVS-VNE 
Irgb13(rat)    262 AHKRHIFMLSLHNVTETAID-RKRDFLKQKIWLEALKAGAWTTIPFGGLVHD-KKQTLEDTLNLYRSYFGLDEASLEKIANNFNVS-VDE 
Irgb6          240 AHKRHVFSLSLQSLTEATIN-YKRDSLKQKVFLEAMKAGALATIPLGGMISD-ILENLDETFNLYRSYFGLDDASLENIAQDLNMS-VDD 
Irgb10(rat)    248 AHKRHVFMQCLPSITERAID-RRRDALRQKIWLEALKYGASATIPMMCFFND-DIEELEKILTHYRGSFGLDDESLKNMASEWSMS-VEE 
Irgb10             ------------------------------------------------------------------------------------------ 
Irga3          254 AEKRQNFLLSLPNITEAAIQ-KKYNSTKQIIWLQATKDGLLATVPVVGILKDLDKERLKKRLDYYRDLFGVDDESLMFMAKDAQVP-VEL 
Irga8          254 AEKRHNFLLSLPNITEAAIQ-KKYNSPKQYIWLQAMEDGLLATVPAVGILKDLDKERLKRSLDYYRDLFGVDDESLMFMAKDAQVP-FEL 
Irga16(rat)    245 AEKRHNFLPSLPNITEAAIQTKKYNSTKQFIWLEAMKDGVLATVPVVGILNDLDMEGLQVSRPLG------SRGRIPSIPGGCPSA-VDL 
Irga4          253 VQKRHNFMLSLPNFTDQAID-RKYKATQQFIWLEAFKIGVVAIFPVLGNLRNKDMKKIKNTLNYYQKIFGVDDESLELVAKDFQVP-VEQ 
Irga7          254 AEKRHNFMLSLPGITEAAID-RKHKATQQIVWLEAFNVGLLANFPVTGILGDNDVKKLEKSLNYYRKIFGVDDESLELVAKDFQVP-VEQ 
Irga15(rat)    255 AQKRYNFMLSLPKITEAAID-RKHKAMQEFVWLEAFKTGALATIPALGILRDNDVEKLRQKLNNYRQLFGVDDESLEFMAKDFQVP-VAQ 
Irga12(rat)    252 VYKRHTFMLSLPNITDSTIE-MKRQCLKQRIWLEAFAADLLRILPSLTFLLDSDLETLKKCLKFYRTVFGVDDAALQSLAKDWQMP-LVE 
Irga11(rat)    253 VYKRHTFMLSLPNITDSTIE-MKRQCLKQRIWLEAFAADLLRILPSLTFLLDSDLETLKKCLKFYRTVFGVDDAALQSLAKDWQMP-LVE 
Irga13(rat)    252 VYKRHTFMLSLPNITDSAIE-KKRQSLKQKIWLEAFAADLLSIIPSLTFLLDSDLETLKKCLKFYRTVFGVDDAALQSLAKDWQMP-LVE 
Irga2          252 VFKRQNFMFSLPNITDSVIE-KKRNFLRWKTWLEGFADGLL------SFFLESDLETLEKSMKFYRTVFGVDDASLQRLARAWEIDQVDQ 
Irga6          253 IYKRHNFMVSLPNITDSVIE-KKRQFLKQRIWLEGFAADLVNIIPSLTFLLDSDLETLKKSMKFYRTVFGVDETSLQRLARDWEI-EVDQ 
Irga1          252 DYKRHNFMLSLPNITDSVIE-TKRQSLKQRHWLQGFAGVLLS------------------------------------------------ 
Irga5(rat)     250 THTYHNIMVSLPNITEAAIE-RKHTFIQQFIWLEAFKDGVLMTIPVVDTLKDSDVEKLKMSLNHYRVLFGVDDATLQFMAKDSQVP-VEQ 
Irga5(Edited)      ------------------------------------------------------------------------------------------ 
Irgd(rat)      258 GHKRHMFALLLPNISDASIE-LKKHFLQEKICLEALKSGAMSFIPFMPFISGFDLPQQEQCLKDYRSYFGLDDKSIEEIAERLETP-LED 
Irgd           258 GHKRHMFALLLPNISDASIE-LKKHFLREKIWLEALKSAAVSFIPFMTFFKGFDLPEQEQCLKDYRSYFGLDDQSIKEIAEKLGAP-LAD 
Irgc(rat)      237 AHRRHAGLLSLPDISLEALQ-KKKDMLQEQVLKTALVSGVIQALPVPGLAAAYDDALLIRSLRGYHRSFGLDDDSLAKLAEQVG-KQAGD 
Irgc           236 AHRRHAGLLSLPDISLEALQ-KKKDMLQEQVLKTALVSGVIQALPVPGLAAAYDDALLIRSLRGYHRSFGLDDDSLAKLAEQVG-KQAGD 
Irgm3(rat)     239 NIRYRDPLETLSQVCDKCIN-NKALSLKEDLMFTKHLEAAVSPPY----DIADLERSL----DTYQKLFGVDNESLRRVAQSTGRP-EMS 
Irgm3          263 SIRYRDPLEIISQVCDKCIS-NKAFSLKEDQMLMKDLEAAVSSED----DTANLERGL----QTYQKLFGVDDGSLQQVARSTGRL-EMG 
Irgm2(rat)     242 DIKYHGLLETLYQICENTIN-ERVESIKKIIDENNLQREFGILTP----DNLTETR------KVFQEIFGVDDQSLSQVSRSMEKP-DTH 
Irgm2          254 VIKYHGLVETLYQVCEKTVN-ERVESIKKSIDEDNLHTEFGISDP----GNAIEIR------KAFQKTFGLDDISLHLVALEMKN---KH 
Irgm1(rat)     240 NIRCCEPLKTLYVIYEKIIG-DKVANWNQIIANGRLKSSLGVRDD----DDMGECL------KRYRLIFGIDDESLQQIAHGMGTV-VME 
Irgm1          254 NIRCCEPLKTLYGTYEKIVG-DKVAVWKQRIANESLKNSLGVRDD----DNMGECL------KVYRLIFGVDDESVQQVAQSMGTV-VME 
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Irgb2          333 LKANIKSPHL--------FSDEPD-TSLTEKLLKYIGNP------------YFSKVFHLQNYFIDTVASDAKIILSKEELFTEQVSSFNS 
Irgb7          348 LKANIKSPHL--------LSDEPD-TSLTEKLLKYIGNP------------YFSKVFHLQNYFIDTVASDVKIILSKEELFTEQVSSFNS 
Irgb5          342 LKANIKSPHL--------LSDEPD-TSLTEKLLKYIGNP------------YFSKVFHLQNYFIDTVASDVKIILSKEELFTEQVSSFNS 
Irgb9          342 LKANIKSPHL--------LSDEPD-TSLTEKLLKYIGNP------------YFSKVFHLQNYFIDTVASDVKIILSKEELFTEQVSSFNS 
Irgb14(rat)    342 LKANIKSPHL--------LSYEPD-ISLRDKLLKYISHP------------YFSKVFHLQNYFIDAVASDVKLILSKEELLTNKVRSFNS 
Irgb3          329 IKAHLRFLQL--------FTKNND-MSFKEKLLKYIEYISCVTGGPLASGLYFRKTYYWQSLFIDTVASDAKSLLNKEEFLSEKPGSCLS 
Irgb4          349 IKAHLRSLQL--------FTKNND-MSFKEKLLKYIEYISCVTGGPLASGLYFRKTYYWQSLFIDTVASDAKSLLNKEEFLSEKPGSCLS 
Irgb8          329 IKAHLRSLQL--------LTKNND-MSFKEKLLKYIEYISCVTGGPLASGLYFRKTYYWQSLFIDTVASDAKSLLNKEEFLSEKPGSCLS 
Irgb1          349 IKAHLRSLQL--------LTKNND-MSFKEKLLKYIEYISCVTGGPLASGLYFSKTYYWQSLFIDTVASDAKSLLNKEEFLSEKPGSCLS 
Irgb13(rat)    349 IKAHIKSLHL--------LTENKD-MSFGEKLLKYIEYISSFTGGPLASGLYFRKTYYWKSLFIDTVASDAKALLNKEAFLSEKPGLRVS 
Irgb6          327 FKVHLRFPHL--------FAEHND-ESLEDKLFKYIKHISSVTGGPVAAVTYYRMAYYLQNLFLDTAANDAIALLNSKALFEKKVGPYIS 
Irgb10(rat)    335 LKSFINSPHL--------LSCEMN-ESVSDKMVKIMEKIFAVTGGLIATGLYFRKSYYMQNYFLDTVSEDAKILLKKKVFLQGSEDSE-- 
Irgb10             ------------------------------------------------------------------------------------------ 
Irga3          342 LIKNLKSPNL--------LKCKEETLEELLLNCVEK--FASANGGLLAAGLYFRKTYYLQFHFLDTVAEDAKVLLKAAQTHFAHSF---- 
Irga8          342 LKIKLKSPYL--------LELEEETLGGLILNCVEK--FASANGGLLATGLYFRKTYYLQFHFLDTVAEDAKVLLKEAY----------- 
Irga16(rat)    328 LKKENLNLLI--------CWKLRKRKHEYCFGTVWRNLLQLINDGFLATGLYFGKTYFLQTYFLDTVTEEPKVLLKEAYSKNIAQTQLAH 
Irga4          341 VKKTMKTPHL--------LKKYRE-ETFRNDFKKLVSTFG----RLLAVGLYFPAIYYLQLHILDTVTEDAKVLLRWKYSKPRSNSTYP- 
Irga7          342 VKEIMKSPHL--------LKTNGK-ETLGEKLLKYLEKFETATGGLLAVGLYFRKTYYLQLHFLDTVTEDAKVLLRWKYSKPRSNSTYP- 
Irga15(rat)    343 LKEILKSPHL--------LKTDRE-ETLQDKLLKYLEIFASANGGLLATGLYFRKTYYLQLHFLDTVAEDAKVLLQWKYSKH-------- 
Irga12(rat)    340 LEAMMKSPIV--------FKPTDE-ETIHERLSRYYHDYCSANGHLFTDDRDLREISYLKYYFLDIVTEDAKTLLKEICVRNKLVSN--- 
Irga11(rat)    341 LEAMMKSPIV--------FKPTDE-ETIHERLSRYYHDYCSANGHLFTDDRDLREISYLKYYFLDIVTEDAKTLLKEICVRNKLVSN--- 
Irga13(rat)    340 LEAKMKSPIV--------FKPTDE-ETIHERLSRYYRDFCLANGYLVTQNLYLREIFYLKFYFLDIVTEDSKTLLKEICLRNKLVS---- 
Irga2          335 VRAMIKSPAV--------FTPTDE-ETIQERLSRYNQEFCLANGYLLPKN-HCREILYLKLYFLDMVTEDAKTLLKEICLRN-------- 
Irga6          341 VEAMIKSPAV--------FKPTDE-ETIQERLSRYIQEFCLANGYLLPKNSFLKEIFYLKYYFLDMVTEDAKTLLKEICLRN-------- 
Irga1          293 ---------------------------------------------------------YLH------------------------------ 
Irga5(rat)     338 LRKIIKSPYL--------LETKKR-KALEGMLLKYMEKSASANGGLLATGLYFRKSFYLQLLFLDTVAEDAKVLLRETHSRN-------- 
Irga5(Edited)      ------------------------------------------------------------------------------------------ 
Irgd(rat)      346 IKGQLKCLDF--------WSFVKD-DSIIARARSAGEAFCSVKGGLGSSVVQALKVYYMRTQFLNVVVEDAKHLLRKMETVNIA------ 
Irgd           346 IKGELKCLDF--------WSLVKD-NSIIAQATSAAEAFCAVKGGPESSAFQALKVYYRRTQFLNIVVDDAKHLLRKIETVNVA------ 
Irgc(rat)      325 LRSVIRSPLANEVSPETVLRLYSQSSDGAMRVARAFERGIPVFGTLVAGGISFGTVYTMLQGCLNEMAEDAQRVRIKALEEDETQG-EVS 
Irgc           324 LRSVIRSPLANEVSPETVLRLYSQSSDGAMRVARAFERGIPVFGTLVAGGISFGTVYTMLQGCLNEMAEDAQRVRIKALEEDEPQGGEVS 
Irgm3(rat)     319 TRALQFQDL--------IKMDRRLRLMMCFVVNILLRVLGSPWWFGLWDVVTRYFRHQRQKRIIEIVAKNTKTSLRRALEDYTLPPEILC 
Irgm3          343 SRALQFQDL--------IKMDRRLELMMCFAVNKFLRLLESSWWYGLWNVVTRYFRHQRHKLVIEIVAENTKTSLRKALKDSVLPPEIH- 
Irgm2(rat)     320 YKASIESQE--------IQGYQQDGWPLVWLHRPVIQFFSTGLDRVPCCFYSPHHRYTQQKGVLDETAGKTKNFLWKILKDSISHLQKT- 
Irgm2          330 FNTSMESQE--------TQRYQQDDWVLARLYRTGTRVGSIGFDYMKCCFTSHHSRCKQQKDILDETAAKAKEVLLKILRLSIPHP---- 
Irgm1(rat)     318 YKANIKSQD--------FHTLRRADWKLRLMTCTTVNALFCLFKFLPCLCHCFKR--MRHKRMLLLVAKDTKNILKKILMDAVSPPQI-- 
Irgm1          332 YKDNMKSQN--------FYTLRREDWKLRLMTCAIVNAFFRLLRFLPCVCCCLRR--LRHKRMLFLVAQDTKNILEKILRDSIFPPQI-- 
 
Irgb2          402 KASPYREESVGKVFPVSPGSTFLFHFFEMFQSDSDKLCHVHVLLLLTSWGLSGETVT 
Irgb7          417 KASPYREESVGEVFPVGPGSTFLFHFFEMFQSDSDKLCHVHVLLLLTSWGLSGETVT 
Irgb5          411 KASLYREESVGKVFPVGPGSTFLFHFIEMFQSDSDELCHVHVLLLLTSGGLSSETVT 
Irgb9          411 KASPYWEESVGKVFPVGPGSTFLFHFFEMFQSDSDKLCHVHVLLLLTSWGLSGETVT 
Irgb14(rat)    411 NVSRQLF-------------------------------------------------- 
Irgb3          410 DLPEYWETGMEL--------------------------------------------- 
Irgb4          430 DLPEYWETGMEL--------------------------------------------- 
Irgb8          410 DLPEYWETGMEL--------------------------------------------- 
Irgb1          430 DLPEYWETGMEL--------------------------------------------- 
Irgb13(rat)    430 DHTEYWEAGMEL--------------------------------------------- 
Irgb6          408 EPPEYWEA------------------------------------------------- 
Irgb10(rat)        --------------------------------------------------------- 
Irgb10             --------------------------------------------------------- 
Irga3              --------------------------------------------------------- 
Irga8              --------------------------------------------------------- 
Irga16(rat)    410 SCRQLRDQRVNSRESLDKFML------------------------------------ 
Irga4              --------------------------------------------------------- 
Irga7              --------------------------------------------------------- 
Irga15(rat)        --------------------------------------------------------- 
Irga12(rat)        --------------------------------------------------------- 
Irga11(rat)        --------------------------------------------------------- 
Irga13(rat)        --------------------------------------------------------- 
Irga2              --------------------------------------------------------- 
Irga6              --------------------------------------------------------- 
Irga1              --------------------------------------------------------- 
Irga5(rat)         --------------------------------------------------------- 
Irga5(Edited)      --------------------------------------------------------- 
Irgd(rat)          --------------------------------------------------------- 
Irgd               --------------------------------------------------------- 
Irgc(rat)      414 LEAAGDNAVEKRSSGEGTSEEAPLSTRRKLGLLLKYILDSWKRRDLSEDK------- 
Irgc           414 LEAAGDNLVEKRSTGEGTSEEAPLSTRRKLGLLLKYILDSWKRRDLSEDK------- 
Irgm3(rat)     401 EGSGVPSSGIQAASGSFCIEP------------------------------------ 
Irgm3              --------------------------------------------------------- 
Irgm2(rat)         --------------------------------------------------------- 
Irgm2              --------------------------------------------------------- 
Irgm1(rat)         --------------------------------------------------------- 
Irgm1              --------------------------------------------------------- 
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V.8.Appendix Figure 4. Multiple alignment of dog  p47 GTPases. 
Alignment was performed using BCM search launcher with default options and highlighted 
using Boxshade server version 3.21. AA557 is the abbreviation of (AACN010048557). Highly 
degraded pseudogene (AACN010088820) is excluded from the protein alignment.  
 
IRGB11    1 -----------MGQSPPSTPSNRNGGDLASSFDKFFKEFKLDS-KIISQETISTIQSHLEKGDLQSAFSAINDALRDIDNAPLNIAVTGE 
IRGB12    1 ------------MGQSSSTPSHKTGGDLASSFGKFFKDFKLES-KILSQEAITSIEKSLKEGNLQKAVSDINKALKDIDNAPLSIAVTGE 
IRGD      1 -----------MDKFMCDFLVGKNFQQLAINFIPHYTTLVNKAGGIIASENLDRIQAALKEAKLKDVADIIEESLVAAENAPLDVAVIGE 
IRGM5     1 ----------------MTQPNHSLHIPLSTSFTSIVPYNMGWT--VLPKATATNIEKALGDGKLLEVVSMIRETLETVSSAPVSIAVTGD 
IRGM6     1 LHCFFPLLQVTPLLSDVTQPTHSLHTPLLTSSNYDMPYNMGWS--SLSKETAINIEKALGGRKLLEVVPMVRETLERASSVPLRIAVTGD 
IRGM4     1 ----------------MAQPTQSLHTPSPTSFTSTVPYHKGGS--ILSESGAMNIEKALGEGKLLDMVSVVRETLETASSVPVSIAVTGD 
IRGC      1 ---------------------------MATSKLRAVPGEEETT-ILMAKEELEALRSAFESGDIPQAASRLRELLASSQSIRLEVGVTGE 
AAC557    1 -----------------------------PMASRVFQSNFTWSKILELWRDTSALKGAFEVGDLPTVATKLQATLHLPENARLDTGITGG 
 
 
IRGB11   79 SGTGKSSFINALRGMGHDEEGAAPTGPVETTFLRKAYKHPKFPNVTFWDLPGIGTTSFQPQDYLEKMVFREYDFFIIICATRFKINDVQL 
IRGB12   78 SGTGKSSFINALRGVGHDEEGAAPIGAVETTFDRTEYKHRKFPNVTLWDLPGVGTTTFHPQEYLEKMKFREYDFFIIISSTRFTINDAQL 
IRGD     80 SGTGKSSFINALRGLSYEEEGSASVGVVETTMKKTPYQHPKYPKVTFWDLPGTGTPNFHPHEYLEMVEFATYDFFIIISSSRFSLNDALL 
IRGM5    73 SGNGMSSFINALREIGHDEKDSAPTGVVRTTQVPTCYSSSHFPYMELWDLPGTGTGTQSLENYLEKIHFSQYDLFIIIASEQFSMNLVKL 
IRGM6    89 SGNGMSSFINALRGIGHDEEDSAPTGVVKTTQIPTCYSYPHFPNVELWDLPGTGAGTQSLENYLEEMKFSWYDLFIIIASEQFSMNLVKL 
IRGM4    73 SGNGMSTFINALRKIGHNEEDSAPTGVVRTTQIPTCYSFSDIPNVELWDLPGTGAATQNLETYLEEMQFSKYDLFIIIASEQFSMNLVKL 
IRGC     63 SGAGKSSLINALRGVGAEDPGAALTGVVETTMQPSPYPHPQFPDVTLWDLPGAGSPGCPADKYLKQVDFGRYDFFLLVSPRRCGAVETRL 
AAC557   62 TGSGKSTFVNAIRGLGDEDPRSAYTGVVEMSVDPTPYAHPKYPNVVIWDLLGIDTPTFQAKKYLQQVLLDRYDFLLLITLESFTAHHTQL 
 
 
IRGB11  169 ATAIKKMKKNFYFVRSKVDSDLYNLKRIKPREFNKDEILQKIRNDCVKHLMEANMSDAQVFLVSSFELSDYDFQSLETTLLRELPSHKRH 
IRGB12  168 ATAIRKMKKNFYFVRSKVDSDLYNLKRTKPSDFNKDEILLKIRNDCITQLQNVKVCDPQVFLVSNLDLSSYDFQSLETTLLKELPAHKRH 
IRGD    170 AQNIKEIGKKFYFVRTKVDNDLYNEEKSKPMSFKRERVLQQIRDNCLANLSNIGVPEPCIFLVSNFDLDDFDFPRLEETLLKELPVHKRH 
IRGM5   163 VKAIQRQGKRFYIVWTKLDRDLS--TRVLP--E--EQVLQNIWENIQETLQKVGVCEPIIFLVSSFEPLLHDFPELRDALNRDISDIRYC 
IRGM6   179 AKAIQVLGKRFYIVWTKLDRDLS--TSALL--K--ERLLQNIQENIQENLQKERVFEPIIFLVSSFEPLLHDFPELRNTLNRDISDIRYC 
IRGM4   163 VKSIQGQGKRFYIVWTKLDRDLS--TCVLS--E--EQLLRNIRENIRETLHKEGVCEPIIFLVSSFNPFLHDFPELRKSLHRDISNIGYR 
IRGC    153 ASEILRQGKKFYFVRTKVDEDLAATRTQRPSGFSEAAVLQEIRDHCAERLRVAGMTDPRIFLVSNLSPARYDFPLLMSTWEHDLPAHRRH 
AAC557  152 ACEILQQGKRFYFIRSKVDVDMRPHAAGAP--------------------------------------APFQRKEHSARPGRTVGNG--- 
 
 
IRGB11  259 IFMQYLPIVTEATIDRKRDCLRQKVWLEAIKAGASASIPLVGYISDNDVETLKDTLTLYRSYFGLDDISLKTIAKDLNVSVEKLKANLMF 
IRGB12  258 IFMQYLPNITESAIDRKRDSLRQKVWLEAVKAGASATIPFMGLINDNEVEKLEETLHLYRSYFGLDDASLETIAKDLNVSVEKLKANLTS 
IRGD    260 IFALLLPNLSYTSIEMKRAFFKEKIWLDALKSSALSFIPFMACFNGFDFPQQEKCLNLYQSHFGLDEKSVKGIAEKLDMSVEEIKSFTKS 
IRGM5   247 GPLENLSDTCEKIINDKVTSFQEQIGSKTFQDILG----------IQDEDDLGQCLIAYHLFFGVDDKSLQQMAQSMGKPMEEYRAIMKS 
IRGM6   263 GPLKNLSHTYEKVISDKVTMFRGKIASKSFDTLG-----------IWNADDLGECLIAYHLFFGVDDESLQQIAQSMGKPMEEYRAIMKS 
IRGM4   247 GHLENLTHTCEKVINGKVTTLQGQIGSKSFQDILG----------IQNANDLGEFLNAYHRLFGVDDDSLQEVAQSMGKPKEEYKAIMKS 
IRGC    243 AGLLSLPDISLEALQKKKDMLQEQVLKTALVSGVIQALPVPGLAAAYDDALLIRSLRGYHRSFGLDDDSLAKLAEQVGKQAGDLRSVIRS 
AAC557  201 -------------------------WKVSLGSGR------------------------WKRVGALGVVDSGGMARPFPFLFQLRPTVGKG 
 
 
IRGB11  349 PHLLSVEKYDEPLGEKLLKYVEKFCSVSGGP----------IAAGIYFRKIYYLKNYFLDTVVSDAKVLLKKEEIFKDPVDSEQTYLHTN 
IRGB12  348 PHLLSVEKEDESLGEKLLRYVEKFCSVSGGL----------IATGVYFRKIFYLQNYFLEAVVSDAKVLLNKEEIFKETVGSGQAYLLQD 
IRGD    350 LDFWLLVK-DDSIAEKAMKCVECYCSVNGGL----------PSTIFQFFKIYFLHLKFINTVADDAKILLHKTLEILSHRR--------- 
IRGM5   327 QDVHTVLTGDWALSCMNCKTASYLYSILSYIPF--------LGDTVINYLRVWKHRHFLEIVAKDTRSIVKKILTDSII----------- 
IRGM6   342 RDLHTIIRGDWAVSCMNCNTSSCLYTILRYIPL--------LGDFIINFLRKWKHRRLLEIVAEDTRTILKKILKDSII----------- 
IRGM4   327 QDLHTALAWDWALSWMNCNAASYLYSVLSYIPI--------LGTTGIHYLKWWSQGHLLEIVAEDTKTILKKILEDAII----------- 
IRGC    333 PLANEVSP--ETVLRLYSQSSDGAMRVARAFEKGIPVFGTLVAGGISFGTVYTMLQGCLNEMAEDAQRVRIKALEEDEPQSEVSLEAAGD 
AAC557  242 SSKVTLRD---------------------------------------------------------------------------------- 
 
 
IRGB11  429 VGNENGKSDTSSS------------------------------- 
IRGB12  428 VGIENRKSDATSS------------------------------- 
IRGD        -------------------------------------------- 
IRGM5       -------------------------------------------- 
IRGM6       -------------------------------------------- 
IRGM4       -------------------------------------------- 
IRGC    421 NGVEKRGSGEGGCEEAPLSARRKLGLLLKYILDSWKKRDLSEEK 
AAC557      -------------------------------------------- 
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V.9.Appendix Figure 5. Multiple alignment of C. elegans  and classical mouse p47 
GTPases. 
Alignment was performed using BCM search launcher with default options and highlighted 
using Boxshade server version 3.21. C46E1.3 was devided into two sequence and edited to align 
properly with other p47 GTPases. 
 
Irga6         1 -------MGQLFSSPKSDENNDLPSSFTGYFKKFNTGRKIISQEILNLIELRMRKGNIQLTNSAISDALKEIDSSVLNVAVTGETGSGKS 
Irgb6         1 --------------------MAWASSFDAFFKNFKRESKIISEYDITLIMTYIEENKLQKAVSVIEKVLRDIESAPLHIAVTGETGAGKS 
Irgd          1 --MDQFISAFLKGASENSFQQLAKEFLPQYSALISKAGGMLSPETLTGIHKALQEGNLSDVMIQIQKAISAAENAILEVAVIGQSGTGKS 
Irgc          1 ------------------------MATSRLPAVPEETTILMAKEELEALRTAFESGDIPQAASRLRELLANSETTRLEVGVTGESGAGKS 
Irgm1         1 MKPSHSSCEAAPLLPNMAETHYAPLSSAFPFVTSYQTGSSRLPEVSRSTERALREGKLLELVYGIKETVATLSQIPVSIFVTGDSGNGMS 
C46E1.3(1)    1 -------------------------------------------------------------------GAFPIDANRKNFGFCGRSGSGKS 
C46E1.3(2)    1 -------------------------------------------------------------------MIRRAGKTCFNYGFIGGRGVGKS 
W09C5         1 -----------------------------MSSRTANSSSRNDESLRTGQHKENPNYWGFANFPNQVFRRAVKNGFDFTLMVVGRSGLGKS 
 
 
Irga6        84 SFINTLRGIGNE---EEGAAKTGVVEVTMERHPYKHPNIP-----NVVFWDLPGIGSTNFPPNTYLEKMKFYEYDFFIIISATRFKKNDI 
Irgb6        71 TFINTLRGVGHE---EKGAAPTGAIETTMKRTPYPHPKLP-----NVTIWDLPGIGTTNFTPQNYLTEMKFGEYDFFIIISATRFKENDA 
Irgd         89 SFINALRGLGHE---ADESADVGTVETTMCKTPYQHPKYP-----KVIFWDLPGTGTPNFHADAYLDQVGFANYDFFIIISSSRFSLNDA 
Irgc         67 SLINALRGLGAE---DPGAALTGVVETTMQPSPYPHPQFP-----DVTLWDLPGAGSPGCSADKYLKQVDFGRYDFFLLVSPRRCGAVES 
Irgm1        91 SFINALRVIGHD---EDASAPTGVVRTTKTRTEYSSSHFP-----NVVLWDLPGLGATAQTVEDYVEEMKFSTCDLFIIIASEQFSSNHV 
C46E1.3(1)   24 SLINSLRGLNNG---DPQSAGR-SHCDRMEPFRFIEGEFQ-----QIVLWEIPYPRTFSSSSVVFDANMGFEKLYESHKLKLFKR---LF 
C46E1.3(2)   24 SLIDAMRGMSSK---NPLSATKLNNRSKAGSCERFEFDDN-----VLKYSVTLYELSYPKKISSYFEFIDLVNVASFTALFILVD----- 
W09C5        62 TFINTLFLAEINNLNEKESAPTHPHPSTVRVEEKLVKLVENSVSLNLTLVDTPGFGDAVNNSKCWEPIVNYVESKFFEQFCEETRIDRGE 
 
 
Irga6       166 DIAKAISMMKKEFYFVRTKVDSDITNEADGKPQTFDKEKVLQDIRLNCVNTFRENGIAEPPIFLLSNKNVCHYDFPVLMDKLISDLPIYK 
Irgb6       153 QLAKAIAQMGMNFYFVRTKIDSDLDNEQKFKPKSFNKEEVLKNIKDYCSNHLQESLDSEPPVFLVSNVDISKYDFPKLETKLLQDLPAHK 
Irgd        171 LLAQKIKDAGKKFYFVRTKVDSDLYNEQKAKPIAFKKEKVLQQIRDYCVTNLIKTGVTEPCIFLISNLDLGAFDFPKLEETLLKELPGHK 
Irgc        149 RLASEILRQGKKFYFVRTKVDEDLAATRSQRPSGFSEAAVLQEIRDHCTERLRVAGVNDPRIFLVSNLSPTRYDFPMLVTTWEHDLPAHR 
Irgm1       173 KLSKIIQSMGKRFYIVWTKLDRDLSTS------VLSEVRLLQNIQENIRENLQKEKVKYPPVFLVSSLDPLLYDFPKLRDTLHKDLSNIR 
C46E1.3(1)  102 ILIPDGAPTDEDITFARVALSRRTSIT-----------FLLTKSDEDLDAENRENG-------------------TKLDQAMKRSYETSA 
C46E1.3(2)  101 -----QTPSEQDLAFAKIAYRRNTTIL-----------FLISKCDKKLAARSRSDE-------------------IPVCDLLKQRYIDKA 
W09C5       152 KIVDKCVHLCLYFIEPSGHGLKPIDIELMKHLHGRVN-IVPVISKADCLTRDELLRFKKQIVKDAETAEIKLYKFPELEDPYTDKVAIEK 
 
 
Irga6       256 RHNFMVSLPNITDSVIEKKRQFLKQRIWLEGFAADLVNIIPSLTFLLDSDLETLKKSMKFYRTVFGVDETSLQRLARDWEIEVDQVEAMI 
Irgb6       243 RHVFSLSLQSLTEATINYKRDSLKQKVFLEAMKAGALATIP-LGGMISDILENLDETFNLYRSYFGLDDASLENIAQDLNMSVDDFKVHL 
Irgd        261 RHMFALLLPNISDASIELKKHFLREKIWLEALKSAAVSFIPFMTFFKGFDLPEQEQCLKDYRSYFGLDDQSIKEIAEKLGAPLADIKGEL 
Irgc        239 RHAGLLSLPDISLEALQKKKDMLQEQVLKTALVSGVIQALPVPGLAAAYDDALLIRSLRGYHRSFGLDDDSLAKLAEQVGKQAGDLRSVI 
Irgm1       257 CCEPLKTLYGTYEKIVGDKVAVWKQRIANESLKNSLGVRDD--DNMG--------ECLKVYRLIFGVDDESVQQVAQSMGTVVMEYKDNM 
C46E1.3(1)  162 RLVFSRYLLSKAQILNDVELLFVNAPTARNLVSGTVGYLHY--LMNE------------ERLLEL-LDLNTGCHYELEVRLRKERDNTET 
C46E1.3(2)  156 LQKFDNIMADKAAELRGRINVFFVSAPVFKALRMGDPRESQ--FVLH--------------------ER-AMFDFLKSRRMIADMLDDPP 
W09C5       241 LRKALPFAIIGSNMLKEKDGKKIRYREYPWGTVEVENMQHNDFLTLRDMIIRTNLIDMIDVTRNVHYENFRFRQMEGLPKNEKNRDPFTH 
 
 
Irga6       346 KSPAVFKPTDEETIQER---------LSRYIQEFCLANGYLLPKNSFLKEIFYLKYYFLDMVTEDAKTLLKEICLRN------------- 
Irgb6       332 RFPHLFAEHNDESLEDK---------LFKYIKHISSVTGGPVAAVTYYRMAYYLQNLFLDTAANDAIALLNSKALFEKKVGPYISEPPEY 
Irgd        351 KCLDFWSLVKDNSIIAQ---------ATSAAEAFCAVKGGPESSAFQALKVYYRRTQFLNIVVDDAKHLLRKIETVNVA----------- 
Irgc        329 RSPLANEVSPETVLRLYSQSSDGAMRVARAFERGIPVFGTLVAGGISFGTVYTMLQGCLNEMAEDAQRVRIKALEEDEPQGGEVSLEAAG 
Irgm1       337 KSQNFYTLRREDWKLRL----------MTCAIVNAFFRLLRFLPCVCCCLRRLRHKRMLFLVAQDTKNILEKILRDSIFPPQI------- 
C46E1.3(1)  237 TKPINGNIETYRLEEKQ----------------------IPQAQAYAVSRPTILADAGFEISFGTDDRIYQSLEPKT------------- 
C46E1.3(2)  223 GEGVYAQLDLDTAGVH-------------------------------------------------------------------------- 
W09C5       331 LEEERRQKEQDLDEKRN---------TLEKVFTEKTSARKKRSDERMSALEELEQQNKQKIDAKRAEIIRLRHEISELKNGNLTSSQTSL 
 
 
Irga6           ------------------------------------------------ 
Irgb6       413 WEA--------------------------------------------- 
Irgd            ------------------------------------------------ 
Irgc        419 DNLVEKRSTGEGTSEEAPLSTRRKLGLLLKYILDSWKRRDLSEDK--- 
Irgm1           ------------------------------------------------ 
C46E1.3(1)      ------------------------------------------------ 
C46E1.3(2)      ------------------------------------------------ 
W09C5       412 AMYNENNHSQNSTLNSTTKSSPPPTSATSSSSGTMKKRMGGLGLFNRN
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VII.SUMMARY 
 
The interferon-inducible p47 GTPases are probably the most powerful resistance system 
in the mouse against intracellular pathogens. It is shown that the genome of the C57BL/6 mouse 
contains 23 p47 GTPase genes on chromosomes 7, 11 and 18 of which only 6 have previously 
been described. Among these are 2 probable pseudogenes. Of the 6 p47s thus far published, four 
have been knocked out and all of them have pathogen-sensitive phenotypes. By implication, 
others among this large family are also probably functional and required for normal pathogen 
resistance. Published differences in pathogen resistance profile, extensive divergent sequence 
evolution and radically differentiated intracellular behaviour suggest that the individual proteins 
have been selected for distinct functions, no doubt against distinct intracellular pathogens or 
pathogen classes.  
Surprisingly, there are no reports of p47 GTPase function in human. The human genome 
has only one complete p47 GTPase gene, (IRGC) on chromosome 19, which is 90% identical at 
the protein level to mouse Irgc.  IRGC is expressed in testis and syntenic between the two 
species.  A p47 gene fragment (IRGM) is present on human chromosome 5 in a region syntenic 
to mouse chromosome 18 and mouse chromsome 11. This fragment is transcribed in 5 different 
spliced forms but no protein is detected. The expression profile of IRGM is regulated by a ERV9 
retroviral elements containing promoter. Both of the human genes, IRGC and IRGM, are not 
induced by interferons. Therefore, human has no interferon-inducible p47 GTPase resistance 
system.  
 This different distribution of p47 GTPases in the two mammals has led to a broader 
investigation of the systematics of these interesting proteins. It is shown that the human has lost 
the immunologically functional members during mammalian evolution. The p47 GTPases are 
documented down to the dog, rat and bony fishes and shown that dramatic gain and also loss of 
the family member is going on in these ancient taxonomic groups as well. Variable number of 
p47 GTPases in different species is probably a mechanism to generate diversity of p47 GTPases 
acting on pathogens which are usually known to be fast evolving.
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VIII.ZUSAMMENFASSUNG 
 
Die Interferon induzierbaren p47-GTPasen sind vermutlich das wirkungsvollste 
Resistenzsystem gegen intrazelluläre Pathogene in der Maus. In dieser arbeit es wurde gezeigt, 
dass das Genom der C57BL/6 Maus dreiundzwanzig p47-GTPase-Gene, auf den Chromosomen  
7, 11 und 18, enthält, von welchen sechs früher bereits beschrieben wurden. Zwei diser Gene 
sind wahrscheinlich Pesudogene. Vier der früher sechs publizierten p47-GTPasen wurden durch 
gezielte Mutagenese deaktiviert, die Phänotypen zeigten alle eine erhöhte Anfälligkeit gegenüber 
Pathogenen. In diesen Zusammenhang wird vermutet, dass auch die anderen Mitglieder dieser 
großen Familie funktional sind und für eine normale Resistenz gegenüber Pathogenen benötigt 
werden. Die veröffentlichten Unterschiede in der vermittelten Resistenz gegenüber Pathogenen, 
eine umfassende divergierende Sequenzevolution und radikale Unterschiede im intrazellulären 
Verhalten, lassen vermuten, dass die einzelnen Proteine für verschiedene Funktionen ausgewählt 
wurden, ohne Zweifel gegen verschiedene intrazelluläre Pathogene beziehungsweise 
Pathogenklassen. 
Überaschenderweise, wurde keine p47-GTPase Funktion bei Menschen berichtet. Das 
menschliche Genom hat nur ein vollständiges p47-GTPase-Gen (IRGC) auf dem Chromosom 
19, dieses ist auf dem Proteinlevel zu 90% mit Irgc aus der Maus identisch. IRGC wird in den 
Testes exprimiert und ist synthenisch in den beiden Arten. Ein p47-GTPase-Genfragment 
(IRGM) befindet sich auf dem menschlichen Chromosom 5, in einer Region welche synthenisch 
zu Maus Chromosom 18 und 11 ist. Dieses Fragment wird in fünf verschiedenen Spleißformen 
transkribiert, ein Protein wurde nicht detektiert. Das Expressionsprofil des IRGM wird durch 
einen Promotor reguliert, der ein ERV9 retrovirales Element enthält. Beide menschlichen Gene, 
IRGC und IRGM, sind durch Interferone nicht induzierbar. Deshalb besitzt der Mensch kein 
Interferon induzierbares p47-GTPase Resistenzsystem. 
Die unterschiedliche Verteilung der p47-GTPasen in den zwei Säugern veranlasste eine 
umfassende Untersuchung der Systematik dieser interessanten Proteine. Es wurde gezeigt, dass 
der Mensch die in die Immunologie involvierten Mitglieder dieser Familie während der 
Säugerevolution verloren hat. Die p47-GTPasen wurden bis Hund, Ratte und den 
Knochenfischen dokumentiert. Es wurde ebenfalls ein dramatischer zugewinn und Verlust von 
Familienmitgliedern in dieser taxonomisch alten Gruppe gezeigt. Die variable Anzahl der p47-
GTPasen in unterschiedlichen Arten ist vermutlich ein Mechanismus um Diversität in der 
Familie der p47-GTPasen, deren Mitglider auf gewöhnlich schnell evolvieren Pathogene 
einwirken, zu generieren.
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